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Abstract 
As direct effector cells for osteogenesis, osteoblastic lineage cells are commonly 
used to evaluate the in vitro osteogenic capacity of bone biomaterials. This strategy 
has achieved a degree of success in developing novel bone biomaterials; however, 
inconsistencies between in vitro and in vivo studies are common, indicating that the 
mechanisms that govern the material’s capacity to mediate osteogenesis are still not 
well understood. Osteoimmunology has revealed the important role of immune cells 
in the regulation of bone formation and remodelling. This has informed a paradigm 
shift in the development of bone biomaterials, from an inert to an 
osteoimmunomodulatory material, highlighting the important role of immune cells in 
materials-mediated osteogenesis. Neglecting the importance of the immune response 
can be a major shortcoming when assessing materials, and may explain the 
inconsistent results between in vitro and in vivo experiments. Therefore, this thesis 
aims to introduce the intellectual framework of osteoimmunology into the field of 
bone biomaterials to optimise development and assessment strategies of novel and 
clinically useful materials.  
First, the involvement of immune cells (macrophages) in the bone biomaterials (β-
tricalcium phosphate, β-TCP)-mediated osteogenesis was demonstrated. β-TCP 
elicited significant effects on macrophages, resulting in the M2 phenotype switch, 
involving the inhibition of gene expression of pro-inflammatory cytokines. The 
osteogenic differentiation of bone marrow stroma cells (BMSCs) was enhanced by 
the macrophages/β-TCP conditioned medium compared with that of the β-TCP 
material extract, which can be correlated to the release of bone morphogenetic 
protein 2 (BMP2) from β-TCP stimulated macrophages. Together, these results 
indicate that the materials-mediated immune response actively participates in 
subsequent osteogenesis and must, therefore, be taken into account when developing 
and assessing bone biomaterials. 
Next, the concept of osteoimmunomodulation was applied to refine the evaluation of 
the in vitro osteogenic potential of a biomaterial, by adding immune cells to the 
interaction between the biomaterial and bone cells. This approach altered the in vitro 
dynamics resulting in a significant different response of the bone cells compared to 
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the control condition in which no immune cells were involved. CCP (cobalt 
incorporated tricalcium phosphate) extract by itself was sufficient to enhance 
osteogenic differentiation of BMSCs, whereas in the presence of macrophages this 
effect was negated. The results from the trilateral interaction between biomaterial, 
immune cells and bone cells better reflected subsequent in vivo outcomes. When the 
CCPs were implanted into defects in the femoral condyle, this manifested itself by an 
increase of inflammatory markers and bone destruction, coupled with fibrous 
encapsulation, as opposed to new bone formation. This trilateral system of 
biomaterial, immune cells and bone cells system is a sufficient in vitro assessment 
protocol that provides a more accurate picture of material-stimulated osteogenesis 
compared to the standard bilateral approach.   
Finally, the concept of osteoimmunomodulation was also applied to the development 
of bone biomaterials with the result of more favourable osteoimmunomodulatory 
properties. For example, coating magnesium scaffolds with β-TCP resulted in these 
scaffolds having osteoimmunomodulatory properties that greatly enhanced in vitro 
osteogenesis. In another study, nutrient elements (silicon, strontium, and magnesium) 
were combined and coated on a titanium substrate. This novel coating material was 
found to elicit a beneficial osteoimmunomodulatory response, with high bonding 
strength between the coating material and the metal substrate.  
In conclusion, the central concept of this thesis is the importance of 
osteoimmunomodulation as an integral component in both the development and 
assessment of bone biomaterials. It is the candidate’s ambition to highlight the need 
for an appreciation of fundamental principles pertaining to bone biology when 
seeking to develop novel bone biomaterials. Introducing the conceptual framework 
of osteoimmunology is set to radically alter the traditional methods for bone 
biomaterials assessment and contribute to the development of new bone biomaterials 
with osteoimmunomodulatory properties that enhance bone repair and regeneration. 
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1.1  RESEARCH PROBLEMS 
Bone defects are relatively common and typically caused by traumatic fractures, 
tumour resections, aseptic necrosis, osteolysis, osteomyelitis, periodontitis, and spine 
fusion–injuries that often require surgical reconstructions. The market for bone graft 
substitutes is valued at US$1.9 billion in 2010 and is forecast to reach US$3.3 billion 
by 2017, a compound annual growth rate of 8.3% [1]. To meet this demand, a 
number of bone substitute materials have been developed and applied clinically, 
achieving some clinical success [2-5]. However, the majority of these bone 
biomaterials are still not ideal, and require further modifications to optimise their 
bone regenerative capacity.  
Due to the direct relationship between osteoblastic cells and bone formation, the 
major principle for developing bone biomaterials has been to focus on the material’s 
in vitro osteogenic potential of osteoblastic cells and then follow up with an animal 
study to determine the material’s in vivo osteogenic potential. This has been a 
relatively successful approach giving rise to fabrication methods that can tailor bone 
biomaterials with the desired level of osseointegration and osteogenesis. These 
techniques are now so advanced that material scientists can now prepare bone 
biomaterials with specific physicochemical and mechanical properties (from nano to 
particle size, from 2D to customised 3D structure, hydrophilic or hydrophobic, etc). 
However, this approach seldom leads to clinically useful implant materials, with 
many candidate materials failing to make it beyond the confines of the laboratory. 
When trying to determine possible reasons for this lack of success, the focus tends to 
be on optimising the composition, physicochemical and mechanical properties of the 
candidate materials, whereas basic biological principles are often overlooked. Bone 
biology has made great leaps forward in recent years and the molecular mechanisms 
that govern osteogenesis are now much better understood than they were even a 
decade ago. It is now realized that osteogenesis is not simply the product of bone 
cells in the skeletal system, but is rather a collaboration of multiple systems 
(coagulation system, immune system, skeletal system). This points to a possible 
culprit for the low rate of success of bone biomaterials in animal and clinical trials 
and suggests that the biomaterial sciences have not yet caught up with the increased 
knowledge of bone biology in general and osteoimmunology in particular. Therefore, 
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in order to produce an ideal bone biomaterial, it is necessary to keep abreast with the 
latest findings from bone biology and adapt ones’ design parameters to reflect this 
new knowledge. 
Osteoimmunology stands out as one of the greatest conceptual breakthroughs in the 
area of bone biology in recent decades. The immune and skeletal systems were found 
to be closely related, sharing a number of cytokines, receptors, signalling molecules 
and transcription factors [6, 7]. Immune cells play a key role in bone homeostasis 
and inappropriate immune responses, such as excessive inflammation, can lead to 
pathological bone destruction. An implant is immediately recognised by the immune 
system as a foreign body and this triggers a significant immune reaction that affects 
the biological behaviours of bone cells. The nature and magnitude of such an event 
may eventually determine the in vivo fate of bone biomaterials: it either becomes 
entrapped by a fibrous capsule or is replaced by new bone [8, 9]. The immune 
response may, therefore, be a key factor missing when evaluating and developing 
useful bone biomaterials.  
The principal aim of this thesis is to introduce the topic of osteoimmunology as set of 
principles that forms a cornerstone in the field of bone biomaterials development and 
assessment. It is anticipated that such modifications will usher in a new generation of 
bone biomaterials capable of modulating the local immune environment such that 
osteogenesis and the osseointegration of the implant is greatly enhanced. In addition, 
this thesis seeks to introduce advanced bone biological concepts into the bone 
biomaterials field, thus inspiring greater efforts into application of biological 
principles that will lead to the development of ‘smart’ bone biomaterials that can 
meet the expected increase in clinical demand.    
1.2 HYPOTHESIS AND AIMS 
A number of studies have been conducted into materials-mediated immune reactions. 
The conclusions that can be drawn from these studies in that the design paradigm for 
advanced bone biomaterials, must shift from producing materials that elicits 
relatively inert physiological responses to materials with immunomodulatory 
properties, emphasising the important role of immune responses [8, 10, 11]. Most 
bone biomaterials studies have, up until now, tended to focus on the biocompatibility 
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of biomaterials, that is, whether or not the materials are tolerated by the host immune 
system. The effect of biomaterials-induced immune reaction on osteogenesis is 
typically neglected. In the light of the well-documented importance of the immune 
response during bone regeneration, it is reasonable to hypothesize that immune cells 
participate actively and elicit significant effects in material-stimulated 
osteogenesis, and that given an appropriate degree of alteration of the 
physicochemical and mechanical properties of biomaterials, it is possible to modify 
osteoimmunomodulation in such a way that it favours osteogenesis. To test this 
hypothesis, the first aim of this thesis is to prove the involvement and investigate the 
roles of immune cells in the materials-mediated osteogenesis. A novel biological 
property of bone biomaterial, the osteoimmunomodulatory property, was proposed in 
coincidence with the modulatory effects of bone biomaterials on immune cells and 
the regulatory effects of immune cells on bone dynamics.  
Armed with this knowledge, we then sought to redefine how to more accurately 
assess the in vitro osteogenic capacity of bone biomaterials. These findings allow us 
to refine the design principles and paradigms of bone biomaterials, and the rest of 
this thesis describes how we attempted to develop novel bone biomaterials with 
osteoimmunomodulatory property more favourable for bone regeneration. It is the 
overall ambition of this thesis to institute a significant change in how to conduct in 
vitro assessments of bone biomaterials, in the hope that this will aid in developing 
new bone biomaterials with favourable osteoimmunomodulatory property for bone 
tissue engineering. 
The specific aims of this thesis are the following: 
Aim 1: To demonstrate the involvement and possible roles of immune cells in 
biomaterials-stimulated osteogenesis; 
Aim 2: To optimise the assessment strategy for the in vitro osteogenic capacity of 
bone biomaterials; 
Aim 3: To develop novel bone biomaterials with a favourable osteoimmuno-
modulatory property. 
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1.3 LINKAGES BETWEEN THE RESEARCH PAPERS 
The thesis was designed as three separate parts, based on the specific aims described 
above. The detailed project design, methods and materials relating to each research 
paper is contained within the relevant chapters.  
Part 1: To demonstrate the involvement and possible roles of immune cells in 
biomaterials-stimulated osteogenesis. (Chapter 3 Research paper 1) 
In this part, β-tricalcium phosphate (β-TCP) was applied as a model bone substitute 
material, while macrophages were applied as model immune cells. β-TCP was first 
used to stimulate macrophages, to get an indication whether bone substitute materials 
could elicit a measurable effect on the response of immune cells. Then, the 
osteogenic effects of β-TCP/macrophages were evaluated by stimulating bone 
marrow stroma cells (BMSCs) with macrophage conditioned β-TCP material extract, 
to assess if an immune environment modified by bone substitute materials had a 
direct effect on the materials-mediated osteogenesis.  
One paper was generated from this work: Zetao Chen, Chengtie Wu, Wenyi Gu, 
Travis Klein, Ross Crawford, Yin Xiao. Osteogenic differentiation of bone marrow 
MSCs by β-tricalcium phosphate stimulating macrophages via BMP2 signalling 
pathway. Biomaterials, 2014, 35(5): 1507-18. (IF: 8.557). 
Additional in vivo experiments (not included in the publication) were also carried out 
to further support the notion that β-TCP could elicit significant effects on modulating 
the local immune response. β-TCP was implanted subcutaneously in the back of rats. 
After 2, 5, 7 days, the samples were collected to determine the release of 
inflammatory cytokines and the changes with the increase of time. 
Part 2: To optimise the assessment strategy for the in vitro osteogenic capacity 
of bone biomaterials. (Chapter 4 Research paper 2) 
With the knowledge obtained above, the materials/immune cells/bone cells biomimic 
evaluation system was proposed and considered to be more accurate and sufficient 
for the in vitro osteogenic capacity evaluation. β-TCP and cobalt incorporated 
tricalcium phosphate (CCP) were applied as model bone substitute materials, while 
macrophages were applied as model immune cells in this part. The CCP material had 
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already been developed by our group [12] and was chosen as a model bone substitute 
material since it is known that cobalt has a physiological effect on both immune cells 
and BMSCs. We applied both a “traditional” evaluation system (materials/bone cells) 
and the proposed trilateral system (materials/immune cells/bone cells) to evaluate the 
in vitro osteogenic capacity of the novel bone substitute material CCP. This was 
followed by an animal study to compare the predictive power of each approach and 
whether a trilateral assessment protocol had any merit as a predict tool of a material’s 
in vivo osteogenic potential.  
One paper was generated from this part: Zetao Chen, Jones Yuen, Ross Crawford, 
Jiang Chang, Chengtie Wu, Yin Xiao. The effect of osteoimmunomodulation on 
the osteogenic effects of cobalt incorporated β-tricalcium phosphate. Biomaterials, 
2015, 61: 126-38. (IF: 8.557). 
Part 3: To develop novel bone biomaterials with a favourable osteoimmuno-
modulatory property. (Chapters 5-6 Research paper 3-4) 
The work preceding Part 3 highlights the importance of endowing bone biomaterials 
with osteoimmunomodulatory properties that favours osteogenesis. In this section, 
we described how a magnesium based scaffold was coated with β-TCP to modify the 
physiologically detrimental properties of Mg to make it more conducive to 
osteogenesis. This was the first time of applying the concepts and knowledge 
acquired about osteoimmunomodualtion, in an effort to manipulate the biological 
properties of a biomaterial. The method described here, of manipulating the 
osteoimmunomodulatory property of a material, represents a novel and effective 
method to develop and modify bone biomaterials. 
One paper was generated from this part: Zetao Chen, Xueli Mao, Lili Tan, Thor 
Friis, Chengtie Wu, Ross Crawford, Yin Xiao. Osteoimmunomodulatory properties 
of magnesium scaffolds coated with β-tricalcium phosphate. Biomaterials, 2014, 
35(30):8553-65. (IF: 8.557). 
In addition to applying the concept of osteoimmunomodulation to endow potential 
bone biomaterials with superior osteogenic effects, novel bone biomaterials with 
osteoimmunomodulatory properties were also fabricated. Certain nutrient elements 
are known to regulate osteogenesis, osteoclastogenesis and immune reactions. The 
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use of such nutrient elements when developing novel bone biomaterials represents a 
promising strategy. In this section, a novel type of coating material combining three 
different nutrient elements (Sr2MgSi2O7) was used to coat titanium implants in order 
to manipulate their osteoimmunomodulatory properties. This resulted in the 
modulation of the immune environment which favoured osteogenesis over 
osteoclastogenesis, thereby enhancing osseointegration.  
One paper was published from this section: Chengtie Wu, Zetao Chen (Co-first 
author), Deliang Yi, Jiang Chang, Yin Xiao. Multidirectional effects of Sr, Mg and 
Si-containing bioceramic coatings with high bonding strength on inflammation, 
osteoclastogenesis and osteogenesis. ACS Applied Materials & Interfaces, 2014, 6 
(6), 4264-76. (IF: 6.723). 
In Chapter 7, the findings from these studies were summarised and their 
implications were discussed. A definition of osteoimmunomodulation was elaborated 
upon, and the utility of the methods of its evaluation and strategies to manipulate this 
property was discussed.  
One review paper has been generated from the Introduction, Literature review and 
Conclusions sections: Zetao Chen, Travis Klein, Rachael Z Murray, Jiang Chang, 
Ross Crawford, Chengtie Wu, Yin Xiao. Osteoimmunomodulation for the 
development of bone biomaterials. Materials Today, 2015 (IF: 14.107, Under 
revision).  
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2.1 OVERVIEW OF THE INTEGRATION BETWEEN BONE TISSUE AND 
IMPLANTS 
The mechanism underlying bone biomaterial-mediated osteogenesis involves at least 
three interactive components: the host immune cells, the host bone cells and the 
materials. Following implantation, the host body will first undergo a universal 
response to the materials, which is an extension of the mammalian response 
following tissue injury. Proteins from blood and interstitial fluids, such as fibrinogen, 
vitronectin, complement, and fibronectin [8], will adsorb to the material’s surfaces 
within seconds and then form a transient surface matrix. In response, the coagulation 
cascade and complement systems are activated, leading to thrombus formation and 
the activation of other cell populations. 
After the initial blood/material interaction, an acute inflammation is initiated, which 
features the recruitment and activation of neutrophils, or polymorphonuclear 
leukocytes (PMNs). PMNs, in an effort to degrade the materials, release proteolytic 
enzymes and reactive oxygen species (ROS) [13], which will corrode the surface of 
the material. The PMNs rapidly become exhausted, undergoing apoptosis and 
disappearing from the implantation sites within the first two days [14]. Mast cells are 
also active participants in the acute inflammatory reaction and degranulation of these 
cells leads to the release of inflammation-enhancing cytokines and histamine, which 
amplify the immune reaction [15]. 
Chemoattractants and activation cytokines released in the previous phase result in 
monocyte recruitment to the implant, where the monocytes differentiate into 
macrophages. Macrophages are able to engulf particles of up to 5 µm [8, 16]; if the 
particle size is larger, the macrophages will coalesce to form foreign body giant cells 
(FBGCs), driven by stimulation with interleukin 4 (IL-4) and IL-13 [17]. The foreign 
components and molecules released during the host-body/implant interaction can 
positively regulate osteogenic differentiation to form new bone on the surface of the 
implant and entrap it. In the bone remodelling phase newly formed bone undergoes 
functional remodelling and some entrapped implant materials, such as calcium- 
phosphor based bioceramics, can be further degraded. Functional loading and 
mechanical strain is the main cause for the remodelling. Osteocytes are known to 
translate signals related to mechanical strain into biochemical signals and regulate 
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osteoblasts and osteoclasts and, therefore, may play a regulatory role in this late stage 
[18-20]. 
The close relationship that exists between the immune and skeletal systems makes 
the proposition that stimulated immune cells may contribute to both the success and 
failure of an implant seem feasible (Figures 1, 2 and 3). The immune cells would 
exert this effect by releasing cytokines that regulate osteogenesis, –in addition to 
their well-known effects on inflammation, –thus inducing or inhibiting bone 
formation. The immune response to bone biomaterials has both beneficial and 
detrimental effects in regulating osteogenesis. A favourable immune reaction creates 
an osteogenic microenvironment that can improve osteogenesis, whereas an 
inappropriate immune reaction may lead to chronic inflammation and the formation 
of a fibrous capsule around the implant.  
 
 
Figure 1 Schematic illustration of bone biomaterials-mediated de novo bone 
formation. This process can be divided into three phases (early, bone formation, and 
bone remodelling), with the involvement of multiple systems (coagulation system, 
immune system, and skeletal system). The most likely macrophage phenotype switch 
pattern is also presented. The early stage of the repair response is dominated by the 
inflammatory phase, when the majority of macrophages would be of the 
inflammatory M1 phenotype. An efficient and timely switch from M1 to M2 
macrophage phenotype results in an osteogenesis-enhancing cytokine release and 
with it the formation of new bone tissue. Adopted from [21].  
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The capsule formed by the foreign body reaction (FBR) effectively separates the 
implant from the surrounding environment, such that it can remain safely in the host 
body throughout its lifetime [22]. However, this renders the implant an “inert” 
mechanical support, a scenario which fails to meet the demands of a bone substitute 
material since it is intended to induce new bone formation and fill the defect space 
with fully functional bone. A fibrous encapsulation prevents direct interaction 
between bone marrow and the implants such that bone cells cannot attach to the 
surface of implants to form new bone. Instead, the defect will be filled by a fibrous 
tissue, resulting in the failure of bone reconstruction. This illustrates the importance 
of creating a local immune environment that favours bone regeneration and 
osseointegration; manipulating the immune response by targeting modifications of 
the bone biomaterials is, therefore, a good strategy to swing the balance towards this 
direction.  
 
 
Figure 2 Schematic illustration of the failure of bone biomaterials that lead to fibrous 
encapsulation. It is also divided into three phases (acute, chronic inflammation, and 
fibrous encapsulation), with the involvement of the coagulation system, immune 
cells, and fibroblasts. The likely macrophage phenotype switch pattern is shown. The 
early stage is dominated by the inflammatory phase, during which the majority of 
macrophages would be of the inflammatory M1 phenotype. However, a prolonged 
M1 polarization phase leads to an increase in fibrosis-enhancing cytokine release 
pattern by the M2 macrophages, which results in the formation of a fibrocapsule. 
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Figure 3 H&E staining of rat femoral condyle defects four weeks after implantation 
of β-tricalcium phosphate (β-TCP) (A, C, E) and cobalt incorporated β-tricalcium 
phosphate (CCP) (B, D, F). (A). Overview of the defect filled with β-TCP; new bone 
formation was observed in the defect; (B). Overview of the defect treated with CCP; 
no new bone formation was observed and the defect was mainly filled by fibrous 
inflammatory tissue. The defect size was much larger than β-TCP group; (C). New 
bone formation on the surface of the remaining β-TCP particle; (D). Inflammatory 
tissue surrounded the remaining CCP particle; (E). The defect boundary became 
blurred with osteoblasts forming the new bone (arrows); (F). The defect boundary 
was clear and surround by fibrous inflammatory tissue (arrows). 
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2.2 IMMUNE CELLS REGULATION OF OSTEOCLASTOGENESIS AND 
OSTEOGENESIS 
The field of osteoimmunology seeks to understand the interaction between the 
immune and skeletal systems [7]. Immune cells participate actively in bone 
physiology and pathology by releasing regulatory molecules which elicit significant 
effects on osteoclastogenesis and osteogenesis (Figure 4). Abnormal functioning of 
immune cells can lead to an imbalance between osteoclasts and osteoblasts and result 
in conditions such as osteolysis, osteoporosis, osteoarthritis and rheumatoid arthritis. 
In this part, the role of immune cells in osteoclastogenesis and osteogenesis and 
possible molecular mechanisms at play is reviewed. 
2.2.1 Immune cells and osteoclastogenesis 
Immune cells regulate osteoclastogenesis by three major cytokines: macrophage-
colony stimulating factor (M-CSF), receptor activator of NF-κB ligand (RANKL) 
and osteoprotegerin (OPG). M-CSF binds to its cognate receptor c-fms on osteoclast 
precursors and activates signalling through the Akt and MAP kinase pathway [23]. 
RANKL binds to RANK, a receptor on the surface of osteoclast precursors, thereby 
activating signalling through TNF receptor associated factor 6 (TRAF6), nuclear 
factor kappa-light-chain-enhancer of activated B cells (NF-κB), activator protein 1 
(AP-1) and nuclear factor of activated T cells 2 (NFAT2) to induce expression of 
genes for survival and differentiation of osteoclasts [6, 24]. RANKL is expressed, not 
only by osteoblastic cells that support normal osteoclastogenesis in bone tissue, but 
also by activated T cells and neutrophils, indicating the involvement of these immune 
cells during osteoclastogenesis [25, 26]. Macrophages are the precursor of 
osteoclasts, which under the stimulation of M-CSF and RANKL can differentiate 
into osteoclasts during bone remodelling.  
IL-6 and oncostatin M (OSM) are interleukin-6-type cytokines that stimulate 
osteoclast formation and function. IL-6 is believed to play a positive regulatory role 
in osteoclast differentiation by inducing the expression of RANKL on the surface of 
osteoblasts, activating the RANK signalling pathway on osteoclast progenitors [27]. 
The inhibition of IL-6 receptors can directly block osteoclast formation [28]. OSM 
uses gp130, the same receptor subunit as does IL-6, for signalling and these two 
cytokines often have similar and overlapping functions [29]. OSM can enhance 
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osteoclastogenesis in a dose dependent manner, which might be related to its 
synergistic effects with IL-6 [30]. By contrast, interferon-γ (IFN γ) promotes the 
degradation of TRAF6, a key intermediate in RANKL/RANK pathway, thereby 
preventing massive bone destruction during inflammation [6]. Another inflammatory 
cytokine TNF-α was also found to increase RANKL expression in bone marrow 
adipocytes which promote osteoclast differentiation [31]. 
OPG, a decoy receptor derived from osteoblasts, can bind to RANKL and interrupt 
its interaction with RANK, thereby inhibiting osteoclastogenesis [32, 33]. B cells 
have been shown to be the main source of bone marrow-derived OPG [34, 35], 
which implies that B cells are one of the main inhibitors of osteoclastogenesis in 
normal physiology. Depletion of CD4 and CD8 T lymphocyte subsets in mice results 
in a vitamin D3-stimulated osteoclast formation by a mechanism involving increased 
prostaglandin E production [36]. T-cells are thought to work cooperatively with B-
cells and enhance OPG production via CD40/CD40L co-stimulation, based on data 
showing that T-cell-deficient CD40 and CD40L-knock out mice are osteoporotic 
[34].  
Mast cells also participate actively in osteoclastogenesis [37]. A reduction in the 
number of mast cells reduces bone remodelling, whereas the enhancement of 
systemic mastocytosis leads to an increase of bone loss [38, 39]. Histamine, rather 
than pro-inflammatory cytokines, may be the major mediator during this interaction; 
a study in mice showed that a targeted disruption of the histidine decarboxylase gene, 
which leads to a deficiency of histamine, had the effect of reducing bone loss, even 
in response to ovariectomy [40, 41]. 
The interaction between immune cells and osteoclast cells plays a key role in the 
pathology of many bone diseases, such as osteoarthritis, rheumatoid arthritis, and 
osteoporosis. Ovariectomy can enhance T-cell production of TNF-α, activating the 
TNF-α receptor p55 to augment M-CSF-induced and RANKL-induced 
osteoclastogenesis, which can be key mechanisms underlying the bone loss 
associated with oestrogen deficiency [42].  Persistent excessive inflammation is a 
feature of the continuous release of pro-inflammatory cytokines (TNF-α, IL-1α/β and 
IL-6) and usually accompanies an increased RANKL/OPG ratio and elevated  
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Figure 4 Schematic illustration of the role of immune cells in bone dynamics. 
Immune cells participate actively in osteoclastogenesis and osteogenesis by releasing 
regulatory molecules. (Abbreviations: OSM, oncostatin M; IL, interleukin; 
RANKL, receptor activator of nuclear factor kappa-B ligand; OPG, osteoprotegerin; 
M-CSF, macrophage colony stimulating factors; BMP, bone morphogenetic protein; 
WNT, wingless-related MMTV integration site; VEGF, vascular endothelial growth 
factor; TGF, transforming growth factor.) 
osteoclast activity [43]. The result is a shift of bone remodelling towards osteoclast-
mediated progressive bone erosions, characterized by derangement of mineral and 
organic components, which results in excessive bone loss and functional disability. 
2.2.2 Immune cells and osteogenesis 
Immune cells also contribute to osteogenesis, through the expression and secretion of 
a wide range of regulatory molecules [44], such as inflammatory cytokines, bone 
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morphogenetic protein 2 (BMP2), transforming growth factor β (TGF-β), and 
vascular endothelial growth factor (VEGF) [45-47]. Resident macrophages 
(osteomacs) are required for efficient osteoblast mineralization, and the depletion of 
macrophages leads to the complete loss of osteoblast-mediating bone formation in 
vivo [48]. Macrophages can also release some chemoattractants, such as chemokine 
(C-C motif) ligand 2 (CCL2) and CCL18, thereby participating in the recruitment of 
MSCs [49]. The chronic inflammation activated T cells were found to enhance the 
osteogenic differentiation of MSCs, thereby participating in the enhanced bone 
regeneration under chronic inflammation [50]. 
Inflammation plays a vital role in the initiation of bone healing [51]. A combination 
of four major inflammatory cytokines, TNF-α, TGF-β, IFN-γ, and IL-17 at 
physiological concentrations can induce mineralized matrix as effectively as 
dexamethasone, a commonly used osteogenic medium supplement [52]. The loss of 
any one of these four major inflammatory cytokines, results in the loss of the 
enhancing effects on osteogenic differentiation [52]. TNF-α was found to increase 
the alkaline phosphatase (ALP) activity and mineralization by MSCs in a dose-
dependent manner, by the activation of the NF-κB signalling pathway in MSCs [53, 
54]. Low dose TNF-α (1 ng/mL) was also found to recruit the muscle-derived 
stromal cells into the fracture site, and enhance their osteogenic differentiation, 
thereby promoting the fracture repair [47]. The stimulatory effect of the conditioned 
medium from the lipopolysaccharide (LPS)-activated inflammatory M1 macrophages 
on ALP activity is attenuated, when the conditioned medium is pretreated with TNF-
α neutralizing antibody [52]. The mechanism underlying the TNF-α mediated 
recruitment and proliferation of MSCs was found to be related to the NF-κB signal 
transduction pathway, especially the activation of IkappaB kinase 2 (IKK-2) [55].  
However, it is also reported that conditioned medium from the LPS-activated 
inflammatory M1 macrophages induced pre-osteoblast cells to differentiate towards 
fibroblasts even with osteogenic media supplements, and this might be related to the 
upregulation of TNFα, IL-1β and IL-6 [56, 57]. The inhibitory effects of TNF-α have 
been observed on the mineralization and the expression of osteogenic markers on 
osteoblastic cells, by suppressing the release of BMP2 [58, 59]. The upregulation of 
IFN-γ and TNF-α by T lymphocytes is also thought to be responsible for the failure 
of MSCs based bone tissue regeneration and the inhibitory effects can be attenuated 
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by the application of anti-inflammatory drugs such as aspirin [60]. The underlying 
mechanism may be related to the stimulation of NF-κB in MSCs, which promotes 
degradation of β-catenin, thereby inhibiting osteogenic differentiation [61]. This 
reasoning leads to the hypothesis that the effects of inflammatory cytokines on 
osteogenesis may be dose and time dependent and that an adequate concentration and 
appropriate timing of these cytokines could induce osteogenesis. The flip side to this 
is that inadequate concentrations and/or stimulation time of the inflammatory 
cytokines may lead to bone resorption rather than bone formation. 
The observation that immune cells have an important role in bone dynamics is a 
strong argument for considering the immune responses in bone tissue engineering. 
The traditional strategy of focusing on the reactions between materials and bone cells 
is insufficient, as they do not reflect the in vivo condition, which involves immune 
reaction during the process of bone repair. If the importance of the immune system is 
neglected, the conclusions will invariably be drawn when interpreting the results of 
bone tissue engineering experiments.  
 
Figure 5 Inducers, surface markers and functions of macrophage phenotypes. Under 
the influences of different inducers, macrophages can switch into different 
phenotypes [M1, M2 (M2a, M2b, M2c)]. Each phenotype has special surface 
markers and different functions. 
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Table 1 Inducers, surface markers and functions of macrophage phenotypes. 
(Abbreviations: LPS, lipopolysaccharide; GM-CSF, granulocyte/macrophage colony stimulating 
factors; CCR, C-C chemokine receptor; FcR, Fc receptor; CXCL, CXC-chemokine ligand; ROI, 
reactive oxygen intermediates; RNI, reactive nitrogen intermediates; MMPs, Matrix 
metalloproteinases; IC, immune complexes; TLRLs, toll-like receptor ligands; MRC, mannose 
receptor; CCL, C-C chemokine ligand; IL-1ra, IL-1 receptor antagonist.) 
Inducer Surface Marker Function 
M1 
Classically activated 
IFN-γ alone 
or with microbial stimuli  
(e.g. LPS) 
 /cytokines  
(e.g. TNF-α,  
GM-CSF) 
CCR7 [62], 
INOS [62],  
CD80 [63, 64],  
CD86 [65], 
FcR І, ІІ, ІІІ [66],  
MARCO [67], 
CXCL9, CXCL10,  CXCL11 
 [66, 68] 
Enhance Th1 type inflammatory responses, anti-
proliferation,  cytotoxic behaviour: 
Antibacterial effect:  
 IL-12 [69],  IL-23 [69],  
 ROI [66],  RNI[66] 
Pro-inflammatory cytokines:[70]  
 TNF-α, IL-6, IL-1β  
Tissue damage:  
 MMPs[71] 
M2 
Alternatively activated  
IL-33 [72],  
IL-21 [73] 
M2a: IL-4/IL-13 
M2b: IC and TLRLs 
M2c: IL-10 
Glucocorticoid/secosteroid  
CD163 [74], 
Dectin-1 [65],  
Arginase [62], 
MRC1 (CD206) [75],  
MRC2 (CD280),  
FceR ІІ [66]  
Involve in Th2 anti-inflammatory reactions, 
immunoregulation, tissue repair: 
M2a:  
IL-10, IL-1 type ІІ decoy receptor [76], IL-1ra 
[77] 
M2b:  
IL-10, TNF-α, IL-6, IL-1β [70]  
M2c:  
IL-10, TGF-β [78],  VEGF [79] 
2.3 MULTIPLE ROLES OF MACROPHAGES IN THE BONE HEALING 
PROCESS 
Macrophages, among all the immune cells, tend to receive the most attention due to 
their multiple roles in the bone healing process and their high plasticity. 
Macrophages play a central role in inflammation and host defence, especially in the 
innate immune response. Based on distinct functional properties, surface markers, 
and inducers, macrophages have been broadly characterised into M1 and M2 
phenotypes, mirroring the Th1/Th2 nomenclature described for T helper cells [80]. 
M2 macrophages include three sub-populations: M2a, M2b, and M2c. The inducers, 
surface markers and functions of each phenotype are summarized in Figure 5 and 
Table 1. It should be noted that this classification represents only a simplification of 
the in vivo scenario. Most likely the macrophage phenotype occupies a continuum 
between M1 and M2 designations, with many shades of activation yet to be 
identified [81]. This makes distinguishing M1 from M2 macrophages more difficult 
since transient macrophages may possess some characteristics of both phenotypes, 
resulting in unreliable surface markers. Thus, reliance on markers to detect a 
macrophage population would be problematic and multiple criteria are required. 
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The recruitment of monocytes that differentiated into macrophages and the 
subsequent secreting of inflammatory cytokines from macrophage are responsible for 
the activation of osteoblasts, osteoclasts, and MSCs, which are key events during the 
self-bone healing [51]. Despite the well-documented effects of macrophages in bone 
repair, there is still no consensus as to which macrophage phenotype is the most 
beneficial for osteogenesis. Classically activated inflammatory macrophages (M1) 
are well known to secrete many pro-inflammatory cytokines (TNFα, IL-6, IL-1β), 
which are traditionally recognized to induce the osteoclastogenesis, and enhance 
osteoclastic activities, leading to bone resorption. However, some recent studies have 
found that osteogenesis is enhanced in response to M1, as opposed to M2 
macrophages. Guihard, et al., reported that the classically activated inflammatory 
M1, but not M2 macrophages, induced osteogenesis in MSCs via OSM [82]. Similar 
results can be found in LPS activated T lymphocytes, which were found to secrete 
high levels of BMP2, enhancing osteogenic differentiation of MSCs [52]. 
Alternative activated M2 macrophages tend to be more closely associated with the 
late stage of the tissue repair, resulting in either a fibrocapsule or the formation of 
new bone, by the secretion of relevant cytokines. The switch of macrophage 
phenotype into M2 extreme via local delivery of fingolimod (FTY720) was found to 
enhance the bone healing [83]. It was also found that IL-33 induced M2 
macrophages could prevent the TNF-α-mediated bone loss [84]. They not only 
contribute osteoinductive and osteogenic cytokines, such as BMP2 and VEGF, to the 
process of osteogenesis, but also elaborate inflammatory and fibrous agents (TNFα, 
TGF-β1, TGF-β3) to promote pathological fibrosis [57, 85]. In response to excessive 
inflammation, fibrosis-enhancing M2 phenotypes would be induced to regulate the 
formation of a fibrous capsule, thereby separating the inflammatory reaction centre 
from normal bone tissue. This confines the inflammation and preserves the normal 
bone tissue, which would otherwise lead to failure of bone regeneration. An 
excessive switch to the M2 phenotype, on the other hand, results in scar tissue or a 
delay in wound healing [86, 87]. It is, therefore, most probable that an effective and 
adequate switch of macrophage phenotype is important for osteogenesis. This means 
that more attention should be paid to the cytokine profile of activated macrophages in 
addition to investigating their switch to any phenotype.   
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Figure 6 Two macrophage subsets are present during intramembranous bone 
healing. Tibial injury sites from 12-week-old C57Bl/6 mice at 5 (A, B) and 7 (C, D) 
days after surgery. (A, C). A, B and C, D are near serial sections with landmarks 
denoted by #. F4/80+ mature tissue macrophage distribution throughout the entire 
injury site; (B, D). Mac-2+ inflammatory cells are located predominantly in the 
peripheral injury zone. The presence of (F4/80+, Mac-/low) osteomacs on a bone 
surface (arrows) and (F4/80+, Mac+/high) inflammatory macrophages (arrowheads) 
can clearly be distinguished between figure A and figure B. Small clusters of 
inflammatory macrophages (F4/80+, Mac+/high) can be found in the circled area (C, 
D). Adapted from  [88].   
Macrophage phenotypes are dynamic and plastic and respond to environmental cues, 
allowing these cells to alter their phenotype and physiology and this accounts for 
their multiple roles in the bone healing process [89]. The phenotype switch relates to 
the type, concentration and duration of the polarising signals. When treated with IL-
4, macrophages change into a reparative M2 phenotype [90]; however, with the 
addition of LPS and immune complexes, macrophages can take on a hybrid 
phenotype possessing both characteristics of wound-healing and regulatory 
macrophages [91]. It is still unclear whether this phenotypic alteration is derived 
from the in situ macrophages or the migration of a new population of macrophages 
into the tissue site to replace the original cells. Macrophages can be considered as a 
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model cell type for the evaluation of immune response. In addition, the heterogeneity 
and plasticity of macrophages also makes them a prime target for modulation of 
immune response. Some preliminary studies have indicated the importance of 
macrophage phenotype switch patterns during bone healing. SEW2871 (a selective 
S1P1 receptor agonist)-loaded gelatine hydrogels led to an increase of M1 cytokine 
TNFα at day3, which was then replaced by M2 related cytokines OPG, IL-10 and 
TGFβ [92]. This switch pattern was found to promote bone regeneration [92]. More 
studies are required to better understand the macrophage switch pattern and how it 
affects the bone healing process. 
 
Figure 7 Possible properties of bone biomaterials, such as topography, surface 
charge, wettability particle size, ion release and porosity and pore size, can modulate 
the immune cells (macrophages, lymphocytes, etc) and the subsequent major 
immune responses (innate, humoral immune response, etc). 
2.4 BONE BIOMATERIALS MODULATING THE IMMUNE RESPONSE 
Bone biomaterials are recognised by the host’s immune system as a foreign body, 
arousing multiple directional immune responses. The biomaterials are not simply 
passive targets for attacking immune cells, but elicit significant effects that determine 
the type and extent of implant-mediated immune responses. Surface properties, 
particle size, porosity, and the released ions from the biomaterials are all factors 
involved in these responses.  
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2.4.1 Surface properties of bone biomaterials 
Biological behaviours of immune cells on the surfaces of the bone biomaterials are 
largely determined by the surface properties, such as surface microstructure and 
wettability [93-95] (Figures 7, 8 and 9). Generally, hydrophobic materials tend to 
enhance monocyte adhesion in comparison to hydrophilic materials, resulting in a 
local immune response [95, 96]. It was found that the hydrophilic/neutral copolymer 
surfaces inhibited macrophage adhesion and fusion into FBGCs. However, the 
adherent cells produced larger amounts of cytokines (IL-6 and IL-1β) and 
chemokines (IL-8, CCL5, C-X-C motif chemokine 5, and CCL2) than that of the 
hydrophobic and hydrophilic ones [93, 94]. It was also found that increased titanium 
surface hydrophilicity can attenuate pro-inflammatory response by macrophages, and 
thereby accelerate dental implant osseointegration [97]. 
The surface charge also elicits significant effects on the immune response. It is 
generally accepted that positively-charged particles are more likely to induce 
inflammatory reactions than negatively charged and neutral ones [98, 99]. Most 
mammalian cells, including immune cells, have an overall negative surface charge 
[100]. The loss of the negative surface charge of the cell membrane by the positively-
charged particles may influence protein localization and confirmation, which, under 
normal circumstances, induce signal transduction into the cytoplasm resulting in 
significant biological responses, including inflammatory reaction. 
The surface topography of biomaterials is another important property that affects the 
interaction of immune cells [101-104]. The roughness of titanium, for example, 
affects the attachment and spread of immune cells: macrophage adhesion increases 
with time on all surfaces (polished, machined, and grit-blasted commercially pure 
titanium), whereas cell spreading increases with increased surface roughness [103]. 
In addition to the effects on cell attachment, the roughness of titanium could also 
modulate the production of inflammatory cytokines and chemokines by 
macrophages, with the sandblasting and acid etching surface eliciting significant 
stimulatory effects (Figure 8) [102]. Macrophages on the rough titanium surface 
were switched to an M2-like phenotype to enhance wound repair [105], indicating 
the topography can be designed to optimise immune reaction. 
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Figure 8 Topography and immune response 
(A). Scanning electron micrographs of macrophages cultured on various titanium 
surfaces for 48 h. (B). Released inflammatory cytokines from the stimulated 
macrophages were detected by ELISA. TCP: Tissue culture polystyrene, PO: 
polished surface, CB: coarsely blasted surface, AE: acid-etched surface. Adapted 
from [102]. 
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Figure 9 Effects of surface wettability on protein adhesion to biomaterial surfaces. 
(A). Atomic force microscopy topographic images of low density polyethylene 
surfaces following plasma treatment at various time points. The mean water contact 
angle value of each surface is calculated. (B). Average adhesion forces of various 
proteins to low density polyethylene surfaces with different water adhesion tension 
values. Adapted from [106].  
It is estimated that the surface roughness of bone is approximately 32 nm, making 
nanomaterials potentially most biomimetic [107]. Nanoscale microstructures have 
been found to stimulate human MSCs into producing bone minerals in vitro, even in 
the absence of osteogenic supplements. This has generated considerable interest in 
the applications of nanomaterials in bone tissue engineering [108]. It has also been 
found that microstructured, rather than nanostructured topography, induced 
macrophages to an activated state that has both M1 and M2 characteristics [109], and 
titanium surfaces, modified by titania nanotube arrays, can reduce in vitro immune 
response compared to the raw titanium surface [110]. Nanoscale topographic 
structures may, therefore, prove to be a good strategy to modulate the immune 
response of biomaterials.  
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The underlying mechanisms of biomaterial surface properties regulating the immune 
response may be related to how they affect protein adsorption, such as complement 
components, fibrinogen, fibronectin and vitronectin. Upon adsorption, the protein 
structures may experience some changes, leading to the exposure of some masked 
domains or epitopes, which can then be recognised by host cells (including immune 
cells). Binding to these epitopes via specific receptors allow host cells to attach to the 
surfaces of the materials [111]. The initial adsorption of proteins forms a temporal 
matrix on the surface, which then becomes an important link between the material 
and host response. For this reason, it is important to know not only what proteins are 
adsorbed, but also the manner of how they interact with the surface when 
determining subsequent behaviours of host cells [112]. Both surface chemistry and 
wettability influences the conformational changes of adsorbed proteins, mediate 
adsorption kinetics and binding strengths, and the subsequent protein activity [106]. 
Most proteins in blood are hydrophilic on their outside while their hydrophobic 
domains are turned inwards, thus serum proteins tend to bind on the hydrophobic 
surfaces [106, 113], which is important for the subsequent functional activities of 
immune cells.  
Complement components, fibrinogen, fibronectin and vitronectin have all been found 
to attach to the implant surfaces and elicit significant effects on the immune response 
[114, 115]. The complement system participates in the degradation of implants, 
mainly by enhancing phagocytosis of implants and attracting macrophages and 
neutrophils [115]. The main event in the activation of the complement system is the 
enzymatic cleavage of C3 into C3b and C3a, where all three complement pathways 
(the classical pathway, the mannose-binding lectin pathway and the alternative 
pathway) converge [116]. C3 can be adsorbed to the material surface, and the 
adsorption induces conformational changes that change C3 into a C3b-like molecule, 
which can bind to Bb and become C3 convertase, initiating the alternative pathway 
[117]. C3b molecules can themselves bind to the plasma proteins coating the material 
surface, triggering the alternative pathway amplification loop, which produces the 
majority of the C3b molecules for the normal functioning of complement system in 
the implant-mediating immune response [115]. 
Attachment of plasma fibrinogen exposes the pro-inflammatory sequence fragment 
D30, which can bind to the integrin Mac-1 (CD11b/CD18) on the surface of 
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phagocytes, participating actively in the accumulation of phagocytes [114]. 
Fibrinogen may also convert to a fibrin-like conformation on material surfaces, 
facilitating the binding and activation of inflammatory cells [114]. Plasma 
fibronectin is also found to participate actively in the fusion of FBGCs, thereby 
modulating the fibrous encapsulation of implanted materials [118]. Vitronectin can 
adsorb to a surface in the face of competition from other plasma proteins [119] and 
has been found to be a critical protein adhesion substrate for IL-4-induced FBGCs 
formation [120, 121]. 
Adsorption of these proteins from plasma onto biomaterial surfaces can bind to the 
integrin receptors on the surface of immune cells, activating signalling pathways 
[114, 122-124]. Integrins have been characterized extensively as adhesion receptors 
capable of transducing signals inside the cell. It has been suggested that β1 integrin is 
abundantly expressed on the surface of undifferentiated monocytes, while β3 integrin 
expression increases upon macrophage differentiation [125]. During the formation of 
FBGCs, both β1 and β2 integrin-mediated adhesion are present, while β3 integrin-
mediated adhesion is not detected, a process that is known to be important in 
mediating the adhesion of osteoclasts onto bone surfaces [126]. The depletion of β3 
integrin affects the polarization of macrophages, switching the phenotype to M2 
extreme [127]. Anti-β2 integrin antibodies can partly block the adhesion of 
macrophages to the implants, reducing IL-1β production to basal levels, while anti-
β1 and anti-αvβ3 antibodies have no effect [128]. Macrophage-associated integrins 
also contribute to regulation of BMP2 expression: anti-β1 integrin antiserum had a 
relatively greater effect on macrophage BMP2 mRNA expression than did anti-β3 
integrin antiserum [103]. Therefore, integrins are likely to play a key role in 
transducing the signal from the matrix on implant surfaces to the immune cells, 
leading to the cell attachment, spread, division, and differentiation. 
In response to matrix signals, integrins can also transmit the signals inside the cell, 
affecting the cytoskeleton (especially microfilaments), thereby altering cell 
morphology. The correlation of macrophage morphology and inflammatory cytokine 
production resulting from the material contact has also been investigated and 
macrophages with an amoeboid shape produce more TNFα, compared to 
macrophages with hemispherical and spherical shapes [129]. Previous studies have 
also associated spread morphology with the level of activation where a decrease in 
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cell spreading indicates a reduction in the level of activation [104]. The conclusion 
one can draw from these findings is that surface properties affect the biological 
behaviours of immune cells by affecting the cytoskeleton. Cytochalasins can bind to 
actin filaments and block actin polymerization and elongation, thereby inhibiting 
cytoskeleton-dependent cell shape remodelling [130]. Cytochalasin D was used to 
block polymerization of the actin cytoskeleton and the results showed that an intact 
cytoskeleton was necessary for the production of pro-inflammatory cytokine IL-1β 
[128]. Macrophages did not spread but showed a round shape in response to high 
concentrations (50 μM) of cytochalasin B, which inhibited the expression of the 
osteogenesis-enhancing gene BMP2 [103].   
2.4.2. Biomaterials particle size  
Immune cells degrade and process particles from implants in a size dependent 
manner. Particles less than 0.5 µm in size are internalized by macropinocytosis, 
clathrin-mediated, caveolin-mediated, and clathrin/caveolin-independent endocytosis 
[98, 131], whereas particles larger than 0.5 µm are ingested by phagocytosis [98, 
132]. Macrophages are able to phagocytose particles of up to 5 µm [8, 16], but with 
larger particle size macrophages will coalesce to form FBGCs. The phagocytosis of 
microbial pathogens usually leads to the production of inflammatory cytokines and 
subsequent pathogen digestion with lysosomal enzymes [98]. However, it is still 
unclear whether the endocytosis of bone biomaterials can activate the inflammation 
response, which may vary depending on particle size and the corresponding 
endocytosis pathway (Figures 7 and 10). Poly (lactic-glycolic) acid (PLGA) does 
not elicit any significant immune response, although PLGA particles are readily 
phagocytised by macrophages. By comparison, polystyrene latex elicits a robust 
release of inflammatory cytokines (TNFα, TGF-β and nitric oxide) when ingested by 
macrophages [133, 134]. 
For same amount of particles, decrease in the particle size increases the surface area 
and enhances chemical reactivity, thereby strengthening the effects on target cells, or 
even elicit a different effect altogether [131, 135]. Hydroxyapatite particles with the 
smallest size (1-30 µm) stimulate immune cells to produce the greatest amount of 
pro-inflammatory cytokines (TNFα, IL-1β, IL-6) [136]. Bulk gold samples are 
practically inert, whereas gold nanoparticles have been reported to be highly reactive 
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for several immune responses, including production of reactive oxidative species 
(ROS) [137]. However, it does not follow that smaller sized particles necessarily 
mediate a more severe immune reaction. It has been found that large (>1 μm) 
particles can induce a Th1 response, whereas particles smaller than 0.5 µm) are 
associated with Th2 [98, 138]. An in vivo study has demonstrated that a decrease in 
the size of irregularly shaped hydroxyapatite particles decreases the inflammatory 
reaction [139]. A systematic examination of a range of particle sizes within each 
class of bone biomaterials is therefore necessary to quantify how this parameters 
modulate the inflammatory response. 
 
Figure 10 Materials with different particles size phagocytised by macrophages. 
Silica titania hollow nanoparticles (HNPs) with uniform diameters of (A) 25, (B) 50, 
(C) 75, (D) 100, and (E) 125 nm; (F) live cell differential interference contrast and 
fluorescent images of FITC-tagged HNP-treated SK-BR-3/J774A.1 cells. The cells 
were cultured in FITC-tagged HNPs (diameters of 25, 50, 75, 100, and 125 nm) 
containing media (10 µg/mL) for 24 h. Adapted from [135]. 
2.4.3. Porosity and pore size of biomaterials 
Porosity and pore size are two key parameters for the fabrication of bone tissue 
engineering scaffolds, which are important in determining the ingrowth tissue types 
(inflammatory granuloma tissue, vascular tissue, bone tissue) [140] (Figure 7 and 
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11). Small pores may hamper the diffusion of nutrients and oxygen supplied from 
blood and interstitial fluid, especially in the centre of the scaffold, leading to a local 
hypoxic environment [141]. Hypoxia can enhance local inflammation, which is 
inducible for the formation of granuloma. This might block the small pores, creating 
a barrier between the implant and the surrounding bone cells that prevents bone 
tissue ingrowth from taking place [142], resulting in the failure of bone regeneration. 
However, a hypoxic environment also favours angiogenesis and vascularisation by 
stabilisation of hypoxia-inducible factors (HIFs), which is beneficial for bone 
regeneration. Proper pore size should be able to induce a moderate hypoxia 
environment which can avoid significant inflammatory reaction but reserve the 
angiogenic effects. 
Higher porosity (80 - 88 %) and macroporosity (pore size > 50 µm) are thought to be 
more beneficial for the ingrowth of bone tissue [140]. Apart from the relevance for 
the behaviours of bone cells, the importance of porosity and pore size is 
demonstrated in the interaction of implant and host immune system [143]. It seems 
that with an increase in pore size, the activity of the foreign body reaction decreases 
[142, 144]. The underlying mechanism may be related to macrophage polarization 
[145-147] since there appears to be a correlation between increasing fibre/pore size 
and upregulated expression of the M2 markers, along with decreased expression of 
the M1 markers [145] (Figure 11).  
2.4.4. Released ions from bone biomaterials 
Bioactive bone biomaterials normally undergo degradation to different extents 
following implantation, either by physicochemical dissolution, cell-medicated 
dissolution, hydrolysis, enzymatic decomposition, or corrosion [148]. Ions released 
from the biomaterials during degradation can elicit significant effects by altering the 
local biological environment (Figures 7 and 12).  
Calcium (Ca) is one of the major components of calcium phosphate bone 
biomaterials and is well documented to be involved in certain inflammatory 
signalling pathways [149, 150]. The non-canonical Wnt5A/Ca2+ signalling pathway 
is known to enhance inflammation [149]. When Wnt5A binds to frizzled family 
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receptor 5 (Fz5), it can activate the Wnt/Ca2+ signalling pathway via 
Ca2+/Calmodulin(CaM)-dependent protein kinase II (CaMKII) and protein kinase C,- 
 
Figure 11 Macrophage polarization in response to various porosities of electrospun 
polydioxanone scaffolds. (A). Electrospun fibre scaffolds with different porosity 
(69.4%, 81.16% and 82.67%); (B). Infiltration of different macrophage phenotypes 
into the fibrous scaffolds was analysed by hematoxylin and eosin staining; (C). 
Quantification of macrophage infiltration into the fibrous structures of the scaffolds. 
Adapted from [145].  
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- which culminates in the upregulation of downstream inflammatory cytokine genes 
via the transcription factor NF-κB [149]. CaMKII, in particular, acts with the cyclic 
AMP-response element binding protein (CREB) in macrophages and activates 
cyclooxygenase-2 (COX-2) to produce the proinflammatory hormone prostaglandin 
E2 (PGE2) [151]. High concentration of extracellular Ca2+ has also been found to be 
able to activate the calcium sensing receptor (CaSR) signalling cascade leading to the 
production of Wnt5A, which can reduce the expression of TNFα via the inhibition of 
NF-κB and downregulate the TNFR1 via the Wnt5a/Ror2 signalling pathway, 
thereby reducing inflammation [150]. 
Silicon (Si) is an essential trace element associated with bone development [152, 
153] and is found in active calcification sites during the early mineralization process 
of bone regeneration [154]. Lack of dietary Si intake leads to deformities in bones 
[155], whereas dietary Si supplementation can suppress the bone resorption even in 
ovariectomized animals [156]. Aqueous Si has been reported to promote the 
proliferation, differentiation and collagen production of osteoblastic cells [157-159]. 
Ionic products released from Si-containing bioactive glass, bioceramics and coatings 
have a similar positive effect on the proliferation and differentiation of bone-forming 
cells [160-163]. Osteoclasts show a more complex response, with Si levels below 30 
ppm stimulating the development of osteoclasts, while higher levels of Si inhibit 
osteoclast development and their bone resorption activities [158]. Si ions may also 
elicit an immune reaction, for example, the inhalation of silica particle is the major 
cause of pneumosilicosis. Nanometer sized silica has a milder fibrogenic effects than 
does micrometer sized silica, potentially because nanoparticles diffuse and 
translocate more readily compared to microparticles [164]. In addition, it is also 
thought that long-term exposure to components of silicone gel-filled breast implants 
may be associated with autoimmune or inflammatory diseases, since Si is found at 
higher concentrations in the lesions and blood in this patient cohort [165]. On the 
other hand, it has been reported that the immunogenicity and biocompatibility of flat, 
nano-channeled, and nano-porous Si toward human monocytes are approximately 
equivalent to tissue culture polystyrene, indicating the inertness of Si [166]. 
Magnesium (Mg) is a biodegradable and biocompatible metal that is mechanically 
similar to bone and, therefore, eliminates the effects of stress shielding and improves 
in vivo degradation properties [167]. Mg has been proposed as biodegradable 
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metallic bone biomaterials for applications in orthopedics [167, 168]. Mg is reported 
to have a strong relation with the immune system [169]. The deprivation of Mg is 
accompanied by activating immune cells such as neutrophils and macrophages [170], 
and the increased levels of pro-inflammatory cytokines (IL-6, TNF-α) [171]. Mg2+ 
ions are also known to suppress inflammatory cytokine production by inhibiting toll-
like receptor (TLR) pathway [172]. Macrophages recognize foreign bodies via the 
TLR pathway, which induce an immune response in order to degrade or reject the 
implants [8]. Most of the activated TLRs are bound by the adaptor protein myeloid 
differentiation primary response 88 (MyD88), and then activate a downstream 
cascade [173]. However, TLR3 can only conduct through a MyD88-independent 
pathway, using the adaptor protein toll-like receptor adaptor molecule (Ticam), also 
known as TIR domain containing adapter inducing IFN β (TRIF), while TLR4 can 
signal through both pathways [174]. Although they produce signals through different 
adapter proteins, both MyD88-dependent and TRIF-dependent pathways eventually 
recruit NF-κB, which then proceed to express inflammatory cytokines [175]. 
Cobalt (Co) can be used to facilitate angiogenesis by stabilizing the HIFs and 
subsequently activating HIF target genes such as VEGF [176, 177]. Accordingly, a 
number of studies have been carried in which bone substitute materials were 
modified with Co, resulting in the incorporation of Co into tricalcium phosphate, 
45S5 bioglass® and mesoporous bioactive glass [12, 178-180]. These bone 
biomaterials showed significant enhancements of in vitro angiogenesis; however, in 
addition to the effects on angiogenesis, HIF was also found to have some pro-
inflammatory effects. Stabilisation of HIF-1α was found to be essential for the 
infiltration and activation of myeloid cells in vivo through a mechanism independent 
of VEGF [181]. HIF-1α is also required for the functional maturation of 
macrophages [182] and pro-inflammatory cytokines, such as TNFα and IL-1, could 
stabilise HIF-1, thereby amplifying the inflammatory response [183, 184]. It is well 
established that Co ions are toxic and have been implicated in the failure of joint 
prostheses [185-187]; its use in biomaterials is, therefore, controversial.  
Zinc (Zn) has been reported to stimulate bone formation and mineralization [188, 
189] and dietary Zn deficiency can lead to retardation of bone growth [190, 191]. Zn 
has therefore been incorporated into CaP biomaterials to enhance their osteogenic 
capacity. However, in addition to its effects on osteogenesis, it also affects the 
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immune response. Zn-substituted ceramics can promote the release of IL-10 (an anti-
inflammatory cytokine), while reducing the expression of TNFα and IL-1β (pro-
inflammatory cytokines), which may be due to the regulation of TLR-4 pathway 
[192-195]. Patients with inflammatory diseases (such as rheumatoid arthritis) have 
been found to present with low blood Zn levels and a corresponding increased TNFα 
production [196];  supplementation of Zn can reverse this pathological process [197]. 
Zn affects the immune cell responses in a concentration-dependent manner: the 
addition of Zn salt to peripheral blood mononuclear cells grown in complete medium 
resulted in a concentration-dependent stimulation of TNFα (peaking at 250 µmol/L) 
and IL-1β (peaking at 120 µmol/L) [198].  
Strontium (Sr) is a physiological trace element that enhances osteogenesis while 
inhibiting osteoclastogenesis and has been applied as a treatment for osteoporosis 
[199-201]. The underlying mechanism appears to be related to antagonizing the 
inflammatory role of NF-κB, which suggests that Sr is an anti-inflammatory agent 
[202]. Studies in which Sr was introduced into Ca/P materials found that it could 
inhibit the release of pro-inflammatory cytokine TNFα in human primary monocytes, 
at both high (500 µmol/L) and low (10 µmol/L) ion concentrations [203, 204]. Sr has 
also been shown to promote cell proliferation and suppress the expression of the pro-
inflammatory cytokines IL-6 in periodontal ligament cells [204, 205].  
Bioactive ions elicit a range of effects from the immune system, which differ in 
composition and concentration. The strategy to manipulate the immune response by 
controlled release of defined combinations of bioactive elements is, therefore, one 
worthy of careful consideration. Some preliminary studies have been performed to 
investigate the mechanisms of how the bioactive elements affect the immune 
response, but much work remains to fully understand the molecular mechanisms that 
would provide the basic biological knowledge for the development of bioactive bone 
substitute materials. 
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Figure 12 Influence of the substitution of zinc into hydroxyapatite (A) on cytokine 
production by human monocytes. Production of inflammation cytokines (TNFα, IL-
1β, IL-6, and IL-10) by LPS-stimulated macrophages exposed to zinc-substituted 
particles were determined by ELISA (B-E). Adapted from [192].  
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2.5 SUMMARY 
Bone biomaterials can determine an immune response. The type of response is 
related to the properties of the biomaterials, such as surface topography, particle size, 
porosity and pore size, and ion release. Components from the degraded materials and 
released molecular signals from the interaction between immune system and 
implants, significantly affect the biological behaviours of bone cells, thereby 
determining the bone regeneration outcome. However, most of the efforts related to 
material-mediated immune responses have focused on whether the foreign body 
reaction elicited by the materials would lead to excessive inflammation and rejection 
or encapsulation by fibrous tissue in a concept referred to as “biocompatibility”. 
Given the importance of immune cells in bone dynamics, it is equally important to 
investigate the properties of materials that can help generate an immune environment 
favourable to osteogenesis. The weight of evidence from the literature makes it clear 
that a novel property involving biomaterials, bone cells, and immune cells together 
must be defined and added to the system of evaluating bone biomaterials in an effort 
to optimise the development of such materials. Thus, osteoimmunomodulation 
(OIM) was proposed to name it in recognition of the importance of the immune 
response during biomaterial-mediated osteogenesis, which is the major focus of this 
thesis. Biomaterials with the favourable OIM may create an immune environment 
that enhances osteogenesis, and regulate proper osteoclastogenesis that can 
participate in the bone remodelling and cell-mediated materials degradation. 
Biomaterials with poor OIM may cause excessive inflammation and lead to an 
imbalance of osteoclastogenesis over osteogenesis.  
  

 Chapter 3: Research Paper One 39 
 
 
 
 
 
 
Chapter 3: Research Paper One 
Osteogenic differentiation of bone marrow 
MSCs by β-tricalcium phosphate stimulating 
macrophages via BMP2 signalling pathway 
--- To demonstrate the involvement and 
possible roles of immune cells in biomaterials- 
stimulated osteogenesis 
 

 Chapter 3: Research Paper One 41 
Osteogenic differentiation of bone marrow MSCs by β-tricalcium phosphate 
stimulating macrophages via BMP2 signalling pathway 
Zetao Chen, Chengtie Wu, Wenyi Gu, Travis Klein, Ross Crawford, Yin Xiao 
(Manuscript published in Biomaterials) 
 
   Statement of Contribution of Co-Authors for  
   Thesis by Published Paper 
Contributor Statement of contribution* 
Zetao Chen 
experimental design, conducted experiments, data analysis, and 
wrote the manuscript 
Signature 
Date 
Chengtie Wu  
prepare β-TCP, aided data analysis, assisted in reviewing the 
manuscript 
Wenyi Gu technical guidance for flow cytometry, aided data analysis 
Travis Klein aided data analysis, assisted in reviewing the manuscript 
Ross Crawford assisted in reviewing the manuscript 
Yin Xiao  
technical guidance, involved in the conception and design of the 
project, assisted in reviewing the manuscript 
 
Principal Supervisor Confirmation  
I have sighted email or other correspondence from all Co-authors confirming their 
certifying authorship. 
 
_______________________ ____________________ ______________________ 
Name Signature Date 
 
Citation: Zetao Chen, Chengtie Wu, Wenyi Gu, Travis Klein, Ross Crawford, Yin 
Xiao. Osteogenic differentiation of bone marrow MSCs by β-tricalcium phosphate 
stimulating macrophages via BMP2 signalling pathway. Biomaterials, 2014, 35(5): 
1507-18. (Available online: 20 November 2013). 
 

 Chapter 3: Research Paper One 43 
ABSTRACT 
Immune reactions play important roles in determining the in vivo fate of bone 
substitute materials, either in new bone formation or inflammatory fibrous tissue 
encapsulation. The paradigm for the development of bone substitute materials has 
been shifted from inert to immunomodulatory materials, emphasizing the importance 
of immune cells in the material evaluation. Macrophages, the major effector cells in 
the immune reaction to implants, are indispensable for osteogenesis and their 
heterogeneity and plasticity render macrophages a primer target for immune system 
modulation. However, there are very few reports about the effects of macrophages on 
biomaterial-regulated osteogenesis. In this study, we used β-tricalcium phosphate (β-
TCP) as a model biomaterial to investigate the role of macrophages on the material 
stimulated osteogenesis. The macrophage phenotype switched to M2 extreme in 
response to β-TCP extracts, which was related to the activation of calcium-sensing 
receptor (CaSR) pathway. Bone morphogenetic protein 2 (BMP2) was also 
significantly upregulated by the β-TCP stimulation, indicating that macrophage may 
participate in the β-TCP stimulated osteogenesis. Interestingly, when macrophage-
conditioned β-TCP extracts were applied to bone marrow mesenchymal stem cells 
(BMSCs), the osteogenic differentiation of BMSCs was significantly enhanced, 
indicating the important role of macrophages in biomaterial-induced osteogenesis. 
These findings provided valuable insights into the mechanism of material-stimulated 
osteogenesis, and a strategy to optimise the evaluation system for the in vitro 
osteogenesis capacity of bone substitute materials. 
INTRODUCTION 
As exogenous bodies, implants tend to be rejected or isolated by the human body, 
mainly by the foreign body reaction. Aiming to avoid such a reaction, inert materials 
have been developed for in vivo implantation. However, this approach regrettably 
minimizes reconstructive healing and even worse sometimes enhances the foreign 
body reaction, resulting in the encapsulation of the material [206]. With the emergence 
of osteoimmunology, the interaction between bone cells and immune cells has been 
studied more thoroughly [7]. The immune and skeletal systems are closely related, 
sharing a number of cytokines, receptors, signalling molecules and transcription 
factors [207]. Besides its perpetuation leading to chronic inflammation, the immune 
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response plays a vital role in implant integration and osteogenesis [8, 9]. Inflammatory 
cytokines interleukin-1 (IL-1), tumour necrosis factor α (TNF-α), and IL-6 can 
enhance osteoclast differentiation and resorbing activity, and inhibit osteoblast activity 
and bone formation, while anti-inflammatory cytokines IL-4, IL-10, and IL-13 have 
the opposite effect [208]. Instead of osteoblastic cells, B cells have been shown to be 
the main source of bone marrow-derived osteoprotegerin, with a percentage of 64% 
[34, 35], which suggests that B cells are the main inhibitors of osteoclastogenesis in 
normal physiology. This understanding has led to a shift towards the development of 
“smart” bone substitute biomaterials capable of immunomodulation [8]. These “smart” 
biomaterials should be able to arouse an effective immune response, building an 
osteogenesis-enhancing environment for bone cells. In vitro methods previously used 
to evaluate bone substitute materials based on the interactions between bone cells and 
materials are insufficient for evaluating these types of biomaterials, as they do not 
reflect the in vivo condition, which involves early immunoreaction upon 
transplantation. It is therefore of great importance to investigate the effects of immune 
cells on the biomaterial-regulated osteogenesis. 
Among all immune cells, the macrophage is one of the most important effector cells in 
the material-induced immune response. It has been reported that the long-term 
immune response to materials and the outcome of the inflammatory reaction are 
mainly determined by macrophages [209]. In addition, the heterogeneity and plasticity 
of macrophage make it a prime target for immunomodulation [210]. Macrophages 
have several phenotypes, which are dynamics and plastic [68]. In response to the 
environmental signals alteration, macrophages can change their phenotype and 
physiology [79]. They are broadly referred to as either M1 or M2 phenotypes [80]. 
The classically activated M1 phenotype with typical surface markers CD11c and 
CCR7, help to enhance Th1 (T helper cell 1) type inflammation [62]. The alternatively 
activated M2 phenotype with the typical surface markers CD163 and CD206, helps to 
enhance Th2 (T helper cell 2) type inflammation, downregulate inflammation and 
improve tissue healing [74, 75]. In addition to their effects on inflammation, 
macrophages are also known to influence bone physiology and pathology [48, 88]. It 
is well known that macrophages are the precursors of osteoclasts, which participate in 
the bone remodelling and material degradation. Macrophages also contribute to 
osteogenesis through the expression and secretion of a wide range of regulatory 
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molecules [44], such as BMP2, transforming growth factor β (TGF-β), etc [45, 46]. 
Macrophages are required for efficient osteoblast mineralization and the depletion of 
macrophages can decrease osteoblast bone forming capacity [48].  
Given the important roles of macrophages in the bone dynamics, some studies have 
investigated the interactions between bone substitute biomaterials (such as 
bioceramics, polymers, titanium, etc) and macrophages. However, most of these 
studies are limited to either the classic inflammatory contributions or the 
differentiation into osteoclasts on various bone substitute biomaterials [195, 211, 212]. 
Very few reports have been made on the effects of macrophages in regulating 
materials stimulated osteogenesis.  
β-TCP is well recognised as an osteoconductive biomaterial and has been widely used 
for clinical bone regeneration application [213-215]. Although there are many studies 
about the in vitro and in vivo osteogenesis of β-TCP bioceramics, the effect of β-TCP 
on the biological response of macrophages is unclear, and the effect of macrophages 
on β-TCP-coordinated osteogenesis of BMSCs has not been investigated. Therefore, in 
the current study, β-TCP is used as a model biomaterial to investigate the interactions 
between bone substitute materials and macrophages, and to further reveal whether 
macrophages participate in the material-stimulated osteogenesis. 
MATERIALS AND METHODS 
Cell culture 
The murine-derived macrophage cell line RAW 264.7 cells and human bone marrow 
mesenchymal stem cells (BMSCs) were used in this study. RAW 264.7 cell cultures 
were maintained in Dulbecco’s Modified Eagle Medium (DMEM, Life Technologies, 
Carlsbad, California, USA) supplemented with 10% foetal bovine serum (FBS, 
Thermo Scientific, Waltham, Massachusetts, USA), and 1% (v/v) 
penicillin/streptomycin (Life Technologies, Carlsbad, California, USA) at 37 ºC in a 
humidified CO2 incubator. The cells were passaged at approximately 80% confluence 
by scraping and expanded through two passages before being used for the study.  
BMSCs were isolated and cultured based on protocols from previous studies [216, 
217]. Briefly, bone marrow was obtained from patients (50-60 years old) undergoing 
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hip or knee replacement surgery with informed consent given by all donors and the 
procedure was approved by the Ethics Committee of Queensland University of 
Technology. Lymphoprep was added to isolate the mononuclear cells from the bone 
marrow by density gradient centrifugation (Axis-Shield PoC AS, Oslo, Norway). The 
obtained cells were seeded into the tissue culture flasks containing DMEM 
supplemented with 10% FBS and 1% penicillin/streptomycin and incubated at 37 ºC in 
a humidified CO2 incubator. The culture medium was changed every 3 days until the 
primary mesenchymal cells reached 80% confluence. The unattached hematopoietic 
cells were removed through medium change. The confluent cells were routinely 
subcultured by trypsinization. Only early passages (p3–5) of cells were used in this 
study. 
Metabolic activity of RAW264.7 cells with β-TCP extracts 
β-TCP was synthesized by a chemical precipitation method, as previous described 
[12]. The prepared powders were sieved with 60-80 mesh to obtain the particle size of 
180-250 μm before further experiment. Based on the standard ISO/EN 10993-5, the 
cells were cultured in β-TCP powder extract medium [12, 218]. The powder extracts 
were prepared by soaking powders in serum-free DMEM at a series of solid/liquid 
ratio (200, 100, 50, 25, 12.5, 6.25, 0 mg/mL). After incubation at 37 ºC for 24 hours, 
the mixture was centrifuged and the supernatant was collected and sterilized by 
filtration through 0.2 µm filter membranes (Pall Corporation, Port Washington, New 
York, USA).  
RAW 264.7 cells were seeded in a 96-well tissue culture plate at a density of 2000 
cells per well. After 24 hours of incubation, the culture medium was removed and 
replaced by 200 µL of material extract containing 10% FBS. DMEM without extract 
supplemented with 10% FBS was used as a control. At days 1 and 3, a MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] assay was applied to test the 
overall metabolic activity. 20 µL of 5 mg/mL MTT solution was added into each well. 
After incubation for a further 4 hours, the DMEM-MTT solution was carefully 
removed and replaced by 100 µL of DMSO (dimethyl sulfoxide) to dissolve the 
formazan crystals. The absorbance was read at the wavelength of 495 nm by a 
microplate spectrophotometer (Benchmark Plus, Tacoma, Washington, USA). Each 
sample was performed in triplicate. 
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Flow cytometry and fluorescence microscopy 
Expression of M1 and M2 macrophage cell surface marker CD11c and CD163, 
respectively, were determined by flow cytometry. After 5 days of culture, the cells 
were detached by scraping. Nonspecific protein binding was blocked by 1% 
BSA/PBS. Samples were incubated with CD11c and CD163 antibody (1:100) (AbD 
Serotec, Raleigh, North Carolina, USA) for 30 minutes at 4 ºC, followed by incubation 
with a Dylight 488-anti-mouse secondary antibody (DAKO, Multilink, California, 
USA) for 30 minutes at 4 ºC. After washing with 1% BSA/PBS, cells were analysed 
on a FC500 flow cytometer (Beckman Coulter, Brea, California, USA). The data were 
analysed using Flowing Software (www.flowingsoftware.com). For fluorescence 
microscopy, the treated cells were mounted by mounting medium containing 4',6-
diamidino-2-phenylindole (DAPI) (Sigma-Aldrich, St. Louis, Missouri United States), 
to stain the cell nuclei. Figures of the stained slides were then captured using Axion 
software under a fluorescence microscope (Carl Zeiss Microimaging GmbH, 
Gottingen, Germany).  
Effects of β-TCP extracts on the inflammatory and osteogenic gene expression of 
RAW264.7 cells   
Inflammatory gene expression of RAW264.7 cells with β-TCP extracts  
RAW 264.7 cells were seeded in a 6-well plate at a density of 50,000 cells per well. 
After 24 hours of incubation, the culture medium was removed and replaced by 
material extract containing 10% FBS. Culture medium with 10% FBS was used as a 
negative control. After 3 days, media from cells cultured in material extract or culture 
medium were collected, and centrifuged at 1500 rpm to gain the supernatants for 
further conditioned media experiments and ion concentration detection. Total RNA of 
both groups was extracted using TRIzol reagent (Life Technologies, Carlsbad, 
California, USA) for RT-qPCR detection.  
500 ng total RNA was used for the synthesis of complementary DNA using 
DyNAmoTM cDNA Synthesis Kit (Finnzymes, Thermo Scientific, Waltham, 
Massachusetts, USA) following the manufacturer’s instructions. RT-qPCR primers 
(Table 1) were designed based on cDNA sequences from the NCBI Sequence 
database. SYBR Green qPCR Master Mix (Life Technologies, Carlsbad, California, 
 48                                                                                                                                   Chapter 3: Research Paper One 
USA) was used for detection and the target mRNA expressions were assayed on the 
ABI Prism 7300 Thermal Cycler (Applied Biosystems, Foster City, California, USA). 
Each sample was performed in triplicate. The mean cycle threshold (Ct) value of each 
target gene was normalized against Ct value of a house keeping gene to gain the 
relative expression. For the calculation of fold change, ΔΔCt method was applied, 
comparing mRNA expressions between treated groups and negative group (cells 
cultured in the complete culture medium only). 
Mechanism of the inflammatory gene expression change  
To understand the mechanism of the gene expression changes, the ionic concentrations 
of Ca2+, and PO43- ions in complete culture medium, β-TCP extracts and RAW 264.7 
cell conditioned media were quantified by inductive coupled plasma atomic emission 
spectrometry (ICP-AES, PerkinElmer, Waltham, Massachusetts, USA). 
Two Ca2+ involved inflammation signalling pathways, Wnt5A/Ca2+, and CaSR were 
evaluated by RT-qPCR and Western blot. RAW 264.7 cells were seeded in a 6-well 
plate at a density of 50,000 cells per well. After 24 hours of incubation, the culture 
medium was removed and replaced by material extract containing 10% FBS. Culture 
medium with 10% FBS was used as a negative control. After 3 days, media from cells 
cultured in material extract or culture medium were collected. Gene expression of 
Wnt5A, Frizzled family receptor 5 (Fz5), CaSR were detected following the same 
method described previously. The whole cell lysates were collected after 24 hours of 
culture for the Western Blot detection (calmodulin-dependent protein kinase II 
(CaMKII), nuclear factor of kappa light polypeptide gene enhancer in B-cells 
inhibitor, alpha (IκB-α)). 15 μg proteins from each sample were separated on SDS-
PAGE gels and then transferred onto a nitrocellulose membrane (Pall Corporation, 
East Hills, New York, USA). After being blocked in Odyssey blocking buffer for 1 
hour (LI-COR Biosciences, Lincoln, Nebraska, USA), the membranes were incubated 
with primary antibodies against IκB-α (1:1000, rabbit anti-human/mouse; Cell 
Signaling Technology, Danvers, Massachusetts, USA), CamKII (pan, 1:1000, rabbit 
anti-human/mouse; Cell Signaling Technology, Danvers, Massachusetts, USA), and α-
tubulin (1:5000, rabbit anti-human; Abcam, Cambridge, United Kingdom) overnight at 
4 °C. The membranes were washed three times in TBS-Tween buffer, and then 
incubated with anti-rabbit IRDye 800 conjugated secondary antibodies at 1: 4000 
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dilutions for 1 hour at room temperature. The protein bands were visualized using the 
Odyssey infrared imaging system (LI-COR Biosciences, Lincoln, Nebraska, USA). 
The relative intensity of protein bands was quantified using Image J software 
(National Institutes of Health, Bethesda, Maryland, USA). 
Osteogenic gene expression of RAW264.7 cells stimulated with β-TCP extracts 
To investigate the effect of β-TCP extracts on osteogenic gene expression by 
RAW264.7 cells, BMP2, Transforming growth factor beta 1 (TGFβ1) and Vascular 
endothelial growth factor (VEGF) were analysed by RT-qPCR as described 
previously. 
Effects of RAW 264.7 cells-conditioned β-TCP extracts on the osteogenic 
differentiation of BMSCs 
Bone-related gene and protein expression of BMSCs 
To investigate whether RAW 264.7 cells could regulate osteogenesis of BMSCs in 
response to material extracts, the BMSC culture medium was supplemented with the 
collected supernatants detailed previously at a ratio of 1:2 to obtain the conditioned 
media [219]. The pure material extract and culture medium without being conditioned 
by RAW 264.7 cells were used as controls. 
For the detection of bone-related gene [alkaline phosphatase (ALP), osteopontin 
(OPN), osteocalcin (OCN), and collagen, type I (COL1)] and protein expression 
(ALP, OPN) of BMSCs, BMSCs were plated at a density of 1.5 × 105 cells per well in 
separate 6-well plates. After 24 hours of incubation, the culture medium was removed 
and replaced by conditioned medium or control medium. Total RNA of all four groups 
was extracted using TRIzol reagent after 1 and 3 days of culture, and analysed by RT-
qPCR, as described previously. The whole cell lysates were collected after 14 days of 
culture, and analysed by Western blot, as described previously, with primary 
antibodies against ALP (1:10,000, rabbit anti-human; Abcam, Cambridge, United 
Kingdom), OPN (1:1000, rabbit anti-human; Abcam, Cambridge, United Kingdom), 
and α-tubulin (1:5000, rabbit anti-human; Abcam, Cambridge, United Kingdom). 
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The mineralization of BMSCs 
In order to identify mineralization nodules, Alizarin Red S staining was measured on 
day 14 after BMSCs grown in conditioned or control media in a 96-well plate with or 
without osteogenic supplements. The medium was removed and the cells were washed 
with ddH2O and fixed in 4% paraformaldehyde for 10 min at room temperature. After 
gently rinsing with ddH2O, the cells were stained in a solution of 2% Alizarin Red S at 
pH 4.1 for 20 min and were then washed with ddH2O. The samples were air-dried and 
figures were taken under a light microscope.  
BMP2-related signalling pathway of BMSCs 
To investigate the activation of the BMP2 signalling pathway in BMSCs, BMP2 
signalling pathway related genes [Mothers against decapentaplegic homolog 1/4/5 
(SMAD1, SMAD4, SMAD5), bone morphogenetic protein receptor, type IA 
(BMPR1A) and Bone morphogenetic protein receptor type II (BMPR2)] were 
analysed by RT-qPCR as described previously. 
Statistical analysis 
All the analyses were performed using SPSS software (IBM SPSS, Armonk, New 
York, USA). All the data were shown as means ± standard deviation (SD) and 
analysed using one-way ANOVA followed by least significant difference post hoc 
test. A level of significance was set at P <0.05. 
RESULTS 
 Metabolic activity of RAW 264.7 cells 
RAW 264.7 cells grew well in both culture medium and medium with series material 
extracts. MTT analysis showed that the overall metabolic activity of most groups with 
various ratios of material extracts increased in a time-dependent manner (Figure 1). 
The medium with highest solid/liquid ratios of material extracts (200 mg/mL) was 
used for the following in vitro studies.  
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Table 1 Primer pairs used in the qRT-PCR 
 
 
Genes Primer sequences 
IL10 Forward: 5'- GAGAAGCATGGCCCAGAAATC -3' 
Reverse: 5'- GAGAAATCGATGACAGCGCC-3' 
IL1ra Forward: 5'- CTCCAGCTGGAGGAAGTTAAC -3' 
Reverse: 5'- CTGACTCAAAGCTGGTGGTG -3' 
TNFα Forward: 5’-CTGAACTTCGGGGTGATCGG-3’ 
Reverse: 5’-GGCTTGTCACTCGAATTTTGAGA-3’ 
IL1β Forward: 5'- TGGAGAGTGTGGATCCCAAG -3' 
Reverse: 5'- GGTGCTGATGTACCAGTTGG -3' 
IL6 Forward: 5'- ATAGTCCTTCCTACCCCAATTTCC -3' 
Reverse: 5'- GATGAATTGGATGGTCTTGGTCC -3' 
BMP2 Forward: 5’-GCTCCACAAACGAGAAAAGC-3’ 
Reverse: 5’-AGCAAGGGGAAAAGGACACT-3’ 
VEGFa Forward: 5’-GTCCCATGAAGTGATCAAGTTC-3’ 
Reverse: 5’-TCTGCATGGTGATGTTGCTCTCTG-3’ 
TGFβ1 Forward: 5'- CAGTACAGCAAGGTCCTTGC-3' 
Reverse: 5'- ACGTAGTAGACGATGGGCAG-3' 
WNT5A Forward: 5’-CAACTGGCAGGACTTTCTCAA-3’ 
Reverse: 5’-CCTGATACAAGTGGCAGAGTTTC-3’ 
Fz5 Forward: 5'- AAGTCCATTACGGCGCTG-3' 
Reverse: 5'- AGCCTCGTAGTGAGTTCAGG-3' 
CaSR Forward: 5'- GGCGGACTCAGAAATGACC-3' 
Reverse: 5'- TGATGACGAAGCTCCGAGAG-3' 
Actinβ Forward: 5'- CATACCCAAGAAGGAAGGCTGG -3' 
Reverse: 5'- GCTATGTTGCTCTAGACTTCGAGC -3' 
ALP Forward: 5’-TCAGAAGCTAACACCAACG-3’ 
Reverse: 5’-TTGTACGTCTTGGAGAGGGC-3’ 
OPN Forward: 5’- TCACCTGTGCCATACCAGTTAA-3’ 
Reverse: 5’-TGAGATGGGTCAGGGTTTAGC-3’ 
OCN Forward: 5’-GCAAAGGTGCAGCCTTTGTG-3’ 
Reverse: 5’-GGCTCCCAGCCATTGATACAG-3’ 
COL1A1 Forward: 5’-AGAACAGCGTGGCCT-3’ 
Reverse: 5’-TCCGGTGTGACTCGT-3’ 
SMAD1 Forward: 5’- GTATGAGCTTTGTGAAGGGC-3’ 
Reverse: 5’- TAAGAACTTTATCCAGCCACTGG-3’ 
SMAD4 Forward: 5’- CTCCAGCTATCAGTCTGTCAG-3’ 
Reverse: 5’- CCCGGTGTAAGTGAATTTCAAT-3’ 
SMAD5 Forward: 5’- TCATCATGGCTTTCATCCCACC-3’ 
Reverse: 5’- GCTCCCCAACCCTTGACAAA-3’ 
BMPR2 Forward: 5’- GGCAGCAGTATACAGATAGGTG-3’ 
Reverse: 5’- CTGCCCTGTTACTGCCATTATT-3’ 
BMP1A Forward: 5’- CCTGGGCCTTGCTGTTAAATTCA-3’ 
Reverse: 5’- TCCACGATCCCTCCTGTGAT-3’ 
18S Forward: 5’- CGGAACTGAGGCCATGATTAAG-3’ 
Reverse: 5’- GTATCTGATCGTCTTCGAACCTCC-3’ 
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Figure 1 The overall metabolic activity of RAW 264.7 cells in medium with 
different concentration of material extracts, detected by MTT. *: Significant 
difference (P < 0.05) compared day1 groups with day3 groups. 
  
Flow cytometry and fluorescence microscopy 
Forward scatter decreased after stimulation of β-TCP extract, whereas side scatter 
increased with same treatment (Figure 2 A, D), indicating that RAW 264.7 cells 
experienced morphology changes in response to the stimulation. Besides the 
morphology change, the mean fluorescence intensity of CD163 increased after the 
material stimulation (Figure 2 B, E). On the contrary, the mean fluorescence intensity 
of CD11c decreased under the same treatment (Figure 2 H, K). Fluorescence 
microscopic analysis showed CD11c or CD163 positively stained cells in both β-TCP 
and control groups (Figure 2 C, F, I, and L). 
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Figure 2  FACS and fluorescence staining results: CD163 (A-F), CD11c (G-L); 
RAW 264.7 cells cultured in complete medium (A-C, G-I), macrophages 
stimulated by material extract (D-F, J-L).  
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Ionic concentration  
The concentrations of Ca2+ and PO43- ions in all collected samples are shown in Table 
2. After soaking with β-TCP powders (200 mg/mL), both Ca2+ and PO43- ionic 
concentrations in the culture medium were decreased. Although both Ca2+ and PO43- 
ionic concentrations in the material extract were increased after being conditioned by 
RAW 264.7 cells, they were still lower than that of macrophage conditioned complete 
culture medium. 
Table 2 The ionic concentrations of β-TCP powder extract (200 mg/mL) and 
macrophage conditioned media 
 
Material immersed - - + + 
Macrophage conditioned - + - + 
Ionic concentrations(mg/ L) 
Ca2+ 68.70±1.81 81.60±0.40 50.82±0.09 74.81±2.14 
PO43- 35.41±0.25 37.20±0.15 18.42±0.37 21.40±0.36 
 
Inflammatory gene expression of RAW264.7 cells  
Anti-inflammatory genes IL-10 and IL-1ra expression were significantly upregulated 
by the stimulation of β-TCP extract (P ˂0.05) (Figure 3 A, B). On the contrary, 
inflammatory genes IL-1β and IL-6 expression were significantly downregulated with 
the same treatment (P ˂0.05) (Figure 3 D, E). TNFα gene expression showed no 
significant change after stimulation (Figure 3 C).  
To explore the mechanism of inflammation related gene expression changes, we 
examined two calcium involved inflammation signalling pathways (Wnt5A/Ca2+, 
Ca2+/CaSR). Although Wnt5A gene expression was significantly upregulated (P 
˂0.05), the downstream molecules Fz5 and CamKII showed no significant change 
(Figure 4 A, B, D).  This indicated that the inflammatory effect may not be caused 
though this pathway. We then examined the CaSR gene expression, which showed an 
activation of this pathway with significantly upregulated CaSR genes and increased 
IκB-α protein (P ˂0.05,  Figure 4 C & D). 
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Figure 3 Relative mRNA expressions of inflammation related genes IL-10 (A), IL-
1ra (B), TNFα (C), IL-1β (D) and IL-6 (E), relative to housekeeping gene β-actin, 
by RAW 264.7 cells with or without stimulation of material extract. *: Significant 
difference (P < 0.05) for β-TCP extract group compared to the negative group. 
 
Figure 4 Relative mRNA expressions of WNT5A (A), Fz5 (B) and CaSR (C) 
relative to  housekeeping gene β-actin by RAW 264.7 cells with or without 
stimulation of material extract. Western blotting analysis of CaMKII and IκB-α 
expression of RAW 264.7 cells with or without stimulation of material extract 
(D). *: Significant difference (P < 0.05) for β-TCP extract group compared to the 
negative group. 
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Figure 5 Relative mRNA expressions of BMP2 (A), TGF β1 (B), and VEGF (C) 
relative to housekeeping gene β-actin by RAW 264.7 cells with or without 
stimulation of material extract. *: Significant difference (P < 0.05) for β-TCP 
extract group compared to the negative group. 
 
Osteogenic gene expression of RAW264.7 cells  
BMP2 gene expression was upregulated by the stimulation of β-TCP extract (P ˂0.05) 
(Figure 5 A). However, VEGF and TGF-β1 gene expression showed no significant 
change with the same treatment (Figure 5 B, C).  
Osteogenic differentiation of BMSCs 
Expression of three measured mineralization-related genes (OPN, OCN, COL1) by 
BMSCs stimulated by RAW 264.7 cell-conditioned media containing β-TCP extracts 
were significantly upregulated compared to β-TCP extract alone (P ˂0.05) (Figure 6 
A, B, C, and D). However, RAW 264.7 cell conditioned medium alone without β-TCP 
extract showed no significant changes in expression of ALP and COL1 in comparison 
with the normal culture medium (P >0.05) (Figure 6 A, D).  
Western blot of ALP and OPN showed a similar trend to the RT-qPCR results. Both 
measured proteins were significantly upregulated by BMSCs stimulated by RAW 
264.7 cell conditioned β-TCP extract relative to β-TCP extract alone (P ˂0.05) 
(Figure 7). 
Alizarin Red S staining showed evidence of calcium deposition and nodule formation. 
Mineralized nodules were observed in all groups with osteogenic medium (Figure 8).  
More distinct nodules were observed in BMSCs stimulated by RAW 264.7 cell 
conditioned β-TCP extract compared to that by β-TCP extract alone (Figure 8). 
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Figure 6 Fold changes of ALP (A), OPN (B), OCN (C) and COL1 (D), by 
comparing BMSCs cultured in complete culture medium with material immersed 
medium, or RAW 264.7 cell conditioned media. *: Significant difference (P < 
0.05). 
  
Figure 7 Western blot analysis of ALP and OPN expression by BMSCs cultured 
in complete culture medium, material immersed medium, or RAW 264.7 cell 
conditioned media. *: Significant difference (P < 0.05). 
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Figure 8 Alizarin Red S staining results: A. BMSCs cultured in complete culture 
medium only, B. BMSCs cultured in material extract, C. BMSCs cultured in 
complete culture medium with osteogenic supplements (OS), D. BMSCs cultured 
in material extract with OS, E. BMSCs cultured in RAW 264.7 cell conditioned 
complete culture medium with osteogenic supplements (OS), F. BMSCs cultured 
in RAW 264.7 cell conditioned material extract with osteogenic supplements 
(OS).  
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Figure 9 Relative mRNA expressions of BMP2 signalling pathway genes BMPR2 
(A), BMPR1A (B), SMAD5 (C), SMAD1 (D) and SMAD4 (E) relative to 
housekeeping gene  18S rRNA. BMSCs cultured in complete culture medium, 
material immersed medium, or RAW 264.7 cell conditioned media. *: Significant 
difference (P < 0.05). 
BMP2 signalling pathway-related gene expression 
To further explore the mechanisms of enhanced osteogenesis, we examined the gene 
expressions of BMP2 signalling pathways. RAW 264.7 cell conditioned medium alone 
without β-TCP extract could not upregulate the BMP2 signalling pathways related 
genes, compared with the normal culture medium. BMPR2 and SMAD4 were even 
downregulated (Figure 9 A, D). However, The expressions of BMPR2, SMAD5 and 
SMAD4 in BMSCs cultured with RAW 264.7 cell conditioned β-TCP extracts showed 
significantly upregulation compared to those cultured with β-TCP extract alone (P 
˂0.05) (Figure 9 A, C, E). 
DISCUSSION 
Macrophages play important roles in the interaction between the host body and bone 
substitute materials. Such effects are commonly attributed to an inflammatory 
response and material degradation.  While these effects are undoubtedly important, our 
study further revealed that in response to the β-TCP extract, macrophages could switch 
their phenotype to an M2 extreme, leading to the release of osteoinductive molecules 
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and anti-inflammatory cytokines, which enhanced the osteogenesis of BMSCs through 
the BMP2 pathway. These findings demonstrate that macrophage participated and 
made important contributions to the β-TCP stimulated osteogenesis.  
Effects of β-TCP extracts on macrophages 
The macrophage phenotype occurs along a continuum between M1 and M2 extremes 
[81], and can switch its phenotype in response to environmental change. Whether 
macrophages could respond to β-TCP extract leading to a phenotype switch was still 
not clear, therefore, the effects of β-TCP extract on macrophages were investigated 
first. Three criteria (functional properties, surface markers, and inducers) were applied 
to define a specific macrophage phenotype [68]. With the induction of β-TCP extract, 
more macrophages expressed M2 surface marker CD163 and anti-inflammatory 
cytokines (IL-10 and IL-1ra). These results indicated that β-TCP extract elicited some 
effects on macrophage polarization, which switched it towards the M2 extremity.  
Calcium has been known to involve in some inflammation signalling pathways [149]. 
Wnt/Ca2+ signalling pathway is among one of them [149, 150]. Wnt5A can bind to 
Fz5 activating the Wnt/Ca2+ signalling pathway via CaMKII and Protein kinase C, 
which culminates the expression of downstream inflammatory cytokine genes via 
transcription factor NFκB [149]. When β-TCP was immersed in culture medium, 
dissolved Ca and P in the medium were removed from the solution, forming a 
deposition on surface of the ceramics, which led to the decrease of Ca2+ concentration 
in the culture media [20]. It is a logical extension to hypothesize that the decrease of 
Ca2+ concentration may inhibit the Wnt/Ca2+ signalling pathway, leading to the anti-
inflammatory effects. However, Fz5 and CaMKII showed no significant change by the 
stimulation of β-TCP extract, while Wnt5A was even found to be upregulated. This 
suggests that the observed anti-inflammatory effects were not produced via this 
pathway.  
Extracellular Ca2+ has also been found to be able to activate the CaSR signalling 
cascade leading to the production of Wnt5A, which can reduce the expression of 
TNFα via inhibition of NFκB and downregulates the TNFR1 via the Wnt5a/Ror2 
signalling pathway, thereby reducing the inflammation [150]. In this study, both CaSR 
and Wnt5A gene expressions were upregulated by the material stimulation, and the 
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NFκB inhibitor IκB was also upregulated, which indicated that the anti-inflammatory 
effects might be caused through CaSR pathway. It should be noted that activation of 
CaSR signalling pathway was always related to the high concentration of Ca2+. 
However, the Ca2+ concentration in this study was decreased by the material 
immersion. How the low concentration of Ca2+ activates the CaSR signalling pathway 
requires further studies. 
β-TCP stimulated macrophages enhanced the osteogenic differentiation of BMSCs  
Although macrophages have been proved to be involved in the osteogenesis, there is 
still no consensus on which phenotype is more beneficial for the osteogenesis. Guihard 
et al reported that it was the classically activated inflammatory M1, not M2 
macrophages, which induced osteogenesis in MSCs via Oncostatin M [82]. However, 
it was also reported that culture media from lipopolysaccharide activated macrophages 
induced pre-osteoblast cells to differentiate towards fibroblasts even with osteogenic 
medium, which might be related to the upregulation of TNFα, IL-1β and IL-6 [56, 57].  
After implantation, bone substitute materials are either degraded and replaced by new 
bone, or encapsulated and replaced by inflammatory fibrous tissue. M2 macrophages 
participate in both ends, via secreting relating cytokines. They may contribute 
osteoinductive and osteogenic cytokines (BMP2, VEGF etc) to enhance osteogenesis, 
but also elaborate inflammatory and fibrous agents (TNFα, VEGF, TGF-β1, TGF-β3 
etc) to promote pathological fibrosis [57, 85]. In addition, it was indicated that excess 
switch of M2 phenotype may result in scar tissue or a delay in wound healing [86]. 
Therefore, the conclusion still could not be made that M2 macrophages played a major 
role in regulating osteogenesis. An effective and adequate switch in macrophage 
phenotype might be of great importance for enhancing osteogenesis.  
BMP2 is a founding member of the BMP family, acting as an osteoinductive agent 
[220-222]. On receptor activation, BMP2 transmit signals through SMAD-dependent 
and SMAD-independent pathways, leading to osteoblast differentiation of 
mesenchymal progenitor cells [223]. Macrophages produce BMP2, which contributes 
to osteogenesis during bone healing [57]. In this study, we found that β-TCP extract 
significantly upregulated the BMP2 expression by macrophages. The released BMP2 
could bind to the BMPR2, leading to the activation of SMAD5 [223]. Activated 
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SMAD5 could then form a complex with SMAD4, which translocates into the nucleus, 
facilitating the expression of distalless homeobox5 (Dlx5) [223]. Dlx5 has been shown 
to induce the expression of Runt-related transcription factor 2 (Runx2), resulting in 
osteogenic differentiation of BMSCs [223]. The mechanism for the upregulation of 
BMP2 after β-TCP stimulation was still not clear. In addition to the anti-inflammatory 
effects, CaSR was also reported to cause BMP2 synthesis and secretion via 
phosphatidylinostitol 3-kinase activation [224]. The deletion of CaSR completely 
inhibited BMP2 secretion [224]. The upregulation of BMP2 might be related to the 
upregulation of CaSR.  
TNFα contributes to fibrosis via the mediator TNFR2, which then acts through 
Extracellular signal-regulated kinases 1/2 (ERK1/2) to stimulate proliferation and 
inhibit collagen degradation [225]. TNFα was also found to activate the ERK-specific 
mitogen-activated protein kinase pathway, leading to increased TGF-β1 production in 
fibroblasts [226]. TGF-β1 is a key cytokine in the fibrosis process, where it induces 
fibroblast proliferation via the Fibroblast growth factor 2/ERK pathway [227]. VEGF 
is another important cytokine for fibrosis, playing fundamental role in the 
angiogenesis and vasculogenesis [228]. All three tested fibrosis-promoting genes 
TNFα, VEGF and TGF-β1, showed no significant changes. This indicates that the β-
TCP-induced macrophage phenotype switch did not enhance the inflammatory 
fibrosis, but was effective and adequate for improving osteogenesis. These findings 
align with previous in vivo and clinical studies, demonstrating enhanced new bone 
formation by β-TCP [213, 215, 229, 230]. 
Possible effects of macrophages in the process of β-TCP material inducing 
osteogenesis are summarised in Figure 10. Degradation products released from the 
materials elicit some effects on the macrophages. The stimulated macrophages switch 
their phenotype into M2 via CaSR signalling pathway, resulting in the downregulation 
inflammatory cytokines (IL-1β, IL-6), and the upregulation of anti-inflammatory 
cytokines (IL-10, IL-1ra). The stimulated macrophages also uprelulate BMP2 gene 
expression, which activates the BMP2 signalling pathway in BMSCs, leading to 
osteogenic differentiation.  
For evaluating the in vitro osteogenesis capacity of bone substitute materials, 
osteoblastic cells (e.g. preosteoblasts, osteoblasts) are typically used [231-233]. The - 
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Figure 10 Summary of possible effects of macrophages in the process of β-TCP 
material inducing osteogenesis. 
- potentially osteogenesis-promoting materials will then be further evaluated in vivo. 
However, the in vitro and in vivo biological responses to biomaterials are not always 
consistent, due to the lack of immune cells in vitro [234, 235]. β-TCP itself was not 
sufficient to improve the osteogenic effect of BMSCs, however, macrophages 
conditioned β-TCP could release osteogenic cytokines, thereby enhancing the 
osteogenic effect of BMSCs, which was more consistent with in vivo results. The 
confirmation that macrophages behave actively during the process of osteogenesis 
caused by β-TCP is meaningful. Inadequately activated macrophages might cause 
failure of bone regeneration, leading to undesired inflammatory fibrosis. Immune 
cells, especially macrophages should be taken into consideration for evaluating the in 
vitro osteogenesis capacity of bone substitute materials. It should be noted that only 
RAW 264.7 macrophage cell line and β-TCP bioceramics were used in this study. 
Future research will aim to test primary macrophages and other types of bone 
substitute materials to draw more general conclusions. 
CONCLUSIONS 
Macrophages played important roles in β-TCP-induced osteogenesis. β-TCP extracts 
elicited significant effects on macrophages, inducing an effective and adequate M2 
macrophage phenotype switch, which inhibited the inflammation and enhance the 
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osteogenic differentiation of BMSCs. Adequately activated macrophages are vital for 
the success of material-stimulated bone regeneration. The interaction with immune 
cells, especially macrophages, should be elucidated when evaluating the in vitro 
osteogenesis capacity of bone substitute biomaterials.   
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SUPPLEMENTARY EXPERIMENTS FOR RESEARCH PAPER ONE 
Introduction 
It is indicated in Chapter 3 that β-TCP could elicit significant effects on macrophages 
and led to the functional phenotype switch that enhanced the osteogenic differentiation 
of BMSCs. In this supplementary study, the effects of β-TCP on modulating the 
immune environment were further investigated in vivo, to confirm the in vitro findings 
and further prove the immunomodulatory effects of bone biomaterials.  
Materials and Methods 
β-TCP powders (prepared using the same method as described in Chapter 3) were 
embedded subcutaneously in the back of the Wistar rats to investigate the 
inflammatory reaction towards this material (Figure 11). A 1cm incision was made in 
the back skin of rats and a pocket was created subcutaneously for the implantation of 
materials. To enable the handling of the materials for subcutaneous transplantation, the 
powder materials were mixed with blood. Specifically, materials were placed in 1 mL 
sterile syringes by mixing 50 mg particles with 50 uL blood collected from the rat tail. 
After coagulation (around 15min), the particles were kept intact as small implantable 
blocks, which were then implanted into the subcutaneous pockets. The animals were 
sacrificed after 2, 4, and 7 days, after which the samples were collected and put into 
the RIPA (Radio-Immunoprecipitation Assay) cell lysis buffer and stored in -80°C 
freezer for the further ELISA analysis (IL-1β, TNFα, and IFNγ).  
All collected subcutaneous implant samples were homogenised using a beadbeater 
machine (Mini-Beadbeater-24, BioSpec, Bartlesville, USA) and then centrifuged at 
14,000 g for 15 mins. After measuring protein concentrations in the supernatants using 
BCA assay, 150 µg total proteins in 100 µl lysis buffer were applied for the IL-1β, 
TNFα, and IFNγ rat ELISA essay (R&D Systems, Minneapolis, Minnesota, USA) 
performed according to the manufacturer's instruction. The cytokine concentrations 
were determined by correlation with a standard curve, and the results were expressed 
as the amount (pg) of cytokines per mL of tissue lysate.  
Results and Discussions 
ELISA results showed that the release of inflammatory cytokines IL-1β was 
significantly decreased as the incubation time went on (Figure 12), indicating the 
 66                                                                                                                                   Chapter 3: Research Paper One 
possible inhibitory effects of β-TCP on the release of IL-1β, which was consistent with 
the in vitro finding. The release of TNFα was decreased at both day 4 and 7 when 
compared with that of day 2, while no significant change was observed from day 4 to 
day 7 (Figure 12). This indicates that the regulatory effects of β-TCP on TNFα could 
be at the early stage of β-TCP-mediated immune response. The release of IFNγ were 
too low to be detected at day 2, however, it increased to around 50 pg/mL and kept 
steady release until day 7 (Figure 12). β-TCP elicited significant effects on 
modulating the local immune environment, decreasing the release of IL-1β and TNFα 
while increasing the release of IFNγ at later stage. 
 
Figure 11 Subcutaneous implantation of bone substitute materials. The materials 
were placed in 1 mL sterile syringes (A). 50 uL blood was collected from the rat 
tail and mixed with 50 mg particles (B). After coagulation (around 15min), the 
particles were kept intact as a small implantable block (C), which were then 
implanted into the subcutaneous pocket (D, E). 
 
Figure 12 Release of pro-inflammatory cytokines IL-1β, TNFα, and IFNγ after 
subcutaneous implantation of β-TCP after 2, 4, 7 days incubation. The expression 
was detected by ELISA. *: Significant difference (P < 0.05) for day 4/7 group 
compared to day 2 group. 
A B C 
D E 
Chapter 4: Research Paper Two 67 
Chapter 4: Research Paper Two 
The effect of osteoimmunomodulation on the 
osteogenic effects of cobalt incorporated β-
tricalcium phosphate 
----- Optimising the traditional in vitro 
osteogenic capacity evaluation system of 
bone biomaterials by adding immune cells 
DOI: 10.1016/j.biomaterials.2015.04.044

 Chapter 4: Research Paper Two 69 
The effect of osteoimmunomodulation on the osteogenic effects of cobalt 
incorporated β-tricalcium phosphate 
Zetao Chen, Jones Yuen, Ross Crawford, Jiang Chang, Chengtie Wu, Yin Xiao 
 (Manuscript published in Biomaterials) 
 
   Statement of Contribution of Co-Authors for  
   Thesis by Published Paper 
Contributor Statement of contribution* 
Zetao Chen 
experimental design, conducted experiments, data analysis, and 
wrote the manuscript 
Signature 
Date 
Jones Yuen assisted in the animal surgery 
Ross Crawford assisted in reviewing the manuscript 
Jiang Chang assisted in reviewing the manuscript 
Chengtie Wu 
prepare Co-TCP, involved in the conception and design of the 
project, assisted in reviewing the manuscript  
Yin Xiao  
technical guidance, involved in the conception and design of the 
project, assisted in reviewing the manuscript 
 
Principal Supervisor Confirmation  
I have sighted email or other correspondence from all Co-authors confirming their 
certifying authorship. 
 
_______________________ ____________________ ______________________ 
Name Signature Date 
 
Citation: Zetao Chen, Jones Yuen, Ross Crawford, Jiang Chang, Chengtie Wu, Yin 
Xiao. The effect of osteoimmunomodulation on the osteogenic effects of cobalt 
incorporated β-tricalcium phosphate. Biomaterials, 2015, 61: 126-38. (Available 
online 14/05/2015). 
 

 Chapter 4: Research Paper Two 71 
ABSTRACT 
Osteoblast lineage cells are direct effectors of osteogenesis and are, therefore, 
commonly used to evaluate the in vitro osteogenic capacity of bone substitute 
materials. This method has served its purposes when testing novel bone biomaterials; 
however, inconsistent results between in vitro and in vivo studies suggest the 
mechanisms that govern a material’s capacity to mediate osteogenesis are not well 
understood. The emerging field of osteoimmunology and immunomodulation has 
informed a paradigm shift in our view of bone biomaterials–from one of an inert to an 
osteoimmunomodulatory material–highlighting the importance of immune cells in 
materials-mediated osteogenesis. Neglecting the importance of the immune response 
during this process is a major shortcoming of the current evaluation protocol. In this 
study we evaluated a potential angiogenic bone substitute material cobalt incorporated 
with β-tricalcium phosphate (CCP), comparing the traditional “one cell type” approach 
with a “multiple cell types” approach to assess osteogenesis, the latter including the 
use of immune cells. We found that CCP extract by itself was sufficient to enhance 
osteogenic differentiation of bone marrow stem cells (BMSCs), whereas this effect 
was cancelled out when macrophages were involved. In response to CCP, the 
macrophage phenotype switched to the M1 extreme, releasing pro-inflammatory 
cytokines and bone catabolic factors. When the CCP materials were implanted into a 
rat femur condyle defect model, there was a significant increase of inflammatory 
markers and bone destruction, coupled with fibrous encapsulation rather than new 
bone formation. These findings demonstrated that the inclusion of immune cells 
(macrophages) in the in vitro assessment matched the in vivo tissue response, and that 
this method provides a more accurate indication of the essential role of immune cells 
when assessing materials-stimulated osteogenesis in vitro.  
INTRODUCTION 
With a more sophisticated understanding of the interaction between host tissues and 
biomaterials, it has come to an appreciation that the immune response is an essential 
component of the biomaterials-mediated reconstruction of a functional tissue. The 
immune system is modulatory and can be manipulated by modifying the properties of 
biomaterials. Accordingly, the paradigm on the nature of biomaterials has shifted from 
being an ‘inert’ (i.e. biocompatible) material to ‘immunomodulatory’; the focus now 
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being to apply strategies that incorporates, modulates and even encourages an immune 
response rather than attempting to suppress it [8, 87, 236]. The close relationship 
between the immune and skeletal systems was flagged already in the 1970s [237, 238]. 
Immune cells participate actively in bone dynamics under both physiological and 
pathological conditions via secretion of a number of regulatory molecules, including 
cytokines, signalling molecules and transcription factors. The term osteoimmunology 
was thereby proposed to cover the overlapping scientific fields of osteology and 
immunology [7, 9]. Due to the specialized nature of immuno-biology within the bone 
environment, modulation of bone immune response should be categorized as 
osteoimmunomodulation, and the immunomodulatory property of bone biomaterials 
should be modified as the “osteoimmunomodulatory” property [239].  
As direct effector cells for osteogenesis, osteoblastic lineage cells are commonly used 
to evaluate the in vitro osteogenic capacity of bone substitute materials, a strategy that 
had some success when developing novel bone biomaterials. However, inconsistencies 
between in vitro and in vivo studies are not uncommon, and many bone substitute 
materials developed using this approach are subsequently found to underperform in 
vivo in term of bone regeneration. Based on the knowledge of the immunomodulatory 
properties of biomaterials and osteoimmunology it is a logical extension that the 
traditional strategy, which relies only on the response of osteoblastic lineage cells, is 
insufficient for evaluating and developing bone biomaterials and that neglecting the 
role of immune cells may account for the inconsistent results between the in vitro and 
in vivo experiments. An earlier study by our lab has demonstrated the important role of 
macrophages in the β-tricalcium phosphate (β-TCP)-mediated osteogenic 
differentiation of bone mesenchymal stem cells (BMSCs) [240], which implies the 
need to include immune cells in the evaluation strategy.  
Macrophages are innate immune cells and have a key role as effector cells in the 
material-induced immune response by initiating and maintaining inflammation; this 
process closely correlates with the formation of a fibrous capsule. Macrophages also 
influence bone physiology and pathology [48, 88] by acting as precursors to 
osteoclasts, thus participating directly in bone remodelling and material degradation. 
Macrophages have a direct role in osteogenesis by the expression and secretion of 
important regulatory molecules [44], such as bone morphogenetic protein 2 (BMP2) 
and transforming growth factor β (TGF-β) [45, 46]. As such, macrophages are 
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required for the efficient osteoblast mineralization and their depletion dampen 
osteoblast bone forming capacity [48]. This suggests that macrophages could be the 
key cell type determining the in vivo fate of bone substitute materials. Given this 
important role in the bone dynamics, a macrophage cell line was applied as a model 
immune cell for the in vitro evaluation of osteogenesis with bone substitute 
biomaterials. 
β-TCP is a well-documented osteoconductive biomaterial and has already been applied 
in bone regeneration [213-215]. However, there are still major challenges to 
overcome, not least the issue of nutrient supply and cell viability, particularly in the 
centre of the defect. It is therefore of great importance to endow β-TCP with a capacity 
to aid in new blood vessel regeneration to overcome the issue of nutrient and oxygen 
exchange. Cobalt (Co) can mimic a hypoxic environment in vitro, thereby stabilizing 
hypoxia inducible factor (HIF) with the subsequent activation of HIF target genes such 
as vascular endothelial growth factor (VEGF) [177] which enhances angiogenesis. 
This prompted us to incorporate Co with β-TCP with (CCP), a combination that was 
found to enhance the in vitro angiogenesis [12] and suggested that CCPs could be a 
viable bone substitute material. However, on the downside Co has been reported to 
lead to increased inflammation [241, 242], something which usually has adverse 
effects on osteogenesis [243]. Overall this means that the osteogenic properties of 
CCP were uncertain, particularly if immune cells were factored in. We therefore 
applied CCP as a model bone substitute material to test the hypothesis that the absence 
of immune cells skews the results of in vitro experiments in such a way that, when the 
same material is used for in vivo experiments, they have little or no power to predict 
the material’s osteogenic capacity. 
In this study, we tested the in vitro osteogenic capacity of CCP and compared the 
traditional “one cell type” method with the novel approach of including macrophages. 
This was followed by an in vivo study which allowed us to compare the two in vitro 
results in order to determine if the inclusion of immune cells gives better power of 
prediction as to how a biomaterial would behave. The major contribution of this study 
is to apply the knowledge of osteoimmunology into the evaluation of bone substitute 
materials. Consequently, the term “osteoimmunomodulation” is proposed to describe 
this property and we discuss how its possible applications in the area of bone 
 74                                                                                                                                Chapter 4: Research Paper Two 
substitute materials, which provides a more accurate indication of the essential role of 
immune cells when assessing in vitro material-stimulated osteogenesis.  
MATERIALS AND METHODS 
Cell culture 
RAW 264.7 cells (RAW cells, a macrophage cell line) and human BMSCs were 
applied in the subsequent experiments. 5% heat inactivated foetal bovine serum (FBS, 
Thermo Scientific), and 1% (v/v) penicillin/streptomycin (Life Technologies) were 
added into Dulbecco’s Modified Eagle Medium (DMEM, Life Technologies) to 
prepare RAW cells culture medium (complete medium). RAW cell cultures were 
maintained in complete medium under a humidified environment with 5% CO2 and the 
temperature set at 37 ºC. The cells were gently scraped off and passaged when 
reaching around 90% confluence and expanded through two passages before used for 
the following experiments [244, 245].  
BMSCs were isolated and cultured as previously described [20, 217, 246]. Briefly, 
bone marrow was sourced from patients (age range: 50-60 years) undergoing elective 
hip or knee replacement surgery at the Prince Charles Hospital in Brisbane; informed 
consent was given by all donors and the ethic approval was from the Ethics Committee 
of Queensland University of Technology. Mononuclear cells were isolated from the 
bone marrow by density gradient centrifugation using Lymphoprep (Axis-Shield PoC 
AS, Oslo, Norway), following the manufacturer’s instructions. The isolated cells were 
transfer to culture flasks containing culture medium (DMEM supplemented with 10% 
FBS and 1% (v/v) penicillin/streptomycin) and incubated in a humidified incubator 
(37 ºC, 5% CO2). The unattached hematopoietic cells were removed via medium 
changes, and the attached cells were passaged using trypsin when reaching 90% 
confluence.  
Preparation of CCP and material extracts 
CCP was prepared using a chemical precipitation method, based on protocol from 
previous studies [12]. To obtain uniform particle size (180-250 μm), the synthesized 
powders were sieved with a 60-80 mesh prior to subsequent experiments. Following 
the standard ISO/EN 10993-5, RAW cells were cultured in mediums with of CCP 
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powder extracts [12, 218]. CCP powders were added in DMEM at defined weight to 
liquid ratios (200, 100, 50, 25, 12.5, 6.25, 0 mg/mL) to prepare material extracts. The 
liquid/powders mixtures were kept in a humidified environment with 5% CO2 and the 
temperature set at 37 ºC. After incubation 24 hours, the mixtures were centrifuged, and 
supernatants were collected and sterilized through 0.2 µm filter membranes (Pall 
Corporation, Port Washington, New York, USA).  
Determining the effects of CCP material extracts on the osteogenic differentiation of 
BMSCs 
Osteogenesis-related gene and protein expression in BMSCs 
The mRNA expression of the osteogenesis-related genes alkaline phosphatase (ALP), 
osteopontin (OPN), osteocalcin (OCN), and bone sialoprotein 2 (IBSP) was assayed in 
BMSCs. Cells were plated in 6-well plates at a density of 1.5 × 105 cells per well. 
After reaching 80% confluence, the medium was removed and replaced by medium 
containing material extracts (200 mg/mL). The stimulation time was 3 days, then total 
RNA of the treated BMSCs was extracted by using TRIzol reagent and the mRNA 
expression was analysed by RT-qPCR. 
Complementary DNA was synthesized from 500 ng total RNA using the DyNAmoTM 
cDNA Synthesis Kit (Finnzymes, Thermo Scientific). RT-qPCR primers used in this 
study were listed in Supplementary document Table 1. SYBR Green qPCR Master 
Mix (Life Technologies) was used for assay using an ABI Prism 7300 Thermal Cycler 
(Applied Biosystems, Foster City, California, USA). The relative expression was 
obtained by normalizing the mean cycle threshold (Ct) value of each target gene with 
the Ct value of the house keeping gene (GAPDH).  
For the protein extraction, RIPA (Radio-Immunoprecipitation Assay) buffer was 
added after 14 days. Whole cell lysates were then collected for the detection of ALP 
protein expression by Western blot. Proteins (15 mg) separation was performed on 
SDS-PAGE gels, which were subsequently transferred onto a nitrocellulose membrane 
(Pall Corporation, East Hills, New York, USA). The membranes were blocked in 
Odyssey blocking buffer for 1 hour (LI-COR Biosciences, Lincoln, Nebraska, USA), 
before incubation with a rabbit polyclonal anti-ALP antibody (1:10,000; Abcam, 
Sapphire Biosciences, NSW, Australia) and a rabbit polyclonal anti- α-tubulin 
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antibody (1:5,000; Abcam) overnight at 4 °C. After washed three times by TBS-
Tween buffer, anti- rabbit IRDye 800 conjugated secondary antibody (Rockland, 
Gilbertsville, Pennsylvania, USA) at 1: 10,000 dilutions was added and kept for 1 hour 
at room temperature. The protein bands were visualized and the generated images 
were taken using the Odyssey infrared imaging system (LI-COR Biosciences). The 
quantification of protein bands were analysed using Image J software 
(http://imagej.nih.gov/ij/).  
Alkaline phosphatase activity of BMSCs 
BMSCs were seeded in 24-well plates at a density of 35,000 cells per well. After 
reaching 80% confluence, the medium was removed and replaced by medium 
containing material extracts and osteogenic supplements (2 mM β-glycerophosphate, 
100 µM L-ascorbic acid 2-phosphate, 10 nM dexamethasone; Sigma–Aldrich, NSW, 
Australia). The ALP activity assay was performed after 7 days of stimulation. Triton 
X-100 (100 μL, 0.2%) was applied to lysed the cells were lysed. The collected lysates 
were then centrifuged at 18,000 g for 15 min at 4 °C. 150 μL of working solution was 
mixed with 50 μL supernatant samples, which was subsequently evaluated using the 
QuantiChromTM Alkaline Phosphatase Assay Kit (BioAssay Systems, Biocore, NSW, 
Australia) following the manufacturer’s instructions. The ALP activity was calculated 
as the changed optical density (OD) values. 
The mineralisation of BMSCs 
Alizarin Red S staining was used to identify mineralisation nodules by BMSCs grown 
for 14 days in material extracts with osteogenic supplements.  Paraformaldehyde (4% 
in PBS) was applied to fix the cells for 10 min at room temperature. After gently 
rinsing with ddH2O, 2% Alizarin Red S (pH 4.1) were added and kept for 20 min to 
visualise the nodules. Images were captured by light microscopy after the samples 
were air-dried. 
Determining the effects of CCP material extracts on phenotype switch of 
macrophage 
Proliferation of RAW264.7 cells with CCP extracts 
MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] assay was used  
to evaluate the proliferation of RAW cells with CCP extracts. RAW cells were seeded- 
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Supplementary document Table 1 Primer pairs used in the qRT-PCR. 
Genes Primer sequences 
IL10 Forward: 5'- GAGAAGCATGGCCCAGAAATC -3' 
Reverse: 5'- GAGAAATCGATGACAGCGCC-3' 
IL1ra Forward: 5'- CTCCAGCTGGAGGAAGTTAAC -3' 
Reverse: 5'- CTGACTCAAAGCTGGTGGTG -3' 
TNFα Forward: 5’-CTGAACTTCGGGGTGATCGG-3’ 
Reverse: 5’-GGCTTGTCACTCGAATTTTGAGA-3’ 
IL1β Forward: 5'- TGGAGAGTGTGGATCCCAAG -3' 
Reverse: 5'- GGTGCTGATGTACCAGTTGG -3' 
IL6 Forward: 5'- ATAGTCCTTCCTACCCCAATTTCC -3' 
Reverse: 5'- GATGAATTGGATGGTCTTGGTCC -3' 
IFNγ Forward: 5'- GGCCATCAGCAACAACATAAGC -3' 
Reverse: 5'- GGGTTGTTGACCTCAAACTTGG -3' 
HIF-1α Forward: 5'- TCAAGCAGCAGGAAT TGGAAC  -3' 
Reverse: 5'- CAGTCTGCATGCTAAATCGGAG -3' 
HIF-2α Forward: 5'- GAGGTCTGCAAAGGACTTCG -3' 
Reverse: 5'- GAAGGCTTGCTCCTCATACTC -3' 
MCSF Forward: 5'- AGCAGAACAAGGCCT GTGTC -3' 
Reverse: 5'- AAGCTGTTGTTGCAGTTCTTG G -3' 
TRAP Forward: 5'- CACTCCCACCCTGAGATTTGT-3' 
Reverse: 5'- CATCGTCTGCACGGTTCTG-3' 
BMP2 Forward: 5’-GCTCCACAAACGAGAAAAGC-3’ 
Reverse: 5’-AGCAAGGGGAAAAGGACACT-3’ 
VEGFa Forward: 5’-GTCCCATGAAGTGATCAAGTTC-3’ 
Reverse: 5’-TCTGCATGGTGATGTTGCTCTCTG-3’ 
TGFβ1 Forward: 5'- CAGTACAGCAAGGTCCTTGC-3' 
Reverse: 5'- ACGTAGTAGACGATGGGCAG-3' 
TGFβ3 Forward: 5'- CAACACCCTGAACCCAGAG -3' 
Reverse: 5'- CTTCACCACCATGTTGGACAG -3' 
Actinβ Forward: 5'- CATACCCAAGAAGGAAGGCTGG -3' 
Reverse: 5'- GCTATGTTGCTCTAGACTTCGAGC -3' 
ALP Forward: 5’-TCAGAAGCTAACACCAACG-3’ 
Reverse: 5’-TTGTACGTCTTGGAGAGGGC-3’ 
OPN Forward: 5’- TCACCTGTGCCATACCAGTTAA-3’ 
Reverse: 5’-TGAGATGGGTCAGGGTTTAGC-3’ 
OCN Forward: 5’-GCAAAGGTGCAGCCTTTGTG-3’ 
Reverse: 5’-GGCTCCCAGCCATTGATACAG-3’ 
IBSP Forward: 5’-TTTCTGCTACAACACTGGGCTATG-3’ 
Reverse: 5’-TTGTTATATCCCCAGCCTTCTTG-3’ 
GAPDH 
 
Forward: 5’-TCAGCAATGCCTCCTGCAC-3’ 
Reverse: 5’-TCTGGGTGGCAGTGATGGC-3’ 
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-in a density of 2,000 cells per well (96 well plate) and cultured overnight. The culture 
medium was subsequently removed and replaced by material extract media. At days 1, 
3 and 7, 20 µL of MTT solution (5 mg/mL in PBS) was added to the media in each 
well. The MTT/medium solution was removed after 4 hours culture and 100 µL of 
dimethyl sulfoxide was added to dissolve the formazan crystals. Quantitative detection 
was done on a microplate reader to measure the absorbance at the wavelength of 495 
nm.  
Flow cytometry  
Expression of macrophage surface markers CCR7 (M1 marker) and CD163 (M2 
marker) were detected by flow cytometry. After 3 days of stimulation by material 
extracts, the cells were physically detached and centrifuged. The cell pellets were 
resuspended with 1% w/v BSA/PBS to block nonspecific proteins. Samples were then 
incubated with primary antibodies [CCR7 (1:25) (GeneTex, Irvine, California, USA) 
and CD163 antibody (1:50) (AbD Serotec, Abacus ALS Australia, QLD, Australia)] in 
ice. After 30 min, FITC-anti-goat (Santa Cruz Biotechnology, VWR International, 
QLD, Australia) and Dylight 488-anti-mouse secondary antibodies (DAKO, Multilink, 
California, USA) were added to label CCR7 and CD163 respectively. The treated cells 
were analysed on a FC500 Flow Cytometer (Beckman Coulter Australia, QLD, 
Australia) and data analysis were accomplished using Flowing Software 
(www.flowingsoftware.com).  
Inflammatory cytokines expression in RAW cells treated with CCP extracts  
RAW cells were seeded in a density of 1.5 × 105 cells per well (6 well plate). After 
cell confluence reached 80 %, the culture medium was replaced by material’s extract 
media. After 3 days, the media were collected and clarified by centrifugation at 210 g 
and the supernatants were used for further enzyme-linked immunosorbent assay 
(ELISA). The supernatants were also mixed with culture medium at a ratio of 1:2 and 
kept in -80°C for the subsequent conditioned-media experiments. Total RNA was 
extracted from both groups and gene expression assays performed as previous section. 
For the ELISA, the IL-10 and IL-6 content were quantified using mouse ELISA kits 
(R&D Systems, Gymea, NSW, Australia) following the manufacturer's instruction. 
The IL-10 and IL-6 concentration were calculated by correlation with a standard 
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curve, and the results were presented as the amount (pg) of IL-10 and IL-6 per mL of 
supernatant. 
Mechanism of the inflammatory gene expression change  
The expression of HIF1α, HIF2α and nuclear factor of kappa light polypeptide gene 
enhancer in B-cells inhibitor alpha (IκB-α) were assayed. After 24 hours of stimulation 
by the material’s extract media, total RNA from RAW cells and whole RAW cell 
lysates were collected for the RT-qPCR (gene expression of HIF1α and HIF2α) and 
Western blot analysis as previous section, using a rabbit polyclonal anti-IκB-α 
antibody (1:1000; Cell Signalling Technology, QLD Australia), mouse monoclonal 
anti-HIF1α (1:1000, , Novus Biologicals, Sapphire Bioscience, NSW, Australia), and 
anti-α-tubulin (1:5000; Abcam).  
Determining the effect of Co ions on inflammation on gene expression in RAW264.7 
cells   
RAW cells were seeded in a 6-well plate at a density of 1.5 × 105 cells per well. After 
cell confluence reached 80 %, the culture medium was replaced by culture medium 
containing CoCl2 (50 μM). Complete culture medium was used as a negative control. 
After another 7 hours, inflammatory gene expressions were detected following the 
same method in previous section. 
Determining the effect of RAW cells-conditioned CCP extracts on the osteogenic 
differentiation of BMSCs 
Osteoclastogenesis and osteoinductive gene expression of RAW cells treated with β-
TCP and CCP extracts  
The osteogenic gene expression of RAW cells in response to material extracts were 
determined by assaying osteoinductive genes [BMP2, Vascular endothelial growth 
factor (VEGF), TGFβ1 and TGFβ3] and osteoclastogenesis related genes [macrophage 
colony-stimulating factor (MCSF) and tartrate-resistant acid phosphatase (TRAP)]. 
After 3 days of stimulation by the material’s extract media, total RNA from RAW 
cells was collected for the RT-qPCR analysis as previous section. 
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Bone-related gene and protein expression, ALP activity and mineralisation of BMSCs 
The mRNA expression of bone-related genes (ALP, OPN, OCN, and COL1) and 
protein expression of ALP in BMSCs was assayed. BMSCs were plated at a density of 
1.5 × 105 cells per well in separate 6-well plates. After 24 hours of incubation, the 
culture medium was removed and replaced with conditioned media described in 
previous section. Total RNA was extracted using TRIzol reagent after 3 days of 
culture, and analysed by RT-qPCR, as described in previous section. The whole cell 
lysates were collected after 14 days of culture, and analysed by Western blot, as 
described in previous section, with primary antibodies against ALP (1:10,000; 
Abcam), and α-tubulin (1:5,000; Abcam). ALP activity was detected as described in 
previous section. Alizarin Red S staining was applied to identify mineralisation 
nodules, as described in previous section. 
Animal surgery 
Ten week old Wistar rats were used to compare results from in vivo experiments with 
the in vitro experiments. Animal surgery protocols had the approval of the Animal 
Ethics Committee of Queensland University of Technology. Surgeries were performed 
on the animals while they were under general anaesthetics using isoflurane. β-TCP and 
CCP powders were embedded subcutaneously in the back of the rats to investigate the 
inflammatory reaction towards these two materials. A 1cm incision was made in the 
back skin of the rats and a pocket on each side was created subcutaneously for 
implantation of the materials. To enable the handling of the bone substitute materials 
for subcutaneous transplantation, the powder materials were mixed with blood and 
allowed 15 mins to settle to make them implantable. All the animals were sacrificed 
after one week, after which the samples were collected and put into the RIPA lysis 
buffer and stored in -80°C freezer for the further ELISA analysis (IL-1β, TNFα, IFNγ, 
IL-6, and IL-10). 
The medial femoral condyles were used to test the materials in a bone defect model. 
Following knee arthrotomy, a 3 mm wide and 3 mm deep bone defect was made on 
the medial condyles of the femur using a trephine drill. β-TCP and CCP powders were 
mixed with saline solution to make a paste that was deposited into the defects. 
Gentamycin (5 mg/kg) was administered intra-muscularly as a prophylactical to avoid 
infections of the wound. All animals were sacrificed after four weeks by means of a 
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barbiturate intracardiac injection, after which soft tissues were removed and the 
femoral condyles harvested. The samples were fixed in 4% paraformaldehyde at room 
temperature.  
ELISA analysis of the subcutaneous implant samples 
All collected subcutaneous implant samples were homogenised using a beadbeater 
machine (Mini-Beadbeater-24, BioSpec, Bartlesville, USA) and then centrifuged at 
14,000 g for 15 mins. After measuring protein concentration in the supernatant using 
BCA essay, 100 µg total proteins in 100 µl lysis buffer were applied for the IL-1β, IL-
6, TNFα, IFNγ, and IL-10 rat ELISA essay (R&D Systems) performed as per previous 
section. 
Histological Haematoxylin and Eosin (H & E) staining 
Femoral bone samples were decalcified in 10% ethylenediaminetetraacetic acid 
(EDTA) for 4 weeks. After embedding the samples in paraffin, 5 µm-thick serial 
sections were generated from the paraffin blocks using a microtome. H & E staining 
were performed in selected slides from each sample (HD Scientific, Wetherill Park, 
NSW, Australia) [20]. Briefly, after dewaxing and hydration, cell nuclei were stained 
by Mayer’s haematoxylin. Following dehydration, eosin was applied to stain cell 
plasma and extracellular matrix. Images of the stained slides were captured using a 
Zeiss Axion light microscope (Carl Zeiss Australia, NSW, Australia). 
Immunohistochemical staining 
Selected slides were used for immunohistochemical staining [20]. The universal 
macrophage marker CD68 (Abcam), M1 macrophage markers CCR7 (Novus 
Biologicals) and CD11c (AbD Serotec), and M2 macrophage markers CD163 (AbD 
Serotec) were detected. Tissue slices were dewaxed, hydrated and endogenous 
peroxidase activity eliminated by incubating in 3% H2O2 for 15 min. Non-specific 
proteins were blocked with the incubation of 10% swine serum for 1 hour. Samples 
were incubated with CD68, CCR7, CD11c, and CD163 antibodies (1:300, 1:25, 1:100, 
1:100 respectively) overnight at 4 ºC. After removal of first antibodies, the samples 
were then incubated with a biotinylated swine-anti-mouse, rabbit, goat secondary 
antibody (DAKO) for 15 min at RT, and then treated with steptavidin peroxidate 
(DAKO) for 15 min. The antibody complexes were visulaized by Diaminobenzidine 
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(DAB) solution. Finally, the samples were counter stained with Mayer’s haematoxylin 
for 15 seconds. Images of the stained slides were captured using a Zeiss Axion light 
microscope. 
TRAP staining 
Acetate, tartarte, naphthol AS-BI phosphate, and fast garnet GBC salt solutions were 
mixed in 50 mL of distilled water to prepare the TRAP buffer, according to the 
manufacturer’s instructions (Sigma-Aldrich, NSW, Australia). TRAP buffer without 
tartrate solution was applied as control. After dewaxing and hydration, samples were 
incubated in TRAP buffer or control buffer for 20 min at RT. Samples were then 
incubated for one hour in a humidity environment with the temperature of 37°C. After 
rinsed in distilled water, the samples were counterstained with Mayer’s haematoxylin 
(Sigma-Aldrich). Images of osteoclast activity were captured using a Zeiss Axion light 
microscope. 
Statistical analysis 
Statistical analyses were performed using SPSS software (IBM SPSS, Armonk, New 
York, USA). Data is presented as means ± standard deviation (SD) and analysed using 
one-way ANOVA followed by LSD post hoc test. The level of significance was set at 
P < 0.05. 
RESULTS 
Effects of CCP material extracts on the osteogenic differentiation of BMSCs 
The mRNA expression of the mineralization-related genes OCN and IBSP were 
significantly upregulated in BMSCs stimulated by CCP extracts compared to β-TCP 
extracts (P < 0.05) (Figure 1 A). Western blot analysis showed that ALP protein 
expression had increased significantly in BMSCs incubated in CCP extracts for 14 
days compared with β-TCP treated cells (Figure 1 B). ALP activity also increased in 
the CCP treatment group compared to the controls (Figure 1 C). Alizarin Red S 
revealed mineralized nodules in both groups when subjected to osteogenic 
supplements (Figure 1 D); however, the nodules were more distinct in BMSCs 
stimulated by CCP extract than that by β-TCP extract (Figure 1 D).  
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Figure 1 The effect of CCP extracts on osteogenic differentiation of BMSCs: (A) RT-
qPCR results of osteogenesis marker genes (ALP, OPN, OCN, IBSP), (B) Western 
blot results of ALP, (C) ALP activity results, (D) Alizarin red results, OM: osteogenic 
medium, Negative: BMSCs cultured in standard medium only. *: Significant 
difference (P < 0.05) for CCP extract group compared to β-TCP extract group. 
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Supplementary document Figure 1 The proliferation of RAW cells in medium with 
different concentrations of material extracts, detected by MTT. *: Significant 
difference (P <0.05) for CCP extract group compared to negative control group. 
 
Effects of CCP material extracts on the phenotype switch of macrophage 
Proliferation of RAW cells with β-TCP extracts 
RAW cells grew well in both complete medium and CCP material extracts. The MTT 
assays showed there was no significant difference in cell proliferation between 
treatment groups (supplementary document Figure 1). The medium with the highest 
solid/liquid ratios (200 mg/mL) of material extracts was used for subsequent in vitro 
studies. 
Flow cytometry  
The M1 surface marker CCR7 showed that approximately 18% more CCP extracts 
treated RAW cells had shifted to a higher fluorescence value compared to β-TCP 
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treatment group (Figure 2). The CD163 surface marker showed no significant shift to 
the M2 type; however, the mean fluorescence intensity of the CCP group was smaller 
than that of the β-TCP treatment group (Figure 2). 
Inflammatory gene expression in RAW264.7 cells treated with β-TCP and CCP 
extracts and its mechanism 
The mRNA expression of the anti-inflammatory gene IL1ra had significantly 
downregulated in RAW cells subjected to CCP extracts (P < 0.05) (Figure 3 A), 
whereas the expression of the inflammatory genes IL1β and IL6 had significantly 
upregulated in response to the same treatment (P < 0.05) (Figure 3 A). Neither IFNγ 
nor IL10 showed any significant changes in response to CCP treatment (Figure 3 A). 
IL-10 and IL-6 ELISA results showed similar trends. No significant change was 
observed in release of IL-10 cytokine, whereas the release of IL-6 was significantly 
enhanced (supplementary document Figure 2).  
 
Figure 2 FACS results. RAW cells stimulated with β-TCP and CCP material extracts, 
and then stained with M1 marker CCR7, M2 marker CD163. The mean fluorescence 
intensity was also calculated.  
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Figure 3 Relative mRNA expression of a panel of gene markers in RAW cells 
following stimulation with β-TCP extracts (red bars) or CCP extract (green bars). (A) 
Inflammatory genes: IL-1β, IL-6, IFNγ, IL-10, and IL-1ra. (B). Osteogenesis related 
genes: TRAP, MCSF, TGF β1, TGF β3, VEGF, and BMP2. *: Significant difference (P 
< 0.05) for CCP extract group compared to the β-TCP extract group. 
To explore the mechanism of inflammation related gene expression changes, we 
examined the expression of HIF-1α, HIF-2α, and IκB-α at both gene and protein 
levels. The mRNA expression of both HIF-1α and HIF-2α was both upregulated in 
response to CCP extract treatment (supplementary document Figure 3 A). HIF-1α 
protein expression was also increased, while the expression of IκB-α was 
downregulated in the CCP treatment group (supplementary document Figure 3 B). 
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Supplementary document Figure 2 Release of inflammatory cytokines IL-6 and IL-
10 by RAW cells with the stimulation of material extracts. *: Significant difference (P 
< 0.05) for CCP extract group compared to the β-TCP extract group. 
 
 
Supplementary document Figure 3 Relative mRNA expression of inflammation 
related genes: HIF 1α and HIF 2α on RAW cells when stimulated by material extracts 
(A); Western blot analysis of HIF 1α and IκB-α expression of RAW cells stimulated 
with material extracts (B). *: Significant difference (P <0.05) for CCP extract group 
compared to β-TCP extract group. 
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Supplementary document Figure 4 Relative mRNA expressions of inflammation 
related genes: IL-1β, IL-6, IFNγ, IL-10, and IL-1ra on RAW cells when stimulated 
with CoCl2 containing medium. *: Significant difference (P < 0.05) for CoCl2 group 
compared to culture medium only group. 
The effects of Co ions on the inflammatory gene expression of RAW264.7 cells   
To better understand the effects of Co on inflammatory response in RAW cells, CoCl2 
was applied to the culture medium. mRNA expression of the anti-inflammatory gene 
IL-10 was significantly downregulated in response to CoCl2 (P < 0.05) 
(supplementary document Figure 4 D) whereas the expression of the pro-
inflammatory genes, IL1β, IL6 and IFNγ, were significantly upregulated in response to 
this treatment (P < 0.05) (supplementary document Figure 4 A, B, C).  
Effects of RAW cells-conditioned material extracts on the osteogenic differentiation 
of BMSCs 
The expression of the osteoclastogenesis related genes TRAP and MCSF was 
upregulated in response to CCP extract treatment (P < 0.05) (Figure 3 B). The gene 
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expression of TGFβ1 was downregulated, whereas the expression of both TGF-β3 and 
VEGF was upregulated (Figure 3 B). The mRNA expression of BMP2 showed no 
change in response to CCP extract treatment (Figure 3 B). 
 
Figure 4 The effect of macrophage conditioned CCP extracts on osteogenic 
differentiation of BMSCs: (A) RT-qPCR results of osteogenesis marker genes (ALP, 
OPN, OCN, IBSP), (B) Western blot results, (C) ALP activity results, (D) Alizarin red 
results, OM: osteogenic medium, Negative: BMSCs cultured in standard medium 
only. *: Significant difference (P < 0.05) for CCP extract group compared to β-TCP 
extract group. 
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The mRNA expression of mineralization-related genes ALP, OPN, OCN, IBSP was 
significantly downregulated in BMSCs stimulated by RAW cell conditioned CCP 
extract compared to β-TCP extract (P < 0.05) (Figure 4 A). Western blot analysis 
showed that the protein expression of ALP was significantly downregulated in 
response to conditioned CCP extract medium after 14 days’ stimulation, compared 
with β-TCP extract (Figure 4 B). ALP activity showed similar trend, downregulated 
by the conditioned CCP extract (Figure 4 C).  Alizarin Red S staining showed 
evidence of more distinct mineralization nodules in BMSCs stimulated by RAW 
cell/β-TCP extract than that by CCP extract (Figure 4 D). 
In vivo study results 
The week four implantation samples showed robust new bone formation around the β-
TCP materials and bone integration was seen with the remaining β-TCP particles 
(Figure 5 B, supplementary document Figure 5 B, D). By contrast, there was no 
evidence of new bone formation in the CCP groups; instead, the defect site was filled 
with a fibrous inflammatory tissue and the remaining CCP particles were engulfed by 
inflammatory tissue (Figure 5 A, supplementary document Figure 5 A, C).  
To confirm the presence of macrophages, cells were immunostained with CD68. 
Macrophages and osteoclasts, which both stain positive for CD68, can be 
distinguished from each other morphologically: osteoclasts are larger in size and 
multinucleated. CD68 positive cells were seen in both treatment groups, but only the 
β-TCP group had large multinucleated CD68 positive cells, indicative of the 
macrophages having differentiated into osteoclasts for the purpose of degrading the 
materials (Figure 5 D, F). By contrast, the CD68 positive cells in the treatment CCP 
group were smaller and mono-nucleated, indicating that these macrophages were 
undifferentiated, but remained in situ as immune cells participating in the 
inflammatory response (Figure 5 C, E).  
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Figure 5 H&E staining, CCP group (A) and β-TCP group (B) 4 weeks after 
implantation. (A) Gross morphology of defect filled with CCP. There is no discernible 
new bone formation, instead the defect was predominantly filled with fibrous 
inflammatory tissue. (B) Gross morphology of defect filled with β-TCP. Newly 
formed bone can be seen throughout the defect. Identifications of macrophage and 
osteoclast (C-F). CCP group (C, E) and β-TCP group (D, F); CD68 IHC staining (C, 
D), H&E staining (E, F). C and E: CD68 positively stained cells were small in size and 
usually with one nucleus. D and F: CD68 positively stained cells were larger in size 
and with multiple nuclei compared with CCP group. 
.
 92                                                                                                                                Chapter 4: Research Paper Two 
 
Supplementary document Figure 5 H&E staining, CCP group (A, C) and β-TCP 
group (B, D) 4 weeks after implantation. (A) High magnification of tissue from within 
the CCP filled defect. (B) High magnification of tissue from within the β-TCP filled 
defect. (C) Inflammatory tissue surrounding a CCP fragment. (D) De novo bone seen 
integrating with a β-TCP fragment. 
After confirming the presence of macrophage in the CCP group, 
immunohistochemical staining was performed using the M1 marker (CCR7, CD11c) 
and the M2 marker (CD163) to determine the predominant phenotype switch. More 
CCP treatment cells were positive for CCR7 and CD11c (M1) than CD163 (M2) 
(Figure 6 B) and the ELISA confirmed these results with the release of inflammatory 
cytokines (IL-1β, IFNγ, and IL-6) being significantly higher in the CCP treatment 
group compared to the β-TCP group (Figure 6 A).  
The boundary of the β-TCP filled defect appears blurred, the result of integration with 
the new bone (Figure 7 B). Adjacent osteoclasts are likely to be engaged in bone 
formation and remodelling (Figure 7 D, F). The boundary of the CCP filled defect 
also show evidence of remodelling; it is, however, surrounded by a fibrous capsule 
rather than de novo bone (Figure 7 A). In some areas, degradation of old bone is 
apparent and corresponds to a greater number of highly activated osteoclasts (Figure 7 
C, E). 
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Figure 6 (A). ELISA from subcutaneous implant samples show protein expression of 
inflammatory markers (red bars = β-TCP; green bars = CCP): IL-1β, TNFα, IFNγ, IL-
6, and IL-10; (B) IHC staining of CCP group: CCR7 and CD11c positive cells can be 
seen in respective panels (black arrows indicates positive staining cells). Almost no 
CD163 positive cells were detected. 
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Figure 7 Bone remodelling and destruction on the boundary of bone defect. CCP 
group (A, C, E) and β-TCP group (B, D, F); H&E staining (A, B), CD68 IHC staining 
(C, D), TRAP staining (E, F). (A) Boundary of the defect filled with CCP. Fibrous 
capsule was formed to confine the inflammation (See arrows). (B) Boundary region of 
the β-TCP filled defect. The edge of the defect has become diffuse as new bone is 
integrated into the defect(See arrows). (C) CCP filled defect. Red circle shows site of 
old bone being resorbed by activated osteoclasts in situ. (D) Defect filled with β-TCP. 
Osteoclasts are engaged in active bone remodelling and integration of old and newly 
formed bone. (E) Defect filled with CCP. The destruction of the old bone, with the 
highly activated osteoclasts was observed in situ (See arrows); fibrous capsule was 
formed to preserve the normal bone tissue. (F)  Defect filled with β-TCP. Osteoclasts 
are engaged in degradation of the biomaterial and bone remodelling. 
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DISCUSSION 
Angiogenesis is essential for cell survival and new bone regeneration by facilitating 
nutrient and gas exchange. In an earlier study we demonstrated that cobalt ions could 
mimic a hypoxic environment and stabilize HIF in CCP-type materials with 
subsequent activation of the HIF target gene VEGF and enhanced the in vitro 
angiogenesis. Using a traditional “one cell type” method of evaluation, we showed that 
CCP extracts by itself could enhance the angiogenic activity and osteogenic 
differentiation of BMSCs. By comparison, in the present study we found that 
macrophage-conditioned CCP extracts inhibited osteogenic differentiation of BMSCs. 
This may be related to the observed switch of the macrophage phenotype to the M1 
extreme, which resulted in the release of inflammatory cytokines. In vivo studies 
confirmed that CCPs failed to rehabilitate an induced bone defect, instead leading to 
the formation of a fibrous capsule. These findings demonstrate that a system of in vitro 
evaluation that includes macrophages will yield a more accurate prediction of the in 
vivo properties of a potential bone substitute biomaterial than does the use of 
osteoblastic lineage cells only. These findings confirm the already documented role of 
immune cells (macrophages) in bone metabolism and are an indication that the role of 
macrophages in modulating osteogenesis of bone substitute materials. 
CCP modulated macrophages 
Compared to β-TCP extracts, CCP extracts elicited a significant effect on the 
behaviour of the macrophages by shifting their phenotype to an M1 extreme and 
enhancing inflammation. A previous study by our group showed that immersing CCPs 
in DMEM led to the release of Co ions [12]. Free Co ions can stabilise HIFs, which 
are known to participate actively in the maturation of macrophages and their 
functional activities [182-184]. It was a logical extension to speculate that the 
enhanced inflammation associated with CCP could be related to the release of Co and 
further stabilisation of HIFs. 
The macrophage phenotype exists along a continuum between the M1 and M2 
extremes [81], and the phenotype can switch in response to environmental cues. 
Functional properties, surface markers, and inducers are the three criteria that define a 
specific macrophage phenotype [68]. Following the induction by the CCP extract, 
more macrophages expressed the M1 surface marker CCR7 and released the pro-
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inflammatory cytokines IL-1β and IL-6. These results give a clear indication that 
macrophages switched to M1 phenotype in response to CCP stimulation. A similar 
effect to CCP was seen in in vivo, with macrophage polarization switching towards the 
M1 extreme.  
In addition their effects on angiogenesis, HIFs also elicit pro-inflammatory effects. 
Activation of HIF-1α is essential for the infiltration and activation of myeloid cells 
through a VEGF independent mechanism [181]. HIF-1α is also required for the 
functional maturation of macrophages [182]. Pro-inflammatory cytokines (TNFα, IL-1 
α/β) and lipopolysaccharide (LPS) could reversely activate HIF-1 [183, 184], 
amplifying the inflammation. In addition to HIF-1α, HIF-2α is also regarded as an 
important regulator of innate immunity. HIF-2α knockout mice show a resistance to 
the inflammatory effects of LPS-induced endotoxemia [247]. Therefore, the 
mechanism underlying the CCP-mediated macrophage phenotype switch may be 
related to the activation of HIF-1α and HIF-2α, resulting in the release of pro-
inflammatory cytokines. 
CCP modulated macrophages reverse the osteogenic effects of CCP 
Conditioned medium from LPS-activated inflammatory M1 macrophages can induce 
pre-osteoblast cells to differentiate towards a fibroblast phenotype, even when grown 
in osteogenic medium; it is thought this may be related to the upregulation of pro-
inflammatory cytokines (TNFα, IL-1β and IL-6) [56, 57]. TNF-α has been shown to 
have an inhibitory effects on mineralization and the expression of osteogenic markers 
of osteoblastic cells [58, 59], whereas the upregulation of IFN-γ and TNF-α by T 
lymphocytes is thought to be responsible for the failure of MSCs based bone tissue 
regeneration [60]. It seems that excessive inflammation (high release of pro-
inflammatory cytokines) impedes osteogenic differentiation. In the present study, 
although osteogenic differentiation of BMSCs was enhanced by CCP, this effect was 
attenuated by the release of pro-inflammatory cytokines when macrophages were 
included.  
In addition, inflammation goes hand-in-hand with the destruction of bone tissue [248]. 
Pro-inflammatory cytokines, such as TNFα, IL-1 and IL-6, can enhance 
osteoclastogenesis and osteoclast activities [249]. The upregulation of IL-1β and IL-6 
in particulate can synergistically increase the release of receptor activator of nuclear 
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factor kappa-B ligand (RANKL) [24], which, together with the upregulated MCSF, 
accelerates osteoclastogenic differentiation. Both RANKL and MCSF are the key 
cytokines for survival and differentiation of osteoclasts [24]. HIF-2α was also found to 
enhance the expression of catabolic factors, including matrix metalloproteinases which 
are active participants in the destruction of the bone [250].  From the in vitro 
experiments, we detected an increase of pro-inflammatory cytokines (such as IL-1β 
and IL-6), and other bone destructive factors (such as MCSF and HIF-2α), as well as 
the upregulation of TRAP expression which is indicative of increased bone loss. The 
in vivo study demonstrated destruction rather than regeneration of bone associated 
with CCP and the high osteoclatic activities, as shown by the TRAP staining, was 
consistent with the in vitro outcomes. 
In order to confine the over-active immune response, the host body forms a fibrous 
capsule around the inflammatory core in an effort to protect the normal tissue. TGF-β3 
is a key regulator of fibroblast activation in fibrotic disease and responsible for the 
synthesis of many extracellular matrix proteins involved in fibrosis, including type 1 
collagen, fibronectin, laminin, and proteoglycans. VEGF is another important cytokine 
for fibrosis, playing fundamental role in the angio- and vasculogenesis [228]. TGF-β3 
and VEGF were both upregulated by CCP extract and this may account for the 
formation of fibrous encapsulation and the lack of bone formation.  
It must be stressed that although CCP fails to repair the bone defect, it does not follow 
that hypoxia-mimicking bone substitute materials should be abandoned, but rather that 
the effects of immune cells must be taken into account when developing this type of 
bone substitute materials, especially in respect to its osteogenic capacity. The effects 
of Co ions in osteogenesis, osteoclastogenesis, and inflammation may in fact be dose 
and time dependent. It is therefore imperative that further study be carried out to 
determine the optimum Co ion concentration necessary for bone tissue engineering 
application. 
The need to include immune cells when evaluating novel bone substitute materials 
The mechanisms that govern osteogenesis mediated by bone substitute materials 
involve at least three interactive aspects: host immune cells, bone cells and material 
(Figure 8). Immediately following its implantation, the biomaterial will elicit a 
number of universal inflammatory responses from the host body. These include blood 
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clot formation, protein adsorption forming the transient matrix, and acute 
inflammation (neutrophil migration, mast cells degranulation and antigen presenting). 
The macrophage derived osteoclasts and foreign body giant cells will commence 
decomposing the implants, releasing foreign components into the immediate vicinity 
and altering the local environment. Dendritic cells can ingest potent antigens (such as 
necrotic cells and tissues, proteins with conformation changes mediated by the 
implants) and present them to humoral immune cells (T cells), also release cytokines 
to alter the immune environment to initiate and determine the further antigen-specific 
immune response, which is of particular importance in the nanomedicine [251, 252]. 
The released components could also lead to activation of osteoblastic cells, followed 
by osteogenic differentiation and de novo bone formation on the surface of the 
materials. During the bone remodelling phase, newly formed bone undergoes 
functional remodelling and the entrapped materials will be further degraded. Bone 
remodelling takes its cues from functional loading and the mechanical strain. 
Osteocytes are known to translate signals related to mechanical strain into biochemical 
signals and regulate osteoblasts and osteoclasts, therefore may play a key role in this 
late stage [18-20].  
 
Figure 8 Schematic showing the three phases involved in the mediation of 
osteogenesis by bone substitute materials. An early phase, which involves blood clot 
formation and an acute inflammatory response; the bone formation phase, which 
involves a chronic inflammation and the beginning of de novo bone formation; and the 
bone remodelling phase, which involves osteocytes and osteoclasts. The whole process 
involves the interaction of at least three separate aspects: host immune cells, bone cells 
and the biomaterial(s). 
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Given the close relationship between the immune and skeletal systems, it should come 
as no surprise that stimulated immune cells can also secrete osteogenesis regulating 
cytokines. An appropriate immune reaction should release an adequate amount of 
osteogenic cytokines to facilitate osteogenesis, whereas an inappropriate immune 
reaction can lead to a chronic inflammation and the fibrous encapsulation of the 
implant. This study supports our hypothesis regarding the important role of immune 
cells in biomaterial-stimulated osteogenesis. The traditional approach of only using 
osteoblastic lineage cells when evaluating such biomaterials is clearly inadequate, 
especially in term of the osteoimmunomodulatory properties of the materials. Immune 
cells, such as macrophages, dendritic cells, and T and B cells, must be included when 
evaluating in vitro osteogenesis mediated by bone substitute materials. The realization 
that immune cells actively participate in material mediating osteogenesis is meaningful 
in providing a theoretical basis when developing bone substitute materials that can 
enhance new bone formation. The aim should be to develop “smart” materials capable 
of modulating the immune response in a way that enhances the new bone formation. 
Future studies should focus on the components of the immune system that, when 
triggered by the biomaterial, can enhance osteogenesis. Knowledge such as this will 
inform the design paradigms for the next generation of bone substitute materials. 
It should be noted that the in vitro evaluation system has been deliberately simplified 
to focus only on ions released from β-TCP and CCP into culture mediums, so that the 
effects of osteoimmunomodulation can be better assessed. There are a number of other 
biomaterials properties of biomaterials that can affect the immune response, such as 
surface properties, particle size, porosity, and pore size, all of which must be 
considered when optimising the fabrication parameters of a novel potential bone 
substitute material. Although RAW264.7 cells are well-established macrophage cell 
line and have been used widely in the macrophage-related studies, more macrophage 
cell lines or primary macrophages should be tested when applying this novel in vitro 
evaluation system in the future to draw firmer conclusions of a biomaterial’s 
suitability as a bone substitution scaffold. 
CONCLUSIONS 
CCP extract alone can enhance the in vitro osteogenic differentiation of BMSCs, but 
this effect is cancelled out when macrophages are included. This is principally due to 
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the release of pro-inflammatory cytokines when the macrophages switch to an M1 
phenotype. The in vivo study confirmed that CCP had no positive effect on bone 
regeneration but rather led to bone resorption and fibrous encapsulation of the implant. 
This is a strong indication that neglecting the influence of immune cells, such as 
macrophages, may account for the inconsistencies between the in vitro and in vivo 
osteogenesis. The influence exerted by the bone substitute material on the surrounding 
immune environment, and its effect on osteogenesis, must be considered when 
evaluating the osteogenic capacity of bone substitute biomaterials. In our view, the 
strategy of actively engaging the immune system to regulate the functional behaviours 
of bone cells is a valuable addition when developing advanced bone substitute 
materials with immune-osteogenic properties. 
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SUPPLEMENTARY DOCUMENTS FOR RESEARCH PAPER TWO 
For the bone defect model, the medial femoral condyles were used for the test of 
biomaterials. The animals were operated bilaterally at the same time. The knees were 
shaved and disinfected, then an incision made on the skin followed by the retraction of 
muscle and skin. Following a knee arthrotomy, a drilled bone defect of 3mm diameter 
and a 3mm depth was made on the medial condyle of the femur. This was done by 
means of a Satelec Suni Expert Dental Surgery System with a Straumann drill 
(diameter: 2.8 mm), using the speed of 1500 rpm and cooling with 9000 ppm saline 
irrigation. The cavity was made using a spherical drill. Both femurs are used on each 
rat, implanted with the corresponding powder materials in one femoral condyle, while 
the other femoral condyle left empty as control.  
           
Figure 9 The implantation of bone substitute materials into the femur condyle bone 
defect. The knees were shaved and disinfected (A), and an incision was made on the 
skin (B). Following a knee arthrotomy, the femur condyle was exposed (C), and a 
drilled bone defect was made on the medial side using a Straumann drill (D, E). The 
materials were carefully put into the defect (F). The wound was closed and sutured 
using suitable size sutures (3/0 or 4/0) (G). Alamycin Aerosol and Bitter Spray were 
sprayed on the suture surface to prevent infection and chewing on themselves (H). The 
operated rat recovered well after surgery (I). 
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ABSTRACT 
The osteoimmunomodulatory property of bone biomaterials is a vital property 
determining the in vivo fate of the implants. Endowing bone biomaterials with 
favorable osteoimmunomodulatory properties is of great importance in triggering 
desired immune response and thus supports the bone healing process. Magnesium 
(Mg) has been recognized as a revolutionary metal for applications in orthopedics due 
to it being biodegradable, biocompatible, and having osteoconductive properties. 
However, Mg’s high rate of degradation leads to an excessive inflammatory response 
and this has restricted its application in bone tissue engineering. In this study, β-
tricalcium phosphate (β-TCP) was used to coat Mg scaffolds in an effort to modulate 
the detrimental osteoimmunomodulatory properties of Mg scaffolds, due to the 
reported favorable osteoimmunomodulatory properties of β-TCP. It was noted that 
macrophages switched to the M2 extreme phenotype in response to the Mg-β-TCP 
scaffolds, which could be due to the inhibition of the toll like receptor (TLR) signaling 
pathway. VEGF and BMP2 were significantly upregulated in the macrophages 
exposed to Mg-β-TCP scaffolds, indicating pro-osteogenic properties of macrophages 
in β-TCP modified Mg scaffolds. This was further demonstrated by the macrophage-
mediated osteogenic differentiation of bone marrow stromal cells (BMSCs). When 
BMSCs were stimulated by conditioned medium from macrophages cultured on Mg-β-
TCP scaffolds, osteogenic differentiation of BMSCs was significantly enhanced; 
whereas osteoclastogenesis was inhibited, as indicated by the downregulation of 
MCSF, TRAP and inhibition of the RANKL/RANK system. These findings suggest 
that β-TCP coating of Mg scaffolds can modulate the scaffold’s 
osteoimmunomodulatory properties, shift the immune microenvironment towards one 
that favors osteogenesis over osteoclastogenesis. Endowing bone biomaterials with 
favorable osteoimmunomodulatory properties can be a highly valuable strategy for the 
development or modification of advanced bone biomaterials. 
INTRODUCTION 
Biomaterial implants exert a profound impact on host immune responses, which in 
turn may elicit detrimental or beneficial reactions that significantly affect the healing 
and repair process. The design paradigm of biomaterials have shifted accordingly, 
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from being relatively inert to having immunomodulatory properties; the emphasis is 
now that the implant-host interaction should lead to an immune response that is 
beneficial to the healing process [8]. The field of osteoimmunology has demonstrated 
that the immune and skeletal systems are closely related and share a number of 
cytokines, receptors, signaling molecules and transcription factors [7, 8]. The immune 
response is found to play a pivotal role in bone biomaterial-stimulated osteogenesis [8, 
9, 240]. This implies that the immunomodulatory properties of bone substitute 
materials are very important in determining the outcome of new bone regeneration. 
Given the nature of the bone environment with the involvement of bone cells, the 
immunomodulatory properties for bone biomaterials should be classified as 
osteoimmunomodulatory properties. Optimal osteoimmunomodulatory properties 
should be able to induce an inflammatory response, which creates an overall balance 
between osteogenesis and osteoclastogenesis that favors bone regeneration. The 
traditional design parameters for bone biomaterials have tended to mainly focus on the 
positive regulation of osteoblastic lineage cells; however, this approach fails to take 
into account the role of immune cells in regulating osteogenesis and 
osteoclastogenesis during the healing process, which follows the implantation of the 
material. We have proposed the need to include the response of immune cells, as well 
as bone cells, when evaluating novel bone biomaterials [240].  
Magnesium (Mg) has been found to be mechanically similar to bone, thereby 
eliminating the effects of stress shielding [167, 168] and has been proposed as a 
biodegradable metal, which can potentially be used for a wide range of orthopedics 
applications [167]. However, there are still a number of challenges that must be 
addressed before Mg can be considered as a suitable scaffold material, most notably its 
rapid in vivo degradation, which triggers an acute and unfavorable inflammatory 
response. Excessive inflammation can lead to the destruction of adjacent normal bone 
and the formation of fibrous tissue, which is likely to account for the failure of 
magnesium scaffolds to mediate bone reconstruction and restricts the application of 
magnesium scaffold in clinical settings. 
β-tricalcium phosphate (β-TCP) is a well characterized osteoconductive biomaterial 
that is already in clinical use for bone regeneration [213-215]. In physiological 
conditions, calcium phosphate (CaP) materials degrade at a significantly slower rate 
compared to Mg [253]. Using physicochemical analysis methods, Mg scaffolds coated 
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with β-TCP have been shown to have a slower degradation rate, [254]. β-TCP extract 
has also been found to elicit a favorable osteoimmunomodulatory response that can 
switch the macrophage phenotype to the M2 extreme and release BMP2, which 
enhances osteogenic differentiation of bone marrow stromal cells (BMSCs) [240]. 
These findings led to the hypothesis that coating Mg scaffolds with β-TCP would 
result in scaffolds that combined the beneficial properties of both materials and was 
endowed with osteoimmunomodulatory properties that would favor osteogenesis.  
Macrophages play an important role in the innate immune response that is activated by 
the interaction between host body and bone substitute materials. The classically 
activated M1 phenotype participates actively in T helper cell 1 (Th1) type 
inflammation, whereas the alternatively activated M2 phenotype leads to a Th2 type 
inflammation [62, 74, 75]. Macrophages are both dynamic and plastic and the various 
phenotypes can switch between each other under specific circumstances [68, 80]. 
Macrophages are required for efficient osteoblast mineralization and depletion of 
macrophages leads to the complete loss of in vivo bone formation [44, 48]. Their role 
in osteogenesis is by the secretion of osteoinductive molecules such as bone 
morphogenetic protein 2 (BMP2) and transforming growth factor β (TGF-β) [45, 46]. 
The heterogeneity and plasticity of macrophages make them an obvious target for 
immune modulation [210] and given their roles in the dynamic flux of bone formation 
and homeostasis, the response of macrophages to bone biomaterials was applied for 
the evaluation of osteoimmunomodulatory properties [240].  
In the present study, a chemical immersion method was applied [255, 256] to coat Mg 
scaffolds with β-TCP (Mg-β-TCP) in an effort to manipulate their 
osteoimmunomodulatory properties. It was unknown whether the introduction of β-
TCP would alter the detrimental immune response of Mg materials, so the 
osteoimmunomodulatory properties were evaluated using a bio-mimicking system that 
included biomaterials, osteoblastic lineage cells and immune cells. First, the 
interactions between Mg/Mg-β-TCP scaffolds and macrophages were investigated to 
assess the inflammatory response and release of osteoclastogenic and osteogenic 
cytokines, as a measure of a modulated immune environment. The osteogenesis 
mediated by the Mg/Mg-β-TCP scaffolds was further evaluated in the presence of both 
macrophages and osteoblastic cells, to demonstrate whether the regulated immune 
environment could positively enhance osteogenesis. In summary, this study applied 
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the concept of osteoimmunomodulation to manipulate the properties of bone 
biomaterials in an effort to create an immune environment that favors osteogenesis. It 
sought to determine if and how β-TCP coating of Mg scaffolds could positively affect 
their osteoimmunomodulatory properties and whether or not these immune 
environment changes would influence osteogenesis. 
MATERIALS AND METHODS 
Preparation of Mg and Mg-β-TCP scaffolds 
Porous Mg scaffolds were prepared with the laser perforation technique using a 
programmable multifunctional laser processing machine. The pulse frequency, width 
and effective output were 1-10 Hz, 0.3 ms and 100 W, respectively. The β-TCP coating 
of the Mg scaffolds was performed as follows: the scaffolds were immersed in a super-
saturated Na2HPO4 solution at 37 ºC for 3 h and, after ultrasonic cleaning, heated at 
400ºC for 10 h. Next, they were immersed in a mixture of Na2HPO4·12H2O (47.5 g/L) 
and Ca(NO3)2 (36.4 g/L) at 70ºC for 24 h, followed by washes with distilled water and 
air drying [255, 256]. The morphology of the scaffolds was observed by light 
microscopy (M125, Leica Microsystem, Wetzlar, Germany) and scanning electron 
microscopy (SEM, Zeiss, Oberkochen, Germany). 
Cell culture 
The murine-derived macrophage cell line, RAW 264.7 (RAW), and BMSCs were used 
in this study. RAW cell cultures were maintained in Dulbecco’s modified Eagle 
Medium (DMEM; Life Technologies, VIC, Australia) supplemented with 5% heat 
inactivated fetal bovine serum (FBS, Thermo Scientific) and 1% (v/v) 
penicillin/streptomycin (Life Technologies) at 37 ºC in a humidified CO2 incubator. 
The growing cells were passaged at approximately 80% confluence by scraping and 
expanded for two passages before being used for the study.  
BMSCs were isolated and cultured based on protocols from previous studies [20, 216, 
240, 244]. Briefly, bone marrow was obtained from patients (50-60 years old) 
undergoing hip and knee replacement surgery after informed consent was given. The 
procedure was approved by the Ethics Committee of the Queensland University of 
Technology. Lymphoprep (Axis-Shield PoC AS, Oslo, Norway) was added to isolate 
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the mononuclear cells from the bone marrow by density gradient centrifugation. The 
obtained cells were seeded into the tissue culture flasks containing DMEM 
supplemented with 10% FBS and 1% penicillin/streptomycin and incubated at 37 ºC in 
a humidified CO2 incubator. The culture medium was changed every 3 days until the 
primary mesenchymal cells reached 80% confluence; unattached hematopoietic cells 
were removed by the media changes. The confluent cells were expanded and only 
early passages (p3–5) of cells were used in this study. 
In vitro degradation of Mg and Mg-β-TCP scaffolds 
 RAW cells were seeded on the Mg and Mg-β-TCP scaffolds (8 × 8 × 8 mm) at a 
density of 1x106 cells per scaffold, with scaffolds soaked in the growth medium served 
as controls. The growth medium and scaffolds were collected after 24 h incubation. 
The ionic concentration of Mg, Ca and P in the conditioned media was determined by 
inductively coupled plasma mass spectrometry (ICP-MS, PerkinElmer, MA, USA). 
The scaffolds were then examined by SEM to document degradation and changes to 
the pore size. For this purpose ten pores were chosen randomly from each sample.  
Effects of Mg and Mg-β-TCP scaffolds on RAW cells   
The expression of inflammatory genes by RAW cells cultured on Mg and Mg-β-TCP 
scaffolds 
RAW cells were seeded on scaffolds at a density of 1x106 cells per scaffold. After 
incubation for 24 and 36 h, the supernatants were collected and clarified by 
centrifugation at 1500 rpm for 5 min. The scaffolds were washed twice with PBS and 
total RNA from the cells extracted using TRIzol reagent (Life Technologies). Five 
hundred nanograms of total RNA was used to synthesize complementary DNA using 
the DyNAmoTM cDNA Synthesis Kit (Genesearch, QLD, Australia) following the 
manufacturer’s instructions. RT-qPCR assay was applied to detect the expression of 
inflammatory genes (IL10, IL1ra, TNFα, IL6, IL1β, IFNγ). GAPDH was used as 
housekeeping gene. RT-qPCR primers (Table 1) were designed using the Primer-
BLAST program on the National Center for Biotechnology Information website. 
SYBR Green qPCR Master Mix (Life Technologies) was used for detection, and the 
target mRNA expressions were assayed on an ABI Prism 7500 Thermal Cycler 
(Applied Biosystems, VIC, Australia). The mean cycle threshold (Ct) value of each 
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target gene was normalized against the Ct value of the housekeeping gene. The ΔΔCt 
method was applied to compare the mRNA expression levels between Mg and Mg-β-
TCP scaffolds.  
M1 and M2 surface markers changes of RAW cells   
Expression of the M1 and M2 macrophage cell surface markers CCR7 and CD163 
were estimated by flow cytometry to determine phenotypic changes to the RAW cells. 
Complete culture medium was supplemented with the collected supernatants detailed 
previously at a ratio of 1:3 to obtain the conditioned medium. RAW cells were seeded 
on T25 culture flask at a density of 1x106 cells. After 24 h of culture, the culture 
medium was replaced with conditioned medium and the cells were incubated for a 
further 24 h. The cells were detached by cell scraper and nonspecific macrophage 
proteins were blocked with 1% BSA/PBS. The samples were incubated with CCR7 
(1:25) (GeneTex, Irvine, CA, USA) and CD163 antibody (1:100) (AbD Serotec, 
Raleigh, NC, USA) for 30 min at 4 ºC, followed by incubation with Dylight 488-anti-
mouse and DyLight 405- anti-goat secondary antibody (DAKO, Multilink, California, 
USA) for 30 min at 4 ºC. After washing with 1% BSA/PBS, the expression was 
analyzed on a flow cytometer (FACSAria, BD Biosciences, NSW, Australia). The 
percentages of positively stained cells were determined and compared.  
Mechanisms of the inflammatory regulation  
The Toll-like receptor (TLR) signaling pathway was analyzed to understand the 
mechanisms that underlie the observed gene expression changes. RAW cells were 
seeded on scaffolds at a density of 1x106 cells per scaffold and incubated for 24 h. The 
culture medium was removed. After washed twice by PBS, TRIzol reagent (Life 
Technologies) was added to the scaffold for extraction of RNA. Gene expressions of 
myeloid differentiation factor 88 (MyD88) and TIR domain containing adapter 
inducing interferon-beta (TRIF) were detected following the same method described 
previously. The whole cell lysates were collected after 7 h of culture and the protein 
expression of nuclear factor of kappa light polypeptide gene enhancer in B-cells 
inhibitor alpha (IκB-α) determined by Western blot analysis. Fifteen micrograms of 
protein from each sample were separated by SDS-PAGE and transferred to a 
nitrocellulose membrane (Pall Australia, NSW, Australia). The membranes were 
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blocked in Odyssey blocking buffer for 1 h (LI-COR Biosciences, Millenium Science, 
VIC, Australia), and then incubated with primary antibodies against IκB-α (1:1,000, 
rabbit anti-human; Cell Signaling Technology, Genesearch, Australia) and α-tubulin 
(1:5,000, rabbit anti-human; Abcam, Sapphire Bioscience, NSW, Australia) overnight 
at 4 °C. The membranes were washed three times in TBS-Tween buffer and then 
incubated with anti-rabbit IRDye 800 conjugated secondary antibodies at 1: 4,000 
dilutions for 1 h at room temperature. The protein bands were visualized using the 
Odyssey infrared imaging system (LI-COR Biosciences). The relative intensity of 
protein bands was quantified using the Image J software.  
Osteogenesis-related and osteoclastogenesis-related gene expressions  
To investigate the effect of Mg and Mg-β-TCP scaffolds on osteogenesis and 
osteoclastogenesis, osteogenesis-related genes (BMP2, VEGF, TGFβ1 and TGFβ3) 
and osteoclastogenesis-related genes [macrophage colony-stimulating factor (MCSF) 
and tartrate-resistant acid phosphatase (TRAP)] were analyzed by RT-qPCR, using 
GAPDH as housekeeping gene. RAW cell seeding and treatment were as described 
previously. 
Given the close relationship between osteoclastic and osteoblastic cells, we further 
investigated the osteoclastogenesis-related factors [osteoprotegerin (OPG), MCSF, 
receptor activator of nuclear factor kappa-B ligand (RANKL)] release from BMSCs in 
response to stimulation with conditioned media. The BMSCs were cultured in growth 
medium supplemented with the harvested supernatants as described previously, at a 
ratio of 1:3 (the conditioned media). BMSCs were plated at a density of 1.5x105 cells 
per well in separate 6-well plates. After 24 hours of incubation, the culture medium 
was removed and replaced with conditioned or control growth medium. Total RNA for 
the RT-qPCR analysis was harvested after 3 days of culture using TRIzol reagent. 
Effects of RAW cells-conditioned media on the osteogenic differentiation of BMSCs 
Bone-related gene and protein expression of BMSCs 
The ability of RAW cells to regulate osteogenesis in BMSCs in response to extracts 
released from the scaffolds was investigated. BMSCs were plated at a density of 
1.5x105 cells per well in separate 6-well plates. After 24 h of incubation, the culture 
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medium was removed and replaced with conditioned or control media. Total RNA for 
RT-qPCR analysis was harvested after 7 days of culture using TRIzol reagent to 
determine the osteogenesis related gene expressions [Alkaline phosphatase (ALP), 
Osteopontin (OPN), Osteocalcin (OCN), Bone sialoprotein 2 (IBSP), Collagen type 1 
(COL1)]. The whole cell lysates were collected after 14 days of culture for Western 
Blot analysis. The following primary antibodies were used: ALP (1:10,000, rabbit 
anti-human; Abcam), OPN (1:1,000, rabbit anti-human; Abcam) and α-tubulin 
(1:5,000, rabbit anti-human; Abcam). 
Alkaline phosphatase activity of BMSCs 
BMSCs were cultured in 24-well plates at a density of 35,000 cells per well. The ALP 
activity was assessed after 10 days of culture in conditioned or control media with 
osteogenic supplements [2 mM β-glycerophosphate, 100 µM L-ascorbic acid 2-
phosphate, 10 nM dexamethasone (Sigma–Aldrich, NSW, Australia)]. The cells were 
lysed in 100 μL of 0.2% Triton X-100 then centrifuged at 14,000 rpm for 15 min at 4 
°C. Fifty microliter of supernatant was mixed with 150 μL of working solution and 
assayed using the QuantiChromTM Alkaline Phosphatase Assay Kit (BioAssay 
Systems, Biocore, NSW, Australia). The total protein content was measured using the 
BCA Protein Assay Kit (Thermo Scientific). The relative ALP activity was calculated 
as the changed optical density (OD) values divided by the total protein content. 
The mineralization of BMSCs 
To identify mineralization nodules, Alizarin Red S staining was assayed on day 10 
after BMSCs had grown as a monolayer in conditioned or control media with 
osteogenic supplements in a well plate. The medium was removed and the cells 
washed with ddH2O and fixed in 4% paraformaldehyde for 10 min at room 
temperature. After gently rinsing with ddH2O, the cells were stained in a solution of 
2% Alizarin Red S at pH 4.1 for 20 min and then washed with ddH2O. The samples 
were air-dried, and photos were taken under a light microscope.  
Quantification of staining was performed as described previously [257]. In brief, 350 
μL 10% acetic acid was added to each well, and the plate was incubated at room 
temperature for 30 min. The monolayer was then scraped from the plate and 
transferred with the acetic acid to a 1.5 mL microcentrifuge tube. After vortexing for 
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30 s, the slurry was overlaid with 300 μL mineral oil (Sigma–Aldrich, NSW, 
Australia), heated to 85 °C for 10 min, and transferred to ice for 5 min. The slurry was 
then centrifuged at 20,000 g for 15 min and 300 μL of the supernatant was transferred 
to a fresh 1.5 mL microcentrifuge tube. Then 100 μL of 10% ammonium hydroxide 
was added to neutralize the acid. Aliquots (100 μL) of the supernatant were read in 
triplicate at the wavelength of 405 nm in a 96-well plate reader. 
BMP-related signaling pathway of BMSCs 
To investigate the expression of BMP signaling genes in BMSCs, BMP signaling 
pathway-related genes [Mothers against decapentaplegic homolog 1/4/5 (SMAD1, 
SMAD5, and SMAD4, bone morphogenetic protein receptor, type IA (BMPR1A) and 
Bone morphogenetic protein receptor type II (BMPR2)] were analyzed by RT-qPCR. 
As previous described, BMSCs were treated for 3 days. 
Table 1 Primer pairs used in the qRT-PCR. 
Genes Primer sequences 
IL10 Forward: 5'- GAGAAGCATGGCCCAGAAATC -3' 
Reverse: 5'- GAGAAATCGATGACAGCGCC-3' 
IL1ra Forward: 5'- CTCCAGCTGGAGGAAGTTAAC -3' 
Reverse: 5'- CTGACTCAAAGCTGGTGGTG -3' 
TNFα Forward: 5’-CTGAACTTCGGGGTGATCGG-3’ 
Reverse: 5’-GGCTTGTCACTCGAATTTTGAGA-3’ 
IL1β Forward: 5'- TGGAGAGTGTGGATCCCAAG -3' 
Reverse: 5'- GGTGCTGATGTACCAGTTGG -3' 
IL6 Forward: 5'- ATAGTCCTTCCTACCCCAATTTCC -3' 
Reverse: 5'- GATGAATTGGATGGTCTTGGTCC -3' 
IFNν Forward: 5'- GGCCATCAGCAACAACATAAGC -3' 
Reverse: 5'- GGGTTGTTGACCTCAAACTTGG -3' 
BMP2 Forward: 5’-GCTCCACAAACGAGAAAAGC-3’ 
Reverse: 5’-AGCAAGGGGAAAAGGACACT-3’ 
VEGFa Forward: 5’-GTCCCATGAAGTGATCAAGTTC-3’ 
Reverse: 5’-TCTGCATGGTGATGTTGCTCTCTG-3’ 
TGFβ1 Forward: 5'- CAGTACAGCAAGGTCCTTGC-3' 
Reverse: 5'- ACGTAGTAGACGATGGGCAG-3' 
TGFβ3 Forward: 5'- CAACACCCTGAACCCAGAG -3' 
Reverse: 5'- CTTCACCACCATGTTGGACAG -3' 
MCSF Forward: 5'- AGCAGAACAAGGCCT GTGTC -3' 
Reverse: 5'- AAGCTGTTGTTGCAGTTCTTG G -3' 
TRAP Forward: 5'- CACTCCCACCCTGAGATTTGT-3' 
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Reverse: 5'- CATCGTCTGCACGGTTCTG-3' 
Myd88 Forward: 5'-  AGGTAAGCAGCAGAACCAGG -3' 
Reverse: 5'-  TGTCCTAGGGGGTCATCAAGG -3' 
Ticam1 Forward: 5'- AGATGGTTCAGCTGGGTGTC -3' 
Reverse: 5'-  TGGAGTCTCAAGAAGGGGTTC -3' 
Ticam2 Forward: 5'- CTTGGCGCTGCAAACCATC -3' 
Reverse: 5'-  GCCTCTCAAATACAGACTCCCG -3' 
GAPDH 
(mouse) 
Forward: 5’-TGACCACAGTCCATGCCATC-3’ 
Reverse: 5’-GACGGACACATTGGGGGTAG-3’ 
OPG Forward  5’-CGCTCGTGTTTCTGGACATCT-3’ 
Reverse 5’-CACACGGTCTTCCACTTTGC-3’ 
RANKL Forward: 5’-AGAGCAGAGAAAGCGATGGTG-3’ 
Reverse: 5’-GAACCAGATGGGATGTCGGT-3’ 
MCSF 
(human) 
Forward: 5’-AGCATGACAAGGCCTGCGTC-3’ 
Reverse: 5’-AAGCTGTTGTTGCAGTTCTTGC-3’ 
ALP Forward: 5’-TCAGAAGCTAACACCAACG-3’ 
Reverse: 5’-TTGTACGTCTTGGAGAGGGC-3’ 
OPN Forward: 5’- TCACCTGTGCCATACCAGTTAA-3’ 
Reverse: 5’-TGAGATGGGTCAGGGTTTAGC-3’ 
OCN Forward: 5’-GCAAAGGTGCAGCCTTTGTG-3’ 
Reverse: 5’-GGCTCCCAGCCATTGATACAG-3’ 
COL1A1 Forward: 5’-AGAACAGCGTGGCCT-3’ 
Reverse: 5’-TCCGGTGTGACTCGT-3’ 
IBSP Forward: 5’-TTTCTGCTACAACACTGGGCTATG-3’ 
Reverse: 5’-TTGTTATATCCCCAGCCTTCTTG-3’ 
SMAD1 Forward: 5’- GTATGAGCTTTGTGAAGGGC-3’ 
Reverse: 5’- TAAGAACTTTATCCAGCCACTGG-3’ 
SMAD4 Forward: 5’- CTCCAGCTATCAGTCTGTCAG-3’ 
Reverse: 5’- CCCGGTGTAAGTGAATTTCAAT-3’ 
SMAD5 Forward: 5’- TCATCATGGCTTTCATCCCACC-3’ 
Reverse: 5’- GCTCCCCAACCCTTGACAAA-3’ 
BMPR2 Forward: 5’- GGCAGCAGTATACAGATAGGTG-3’ 
Reverse: 5’- CTGCCCTGTTACTGCCATTATT-3’ 
BMP1A Forward: 5’- CCTGGGCCTTGCTGTTAAATTCA-3’ 
Reverse: 5’- TCCACGATCCCTCCTGTGAT-3’ 
GAPDH 
(human) 
Forward: 5’-TCAGCAATGCCTCCTGCAC-3’ 
Reverse: 5’-TCTGGGTGGCAGTGATGGC-3’ 
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Statistical analysis 
All analyses were performed using the SPSS software (IBM SPSS, Armonk, New 
York, USA). All data are shown as means ± standard deviation (SD) and were 
analyzed using one-way ANOVA. The level of significance was set to P<0.05. 
RESULTS 
In vitro degradation of Mg and Mg-β-TCP scaffolds 
The concentrations of Mg2+, Ca2+ and PO43- ions from all the samples are shown in 
Table 2. After soaking the Mg scaffolds in DMEM for 24 h, the concentrations of 
Ca2+ and PO43- ions decreased to 21% and 81% of their original values, respectively. 
The Mg2+ ion concentration, on the other hand, showed a 52 fold increase. All three 
ions concentrations increased in the medium after soaking the Mg-β-TCP scaffold in 
DMEM. The concentration of Mg2+ ions was five times greater in the Mg scaffold 
medium than in the Mg-β-TCP scaffold medium. Concentrations of both Ca2+ and 
PO43- ions in the macrophage conditioned culture media decreased in both the Mg and 
Mg-β-TCP samples, at 7.5% and 75% of their original values, respectively. However, 
the concentration of Mg2+ ions increased in response to the same treatment with a 67 
fold increase in the Mg scaffold sample and a 17 fold increase in the Mg-β-TCP 
scaffold sample. 
 
Table 2  
The ionic concentrations of scaffold extract and macrophage conditioned medium 
 
Material  - Mg Mg-TCP Mg Mg-TCP 
Culture medium + + + + + 
Macrophage 
conditioned 
- - - + + 
Ionic 
concentrations 
(mg/ L) 
Mg2+ 19.44±2.23 1021±2.13 195.4±0.86 1309±1.41 337.3±1.06 
Ca2+ 76.52±1.19 16.42±1.08 129.3±2.09 5.76±2.9 54.3±2.65 
PO43- 29.71±0.5 23.99±1.33 93.61±3.66 22.16±1.01 32.03±2.93 
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The Mg and Mg-β-TCP scaffolds are shown in Figure 1. The pore diameter of the Mg 
scaffold was approximately 100 μm (Figure 2A, E) and decreased to approximately 
60 μm after being coated with β-TCP (Figure 2B, E). Following incubation in culture 
medium with RAW cells, the scaffolds show evidence of being partly degraded by an 
increase in pore sizes. The Mg scaffold had a larger increase (147.07±9.55 μm, Figure 
2C, E), compared with that of Mg-β-TCP scaffold (82.69±5.62 μm, Figure 2D, E).  
Inflammatory gene expression and surface marker changes of RAW cells on scaffolds  
A comparison of the gene expression of RAW cells grown on either the Mg or Mg-β-
TCP scaffolds showed that the most significant change in inflammatory gene 
expression occurred with the anti-inflammatory gene IL1ra in Mg-β-TCP scaffolds 
both in 24 and 36 hours (P<0.05) (Figure 3). The expressions of other inflammatory 
genes (TNFα, IL6, IL1β and IFNγ) also showed slight increase as a result of the same 
treatment (P<0.05) but the fold changes were significantly less than that of IL1ra 
(Figure 3). IL10 showed no significant change at all.  
 
 
Figure 1 Macro and microphology of Mg and Mg-β-TCP scaffolds by light 
microscope and SEM respectively. The scaffolds are 8 × 8 × 8 mm in size and the 
pore sizes are uniform.  
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Figure 2 Pore size changes of Mg and Mg-β-TCP scaffolds before and after cultured 
with RAW cells. The pore diameter of the Mg scaffold was approximately 100 μm (A, 
E) and decreased to approximately 60 μm after coated with β-TCP (B, E). Following 
incubation in culture medium with RAW cells, the pore size of Mg scaffold increase to 
147.07±9.55 μm (C, E), while  Mg-β-TCP scaffold went up to 82.69±5.62 μm (D, E).  
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Figure 3 Relative mRNA expressions of inflammation related genes: IL-10, IL-
1ra, TNFα, IL-6, IL-1β and IFNγ by RAW cells cultured in Mg and Mg-β-TCP 
scaffolds at 24 h and 36 h. GAPDH was used as housekeeping gene. *: Significant 
difference (P<0.05) for Mg-β-TCP group compared to Mg group. 
 
Stimulation of RAW cells with the RAW cell/Mg-β-TCP scaffold conditioned medium 
(Figure 4 A, B) resulted in a shift towards the M2 phenotype with more cells 
expressing the surface marker CD163 compared to cells stimulated with the RAW 
cell/Mg scaffold conditioned medium alone (Figure 4 C, D). By contrast, the same 
treatment resulted in fewer cells expressing the surface marker CCR7 (Figure 4 E, F) 
in Mg-β-TCP scaffold group compared to Mg scaffold group (Figure 4 G, H).  
Possible mechanisms for the changes of inflammatory gene expression  
To explore the mechanisms underlying inflammation-related gene expression changes, 
we examined the TLRs signaling pathway in RAW cells by both the gene and protein 
expression assays. We tested three genes (MyD88, Ticam1 and Ticam2) in RAW cells, 
all of which were significantly downregulated (P<0.05) (Figure 5). The downstream 
molecular IκB-α, by contrast, was upregulated (Figure 6) in Mg-β-TCP scaffolds 
compared with Mg scaffolds. 
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Figure 4 FACS results of RAW cells stimulated by macrophage/scaffold 
conditioning medium: M2 marker CD163 (A-D), M1 marker CCR7 (E-H). A, C, 
E and G are dot plots, indicating the parameters of cell morphology. RAW cells 
showed similar morphology under different conditioned medium treatments. 
Same region (red color) was selected in each group for the histogram analysis (B, 
D, F, H).  
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Figure 5 Relative mRNA expressions at 24 h and 36 h of MyD88, Ticam1 and 
Ticam2 by RAW cells cultured with Mg and Mg-β-TCP scaffolds. GAPDH was 
used as housekeeping gene. *: Significant difference (P<0.05) for Mg-β-TCP 
group compared to Mg group. 
 
 
Figure 6 The western blot analysis of IκB-α expression of RAW cells cultured in 
Mg and Mg-β-TCP scaffolds. *: Significant difference (P<0.05) for Mg-β-TCP 
group compared to Mg group. 
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Osteogenesis-related and osteoclastogenesis-related gene expressions 
Osteogenesis and osteoclastogenesis-related gene expressions in RAW cells cultured 
on both Mg-β-TCP and Mg scaffolds were investigated by the RT-qPCR. The gene 
expression for both BMP2 and VEGF were significantly upregulated (P<0.05) in 
response to the Mg-β-TCP scaffolds compared with the Mg scaffolds (Figure 7), 
whereas both TGF-β1 and TGF-β3 were downregulated in response to the same 
treatment (Figure 7). Moreover, the osteoclastogenesis-related genes MSCF and 
TRAP were also downregulated in the Mg-β-TCP scaffolds compared with the Mg 
scaffolds. 
Although RANKL was also upregulated (2~fold), OPG, a decoy receptor for RANKL, 
was more than 4.5~fold upregulation in BMSCs by the stimulation of RAW cell/Mg-
β-TCP scaffold conditioned medium (Figure 8). MCSF was downregulated in 
response to the same treatment (Figure 8). 
Effects of RAW 264.7 cells-conditioned media on the osteogenic differentiation of 
BMSCs 
BMSCs stimulated with RAW cell/Mg-β-TCP scaffold conditioned medium had a 
significantly upregulated expression of the mineralization-related genes (ALP, OPN, 
OCN, IBSP, COL1) compared to the Mg scaffold conditioned medium treatment 
(P<0.05) (Figure 8).  
The western blot analysis of OPN and ALP protein expression showed that both were 
significantly upregulated in BMSCs stimulated by RAW cells/Mg-β-TCP scaffold 
conditioned medium compared to that of the Mg scaffold conditioned medium 
treatment (P<0.05) (Figure 9).  
The ALP activity of BMSCs stimulated with RAW cell/Mg-β-TCP scaffold 
conditioned media was significantly enhanced compared to that of the Mg scaffold-
treated group (P<0.05) and even higher that of the BMSCs cultured in the osteogenic 
medium alone (Figure 10). Alizarin Red S staining showed evidence of calcium 
deposition and nodule formation. Mineralized nodules were observed in all groups 
treated with osteogenic media (Figure 10). More distinct nodules were observed in 
BMSCs stimulated by RAW cell/Mg-β-TCP scaffold conditioned media (Figure 10).  
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Upregulation of the BMP signaling pathway in BMSCs in the stimulation of the RAW 
cell/Mg-β-TCP conditioned media  
To explore the mechanisms of enhanced osteogenesis in BMSCs stimulated by the 
RAW cells/Mg-β-TCP conditioned media, we further examined the expressions of 
BMP signaling pathway genes. The expressions of SMAD4, SMAD5 and BMPR1A in 
BMSCs cultured with RAW cells/Mg-β-TCP scaffold conditioned media were 
significantly upregulated compared to those cultured with RAW cells/Mg scaffold 
conditioned media (P<0.05) (Figure 11), indicating the activation of BMP pathways 
in BMSCs under the stimulation of RAW cells/Mg-β-TCP conditioned media. SMAD1 
and BMPR2 showed no significant changes under the same treatments. 
 
 
Figure 7 Relative mRNA expressions of BMP2, VEGF, TGF β1, TGF β3, MCSF, 
and TRAP by RAW cells cultured in Mg and Mg-β-TCP scaffolds at 24 h and 36 
h. GAPDH was used as housekeeping gene. *: Significant difference (P<0.05) for 
Mg-β-TCP group compared to Mg group. 
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Figure 8 Relative mRNA expressions of OPG, MCSF, RANKL, ALP, OPN, OCN, 
IBSP, and COL1 by BMSCs stimulated by macrophage/scaffold conditioned 
medium. GAPDH was used as housekeeping gene. *: Significant difference 
(P<0.05) for Mg-β-TCP group compared to Mg group. 
 
Figure 9 The western blotting analysis of OPN and ALP expression by BMSCs 
cultured in culture medium (Negative) and macrophage/scaffold conditioning 
medium. *: Significant difference (P<0.05) for Mg-β-TCP group compared to Mg 
group. 
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Figure 10 The relative ALP activity of BMSCs cultured in osteogenic medium 
(OM) and macrophage/scaffold conditioned medium with osteogenic supplements 
(A). Alizarin Red S staining of BMSCs cultured in osteogenic medium (OM) and 
macrophage/scaffold conditioning medium with osteogenic supplements (B). *: 
Significant difference (P<0.05) for Mg-β-TCP group compared to Mg group. 
 
 
Figure 11 Relative mRNA expressions of BMP signaling pathway genes SMAD1, 
SMAD4, SMAD5, BMPR1A, and BMPR2 by BMSCs stimulated by 
macrophage/scaffold conditioned medium. GAPDH was used as housekeeping 
gene. *: Significant difference (P<0.05) for Mg-β-TCP group compared to Mg 
group. 
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DISCUSSION 
In this study, we show that it is possible to manipulate the osteoimmunomodulatory 
properties of Mg scaffolds by coating them with β-TCP. This procedure results in a 
change in the osteoimmunomodulatory properties of Mg scaffolds that rendered them 
significantly more conducive to bone formation. Specifically, β-TCP-coated Mg 
scaffolds induced macrophages to switch to the extreme M2 phenotype. This resulted 
in the release of anti-inflammatory cytokines and osteoinductive molecules by the 
macrophages that enhanced the osteogenesis of BMSCs, most likely through the BMP 
signaling pathway. In addition, the β-TCP coating also decreased the rate of 
degradation of the Mg scaffold, not merely by the physicochemical effects by β-TCP, 
but also by inhibiting cell-mediated degradation. These findings show that the 
osteoimmunomodulatory properties of the Mg-β-TCP scaffold were favorable in terms 
of osteogenesis and reduced inflammation and osteoclastogenesis. Mg-β-TCP type 
scaffolds are therefore a promising bioactive material for bone tissue regeneration, 
since the β-TCP can endow the otherwise physiologically unsuitable Mg scaffold with 
favorable osteoimmunomodulatory properties. This procedure can therefore be a 
highly valuable strategy for development or modification of advanced bone 
biomaterials. 
In vitro degradation of Mg-β-TCP scaffolds  
Bone substitute materials are normally degraded after implantation, either by 
physicochemical dissolution, cell-medicating dissolution, hydrolysis, enzymatic 
decomposition, or corrosion [148]. Mg, being a highly reactive metal, corrodes very 
quickly, particularly in physiological solutions. Coating of the Mg scaffolds with β-
TCP greatly decreased the direct contact between the surface of the metal and culture 
medium and, thereby slowing down the rate of corrosion. This was evident by 
significantly lower concentration of Mg2+ ions in solution from Mg-β-TCP scaffolds 
soaked in culture medium compared to Mg scaffolds (Table 2). The fact that both Ca2+ 
and PO43- ion concentrations were elevated under the same treatment (Table 2) could 
account for some of the reduced rate of Mg degradation by raising the pH [254].  
Cell-mediated degradation is another key component for the degradation of a material 
in a physiological system. Both osteoclastic and osteoblastic cells participate in this 
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process. Osteoclastic cells are key mediators of cell-mediating degradation. Individual 
pre-osteoclast macrophages can engulf particles up to a size of 5 µm [8, 16]. If the 
particle is larger, macrophages attempt to coalesce to form foreign body giant cells 
(FBGCs), a process that can be induced by the secreted cytokines IL-4 and IL-13 [17]. 
With the induction of RANKL and MCSF, macrophages can differentiate into 
osteoclasts [207], which attach firmly to the substrate to create a “sealing zone” into 
which they secrete H+, leading to a locally acidic environment with a pH of 4.0–5.0 
[258]. In bone, osteoblastic cells are a source of MCSF and RANKL molecules [58], 
regulating the differentiation and maturation of osteoclasts, thereby contributing to 
cell-mediating material degradation.  
The Mg-β-TCP scaffold appears to dampen cell-induced material degradation by the 
RAW macrophage cells, which was evidenced by the Mg scaffolds having increased 
pore size (Figure 2) compared to Mg-β-TCP scaffolds. This is in addition to the 
physiochemical effects of, for example, lower pH from the greater concentration of 
Ca2+ and PO43- due to β-TCP [254]. The RANKL/RANK/OPG signaling system is a 
well-known regulator of osteoclastogenesis. RANKL binds to RANK receptors on the 
surface of osteoclast precursors to activate signaling through the NF-κB activator 
protein 1 (AP-1) and nuclear factor of activated T cells 2 (NFAT2), resulting in the 
expression of genes responsible for the survival and differentiation of osteoclasts [24]. 
OPG, which was strongly upregulated in BMSCs stimulated with RAW/Mg-β-TCP 
condition medium (Figure 8), is a decoy receptor that binds RANKL and interrupt its 
interaction with RANK receptor to inhibit osteoclastogenesis [32, 33]. MCSF is 
another key factor for the differentiation of osteoclasts, that binds to its cognate 
receptor, c-fms, on osteoclast precursors (e.g., macrophage), which then activates 
signaling through the protein kinase B and mitogen-activated protein kinases (MAPK) 
pathways. TRAP, which is highly expressed by osteoclasts, is commonly used as a 
marker of osteoclast function [259]. The inhibition of the RANKL/RANK system and 
downregulation of the MCSF and TRAP genes gives an indication of inhibition of 
cell-mediated degradation by the β-TCP modified Mg scaffolds. We must point out 
that although pre-osteoclasts macrophages were used to represent osteoclastic cells 
and BMSCs used to represent osteoblastic cell lineages, the use of more committed 
cell types, such as osteoclasts and osteoblasts, would have allowed more conclusive 
hypotheses to be made. 
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Macrophage phenotype and Mg-β-TCP scaffolds 
Macrophage phenotypes follow a continuum between the M1 and M2 designations 
[81]. Three criteria (functional properties, surface markers, and inducers) were used to 
define a specific macrophage phenotype [68]. Exposure to the Mg-β-TCP scaffolds 
resulted in more macrophages expressing the M2 surface marker CD163 and anti-
inflammatory cytokines (IL1ra) compared to cells exposed to the Mg scaffold. These 
findings indicate that the Mg-β-TCP scaffolds can influence macrophage polarization 
by inducing a drift towards the M2 extremity.  
Macrophages recognize foreign bodies via the toll-like receptor (TLR) pathway, which 
induces the innate immune response in an attempt to degrade or expel the foreign 
bodies [8]. MyD88 is one of the key components in this pathway. Most of the 
activated TLRs interact with MyD88, which then activates the downstream cascade 
[173], while some TLRs act via MyD88-independent signaling pathways, i.e., the toll-
like receptor adapter molecule (Ticam), which also known as TIR domain containing 
adapter inducing IFN β (TRIF) [174]. Although they signal via different adapter 
proteins, both MyD88-dependent and Ticam-dependent pathways eventually activate 
NF-κB, which results in the expression of inflammatory cytokines [175]. In the present 
study, the expressions of the MyD88, Ticam1 and Ticam2 genes were all 
downregulated, while the expression of the NF-κB inhibitor IκB-α was upregulated. 
This finding indicates that the β-TCP coated Mg scaffolds dampens the inflammatory 
response potentially by inhibiting the TLR pathway. MgSO4 has been shown to 
decrease inflammatory cytokine production via the inhibition of the TLR receptor 
pathway, however, the Mg2+ concentration used in the recently published in vitro 
study by Sugimoto et al.,[172] was only 60 mg/L, which is significantly lower than the 
concentrations of the scaffold extracts used in the present study. The link between 
Mg2+ concentration and the inhibition of the TLR receptor pathway therefore requires 
further study.  
Effects of the switch on osteogenesis 
Although macrophages have been shown to be involved in osteogenesis, the 
phenotype that is most beneficial to osteogenesis has not yet been established. M1 
macrophages are reported to induce osteogenesis in mesenchymal stem cells via 
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Oncostatin M [82]. However, the culture medium from LPS-activated macrophages 
also induced pre-osteoblast cells to differentiate towards fibroblasts, even during 
osteogenic media conditions. This finding may be related to the upregulation of TNFα, 
IL-1β and IL-6 [56, 57], indicating that the switch to the M1 macrophage phenotype 
does not necessarily enhance osteogenesis. In addition to the secretion of 
osteoinductive and osteogenic cytokines (BMP2, VEGF), M2 macrophages can also 
secrete fibrous agents (such as TGF-βs) to promote pathological fibrosis [57, 85]. An 
excessive switch to the M2 phenotype may result in scar tissue or a delay in wound 
healing [86]. Therefore, an effective and adequate switch in the macrophage 
phenotype may be a more important means of enhancing osteogenesis.  
Angiogenesis and osteogenesis are processes that are closely coupled during bone 
formation. BMP2 is an important member of the BMP family, and a potent 
osteoinductive agent [220-222], whereas VEGF is a key pro-angiogenic factor, 
binding to VEGFR to activate downstream adapters, which drive angiogenesis [260]. 
VEGF and BMP2 expression has been found to be tightly related and synergistic 
[261]. BMP2 is known to activate endothelial cell growth via the activation of 
VEGF/VEGFR2 and angiopoietin/Tie2 signaling, while VEGF reportedly enhances 
BMP2-induced osteogenesis [262]. The inhibition of VEGF could block BMP2-
induced angiogenesis and BMP4-induced bone formation [263]. In this study, we 
found that the Mg-β-TCP scaffold significantly upregulated the BMP2 and VEGF gene 
expression in macrophages, which probably accounted for the activation of the BMP 
signaling pathway. BMP2 binds to BMPR2 which then recruits BMPR1A. This in turn 
activates the cytosolic receptor smads, SMAD 5, which then form a complex with 
SMAD4 and translocates to the nucleus to facilitate the expression of distalless 
homeobox5 (Dlx5). Dlx5 induced the expression of Runx2, which results in 
osteogenic differentiation of BMSCs [223].  
The coating of β-TCP led to the decrease of scaffold pore size (from 107 µm to 63 
µm). Small pores can relatively negatively affect the diffusion of nutrients and oxygen 
supplied from blood and interstitial fluid, especially in the centre of the scaffold, 
leading to a hypoxic environment [141]. Hypoxia is stabilizes the hypoxia-inducible 
factors (HIFs) and subsequently activating HIF target genes, in particular VEGF [176, 
177], which was robustly upregulated in the Mg-β-TCP scaffold samples (Figure 7). 
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Elevated extracellular Ca concentration or CaP crystals have been reported to 
stimulate the secretion of BMP2 by macrophages [45], which could be responsible for 
the aforementioned observation. The calcium sensing receptor (CaSR) reportedly 
causes BMP2 synthesis and secretion via phosphatidylinostitol 3-kinase activation 
[224]. The deletion of CaSR completely inhibited BMP2 secretion [224]. The 
upregulation of BMP2 might be related to the upregulation of CaSR, due to the report 
that elevated extracellular Ca can help enhance the expression of CaSR. However, the 
gene expression of CaSR was not upregulated (data not shown) by the Mg-β-TCP 
scaffold, although the Ca concentration was elevated. Further investigations are 
therefore required to understand this mechanism. As profibrotic cytokines, TGF-βs 
were found to be highly expressed in a wide range of fibrotic tissues [264]. TGF-βs 
upregulate the synthesis of many extracellular matrix (ECM) proteins that promote the 
fibrosis process [265]. TGF-β1, which induces fibroblast proliferation via the FGF-
2/ERK pathway, is a key cytokine in the fibrosis process [227]. TGF-β3 plays an 
important role in ECM production by inducing the expression of type I collagen, 
fibronectin, laminin, and proteoglycans [266]. We assayed both TGF-β1 and TGF-β3, 
which were both downregulated in the Mg-β-TCP scaffold samples. This finding 
indicates that the Mg-β-TCP scaffold-induced macrophage phenotype switch does not 
enhance inflammatory fibrosis, but was effective and adequate in improving 
osteogenesis. 
The putative osteoimmunomodulatory effects of the β-TCP coating on the material 
mediating osteogenesis are summarized in Figure 12. The degradation products 
released from the materials stimulate the macrophages and trigger their phenotype 
switch to M2 by inhibiting the TLR receptor signaling pathway, which results in the 
upregulation of anti-inflammatory cytokines (IL-1ra). The β-TCP stimulated 
macrophages upregulate VEGF and BMP2 gene expression, which activate the BMP2 
signaling pathway in BMSCs, resulting in osteogenic differentiation. Expression of the 
fibrosis-promoting genes TGF-β1 and TGF-β3 are downregulated in response to the 
same treatment, which can account for the possible inhibition of fibrosis. The net 
result is a dampening of the inflammatory response and a commensurate increase of 
osteogenesis. As was stated in the Introduction, given their roles in the dynamic flux 
of bone formation and homeostasis, the response of macrophages to bone biomaterials 
must be considered when evaluating the osteoimmunomodulatory properties. The 
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inflammatory response of macrophages can to some extent act as a measure of the 
overall level of inflammation, but it has to be emphasised that inflammation is a 
complex response that cannot easily be mimicked in vitro. Further in vivo studies must 
therefore be conducted in order to test the in vitro findings. 
The paradigm shift for developing bone biomaterials (osteoimmunomodulatory 
biomaterials) emphasizes the importance of osteoimmunomodulation, indicating that 
these properties must be an essential parameter for the evaluation and development of 
advanced bone biomaterials. Osteoimmunomodulation, as it is defined in this study 
includes not only the regulation of inflammatory reaction towards the implants, but the 
effects of the immune microenvironments towards the behaviors of bone cells, such as 
the balance of osteogenesis versus osteoclastogenesis. This balance effectively 
determines the in vivo fate of bone biomaterials, towards either de novo bone 
formation or fibrosis encapsulation. Traditional strategies for the development of bone 
biomaterials mainly focused on the response of osteoblastic lineage cells to the 
exclusion of immune cells [231-233]. This paradigm does not able to adequately 
reflect in vivo conditions that involve the early immune reaction following an 
implantation. This study proposed a novel strategy for the development or 
modification of bone biomaterials by the targeted modulation of the 
osteoimmunomodulatory properties of osteoinductive scaffolds.  
CONCLUSIONS 
Modifying Mg scaffolds by coating them with β-TCP altered their detrimental 
osteoimmunomodulatory properties in such a way that they were more favorable for 
osteogenesis. Specifically, the coating induced an effective and adequate switch to the 
M2 macrophage phenotype, which inhibits inflammation and osteoclastogenesis, and 
enhances the osteogenic differentiation of BMSCs. The potential mechanisms of this 
process are likely to be the inhibition of the TLR receptor pathway and the activation 
of the BMP2 signaling pathway. Therefore, β-TCP coating can be a valuable method 
to modify scaffolds with fast degradation rate (e.g. Mg scaffolds) for bone tissue 
engineering applications. In addition, endowing bone biomaterials with favorable 
osteoimmunomodulatory properties can be a valuable strategy for the development or 
modification of advanced bone biomaterials.  
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Figure 12 Potential molecular mechanisms of how the interaction of macrophages 
with Mg-β-TCP scaffolds induces osteogenesis. Degradation products released 
from the materials stimulate the macrophages to switch their phenotype to M2 by 
inhibiting the TLR receptor signaling pathway and results in the upregulation of 
anti-inflammatory cytokines (IL-1ra). The stimulated macrophages upregulate 
VEGF and BMP2 gene expression, which activates the BMP signaling pathway in 
BMSCs, resulting in osteogenic differentiation. At the same time, expression of 
the fibrosis-promoting genes TGF-β1 and TGF-β3 are downregulated, which can 
account for reduced fibrosis. The net effect is a dampening of the inflammatory 
response and increased osteogenesis. 
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ABSTRACT 
Ideal coating materials for implants should be able to induce excellent 
osseointegration, which requires several important parameters, such as good bonding 
strength, limited inflammatory reaction, balanced osteoclastogenesis and osteogenesis, 
to obtain well-functional coated implants with long-term life span after implantation. 
Bioactive elements, like Sr, Mg and Si, have been found to play important roles in 
regulating the biological responses. It is of great interest to combine bioactive 
elements for the development of bioactive coatings on Ti-6Al-4V orthopedic implants 
to elicit multidirectional effects on osseointegration. In this study, Sr, Mg and Si-
containing bioactive ceramic [Sr2MgSi2O7 (SMS)] was successfully coated on Ti-6Al-
4V by plasma-spray method. The prepared SMS coating showed significantly higher 
bonding strength (~37 MPa) than conventional pure hydroxyapatite (HA) coatings 
(mostly in the range of 15-25 MPa). It was also found that the prepared SMS coating 
switched the macrophage phenotype into M2 extreme, inhibiting the inflammatory 
reaction via the inhibition of Wnt5A/Ca2+ and Toll-like receptor (TLR) pathway. In 
addition, the osteoclastic activities were inhibited by the SMS coating, indicating from 
the downregulation of related gene expression by the SMS coating. The expression of 
osteoclastogenic genes (RANKL and MCSF) was decreased, while osteoclastogenesis-
inhibiting factor OPG gene expression was enhanced, indicating that the SMS coating 
also downregulated the osteoclastogenesis. However, the osteogenic differentiation of 
BMSCs was comparable between SMS/macrophages and HA/macrophages 
conditioned media. Therefore, the prepared SMS coating showed multidirectional 
effects, such as improving bonding strength, inhibiting inflammatory reaction and 
suppressing osteoclastic activities, but maintaining a favourable osteogenic capacity, 
as compared with the HA coating. The combination of bioactive elements Sr, Mg and 
Si into bioceramic coatings can be a promising method to develop bioactive implants 
with multifunctional properties for orthopaedic application. 
INTRODUCTION 
Plasma-sprayed bioactive ceramics on Ti-6Al-4V, which combines the bioactivity of 
bioceramics and the mechanical properties of titanium alloy, have been widely used 
for orthopaedic applications [267-271]. Due to its high similarity of the bone inorganic 
composition, hydroxyapatite (HA) has been coated on the surface of Ti-6Al-4V, which 
 142                                                                                                                              Chapter 6: Research Paper Five 
achieved certain clinical success. However, there are still some drawbacks arousing 
great attentions, such as relatively low bonding strength, stability and osseointegration 
ability, which affect its long-term clinical performance and success rate [272]. A 
number of bioactive glass materials have been applied as coating materials, which 
demonstrated satisfying bioactivity [273-277]. However, it is still very challenging to 
develop ideal bioactive ceramic-coatings on Ti alloy with superior mechanical and 
physicochemical properties (e.g. high bonding strength and chemical stability), and 
positive biological effects (e.g. limited inflammatory reaction, well balanced 
osteogenesis and osteoclastogenesis) after implantation, because the osseointegration 
of bioactive materials with host bone tissues is affected by a series of important 
factors, including bonding strength, inflammatory reaction, osteoclastogenesis and 
osteogenesis [278-283].   
The bonding strength between a coating material and a metal substrate is an important 
property of coated implants. Although coating materials, like HA, can well integrate 
with the surrounding bone tissue, they also prevent the bone tissue from contacting 
with the titanium surface directly. It means that the bonding strength between a coating 
material and a metal substrate represents most of the overall bonding strength between 
the implant and bone tissue before complete degradation of a coating material. Weak 
bonding strength may result in delamination of a coating material from a metal 
substrate and limits its long-term survival after implantation [284]. Therefore, it is of 
great importance to develop new coating materials which can maintain the promising 
biological behaviours as HA does while enhancing the bonding strength between a 
coating material and a metal substrate. Previous studies have shown that silicate-based 
bioceramic coatings generally have higher bonding strength than HA coatings [271, 
285, 286], indicating the potential of silicate bioceramics to maintain longer life span 
of orthopaedic implants.  
For the successful osseointegration, the implant is supposed to integrate with bone 
tissue directly without any intervening connective tissue. Inflammatory response is a 
key factor in determining the formation of fibrous capsule. Excessive inflammation 
can lead to the formation of fibrous capsule and also separate bone cells from 
contacting and integrating with the implants, resulting in the failure of implants [287]. 
As foreign bodies, implants tend to cause foreign body reaction, which is known to 
enhance the formation of fibrous capsule. From this point of view, developing 
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orthopaedic coatings with the capability of inhibiting inflammatory reaction could be a 
potential strategy. Macrophages are known to be one of the most important cells in the 
immune response to orthopaedic coatings [288], thereby they can be used for 
investigating the interactions between bioactive coatings and immune cells [289]. In 
addition to their effects on inflammation, macrophages are also known to influence 
bone physiology and pathology [48, 88]. Macrophages are the precursors of 
osteoclasts, which participate in the bone remodelling and material degradation. 
Macrophages also contribute to osteogenesis through the expression and secretion of a 
wide range of regulatory molecules [44], such as bone morphogenetic protein 2 
(BMP2), transforming growth factor β (TGF-β) [45, 46, 240]. Despite of these 
findings, there are few studies investigating the osteoclastogenesis and osteogenesis 
induced by orthopaedic coatings with the involvement of macrophages. Therefore, it is 
interesting to evaluate the inflammatory reaction of macrophages towards the novel 
coating materials and its further effects on osteoclastogenesis and osteogenesis.  
Osteoclasts play important roles in degrading implanted biomaterials and remodelling 
new formed bone tissue during osseointegration. The successful osseointegration 
requires adequate and effective osteoclastic activities. However, high osteoclastic 
activities may lead to the formation of bone tissue with inferior quality (poor bone 
mass and density), resulting in the low loading capacity of implants. Such a 
phenomenon is not uncommon clinically, especially in patients with osteoporosis. The 
imbalance between bone resorption and formation is a key reason for high bone 
resorption in osteoporosis patients. It is thereby of great clinical significance to 
develop coating materials, which are capable of inhibiting osteoclastic activities, 
especially for patients with osteoporosis.  
Bone matrix deposition on the implants is another key step for the osseointegration. 
Materials enhancing the osteogenesis would be of great significance in improving the 
quality of new forming bone (high bone mass and density). Osteoblasts are responsible 
for the deposition of bone matrix. They can also regulate the differentiation and 
activity of osteoclasts, thereby maintaining the skeletal architecture. In addition to 
their traditional effects on inflammation, immune cells are supposed to be 
indispensable during osteogenesis of biomaterials, as indicated from the recent 
research outcomes of osteoimmunology [240]. They were found to be closely related 
with bone cells, sharing a number of cytokines, receptors, signalling molecules and 
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transcription factors [207]. It is reported that evaluation system for the in vitro 
osteogenesis capacity involving immune cells is more accurate than that only using 
osteoblastic cells [240]. Therefore, the osteogenesis of bioceramic coatings was 
evaluated by using the biomaterials/immune cells/bone cells biomimic evaluation 
system.  
For these reasons, it is interesting to coat bioactive ceramic on Ti-6Al-4V with high 
bonding strength and the ability to inhibit the inflammatory reaction and 
osteoclastogenesis while maintaining excellent or enhancing osseointergration. 
Increasing evidences have shown that bioactive elements play a key role in regulating 
the inflammatory reaction, osteogenesis and osteoclastogenesis [172, 199, 204]. 
Strontium (Sr) as a trace element in human body has been found to enhance 
osteogenesis while inhibiting osteoclastogenesis, which makes it applied widely in 
treating osteoporosis [200, 201]. In addition, Sr was found to suppress the expression 
of pro-inflammatory cytokines, such as interleukin 6 (IL6) [204, 205]. Magnesium 
(Mg) is essential for bone metabolism. The depletion of Mg can affect all stages of 
skeletal metabolism adversely, causing cessation of bone growth, decreased 
osteoblastic and osteoclastic activity, osteopenia and bone fragility [290, 291]. It was 
also reported to decrease pro-inflammatory cytokine production [172, 292]. Silicon 
(Si) is another important trace element of bone, which is reported to locate at active 
calcification sites, involving in the mineralization process of bone growth [154].  
Previous studies have shown that the released Si-containing ionic products from 
bioactive glass, bioceramics and coatings play an important role in stimulating the 
proliferation and differentiation of bone-forming cells [160-162]. It is reasonable to 
speculate that the combination of Sr, Mg and Si in the bioceramic coatings on Ti-6Al-
4V may lead to the development of novel orthopaedic implants with multidirectional 
effects including the enhancement of bonding strength, inhibition of inflammatory 
reaction and osteoclastogenesis, and stimulation of osteogenesis.  
We have previously synthesized Sr2MgSi2O7 ceramic powders [233]. In this study, the 
synthesized Sr2MgSi2O7 ceramic powders were coated onto the Ti-6Al-4V surface 
employing the plasma-spray method. Systematic evaluation of bonding strength, and 
the effect of the coating on inflammatory reaction, osteogenesis and osteoclastogenesis 
as well as the possible underlying mechanisms of these effects was carried out by 
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investigating the interactions between the prepared coatings and cells including 
macrophages, osteoclasts and BMSCs. 
MATERIALS AND METHODS 
Preparation of the SMS coating on Ti-6Al-4V 
The Sr2MgSi2O7 (SMS) powders were synthesized by a solid-state reaction process 
using SrO, MgO and SiO2 as raw materials according to our previous study [233]. To 
improve flowability of ceramic powders, a sinter-crushing method was used. Briefly, 
the synthesized SMS powders were pressed into tablets, sintered at 1300oC. Then the 
sintered tablets were crushed and sieved by 200 and 400 meshes to obtain SMS 
particles with the diameter of 40-80 μm for further coating process. The prepared SMS 
particles were characterized by scanning electron microscopy (SEM, JSM-6700, 
Japan). 
The reconstituted SMS particles were sprayed on Ti-6Al-4V (Shanghai Yantai 
metallic material Co., Ltd, China) substrate with dimensions of 10×10×2 mm. Prior to 
plasma spraying, the Ti-6Al-4V substrates were grit blasted, ultrasonically washed 
with ethanol and dried at 60oC. An atmosphere plasma sprayed system (sulzer metco, 
Switzerland) was applied to fabricate The SMS coating, and the parameters for plasma 
sprayed the SMS coating were shown as following: argon plasma gas flow rate, 40 
slpm; hydrogen plasma gas flow rate, 10 slpm; spray distance, 120 mm; argon powder 
carrier gas, 3.5 slpm; current, 650 Å; voltage, 66 V. A HA coating were fabricated by 
spraying commercial HA powders onto Ti-6Al-4V substrate according to the previous 
study [271], and used as the control.  
 Characterization, bonding strength and apatite mineralization of the SMS coating 
The surface microstructure of the prepared the SMS coating was observed by SEM 
(JSM-6700, Japan). The crystal phase composition of the prepared SMS coating was 
characterized by X-ray diffraction (XRD, D8 advance, Bruker, Germany) using Cu Kα 
radiation with scanning range of 10-80o and step size 0.02o. The average linear thermal 
expansion coefficient of the SMS-coated titanium and un-coated titanium was tested 
by using push-rod technique according to the standard testing method GB/T 16535-
2008 (Linseis L75 Platinum Series), from room temperature to 800 oC. 
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The bonding strength between the SMS coating and Ti-6Al-4V substrate was 
measured by a mechanical tester (Instron-5592, SATEC, USA) in accordance with 
American Society for Testing and Materials (ASTM) C-633 used in previous study 
[285]. In brief, 10 cylindrical Ti-6Al-4V rods (diameter: 25.4 mm) were prepared. 
Half of the rods were sprayed with the SMS coating, the other half were grit blasted. 
High-performance E-7 glue (Shanghai institute of synthetic resin, Shanghai, China) 
was used to join the two rods (one with the SMS coating and the other grit blasted), a 
compressive stress was applied to both rods end to assure an intimate contact. The 
combined rods were then place into a 100 oC oven for 3 h to solidify the glue. The 
bonding strength was measured by a mechanical tester (Instron-5592, SATEC, USA) 
at a crosshead speed of 2 mm·min-1, and the average of five measurement was 
calculated for the bonding strength of the SMS coating with Ti-6Al-4V substrate. 
To investigate the apatite-mineralization ability of the prepared SMS coating, the 
coated samples  were immersed in acellular simulated body fluids (SBF) [293] and 
kept under shaking conditions at 37 oC for 2, 4 6, 8, 10, 12 and 14 days. The ionic 
concentrations of Sr, Si, Mg, Ca and P ions released from the SMS coating were tested 
by inductively coupled plasma atomic emission spectroscopy (ICP-AES, Varian 
715ES). The formed apatite mineralization on the surface of the SMS coating was 
characterized by fourier transformed infrared spectroscopy (FTIR, Nicolet Co., USA) 
and SEM. 
 Cell culture 
Three kinds of cells, including the murine-derived macrophage cell line RAW 264.7 
cells, osteoclasts and BMSCs were used in this study. RAW 264.7 cell cultures were 
maintained in Dulbecco’s Modified Eagle Medium (DMEM, Life Technologies, 
Carlsbad, California, USA) supplemented with 5% fetal bovine serum (FBS, Thermo 
Scientific, Waltham, Massachusetts, USA), and 1% (v/v) penicillin/streptomycin (Life 
Technologies, Carlsbad, California, USA) at 37 ºC in a humidified CO2 incubator. The 
cells were passaged at approximately 80% confluence by scraping and expanded 
through two passages before used for the subsequent experiments.  
Osteoclasts were derived from RAW 264.7 cells following the protocol as previously 
described [294]. In brief, RAW 264.7 cells were seeded to the T25 flask and cultured 
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in complete medium (DMEM supplemented with 5% FBS and 1% (v/v) 
penicillin/streptomycin) at 37 ºC in a humidified CO2 incubator. After three days, the 
medium was replaced with fresh complete medium consisting of DMEM containing 
5% FBS and 1% (v/v) penicillin/streptomycin, and supplemented with 35 ng/ml of 
recombinant human RANKL (Millipore, Billerica, Massachusetts, USA). Media was 
changed every 3 days and cells were allowed to differentiate into functional 
osteoclasts over a period of 21 days.  
BMSCs were isolated and cultured based on protocols according to our previous 
studies [216, 295, 296]. Briefly, bone marrow was obtained from patients (50-60 years 
old) undergoing hip or knee replacement surgery with informed consent given by all 
donors and the procedure was approved by the Ethics Committee of Queensland 
University of Technology. Lymphoprep was added to isolate the mononuclear cells 
from the bone marrow by density gradient centrifugation (Axis-Shield PoC AS, Oslo, 
Norway). The obtained cells were seeded into the tissue culture flasks containing 
DMEM supplemented with 10% FBS and 1% penicillin/streptomycin and incubated at 
37 ºC in a humidified CO2 incubator. The culture medium was changed every 3 days 
until the primary mesenchymal cells reached 80% confluence. The unattached 
hematopoietic cells were removed through medium change. The confluent cells were 
routinely subcultured by trypsinisation. Only early passages (p3–5) of cells were used 
in this study. 
 The inflammatory response for macrophage RAW 264.7 cells cultured with the 
SMS coating 
Inflammatory gene expression of RAW264.7 cells  
RAW 264.7 cells were seeded on the coating surface at a density of 105/coating disk 
(10×10 mm2). The cells were incubated for 6 days and the medium was changed on 
day 3. On day 3 and 6, the conditioned media were collected, and centrifuged at 1500 
rpm to gain the supernatants. They were then mixed with complete medium at a ratio 
of 1:2 for the conditioned-medium experiments. Total RNA was extracted using 
TRIzol reagent (Life Technologies, Carlsbad, California, USA) on day 6 for RT-qPCR 
detection.  
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500 ng of total RNA was used for the synthesis of complementary DNA using 
DyNAmoTM cDNA Synthesis Kit (Finnzymes, Thermo Scientific, Waltham, 
Massachusetts, USA) following the manufacturer’s instructions. RT-qPCR primers 
(Supporting information Table 1), which were designed based on cDNA sequences 
from the NCBI Sequence database. SYBR Green qPCR Master Mix (Life 
Technologies, Carlsbad, California, USA) was used for detection and the target 
mRNA expressions were assayed on the ABI Prism 7500 Thermal Cycler (Applied 
Biosystems, Foster City, California, USA). Each sample was performed in triplicate. 
The mean cycle threshold (Ct) value of each target gene was normalized against Ct 
value of a house keeping gene to gain the relative expression. For the calculation of 
fold change, ΔΔCt method was applied, comparing mRNA expressions between the 
SMS coating group and the HA coating group. 
Flow cytometry  
To explore the phenotype switch of macrophage, expression of M1 and M2 
macrophage cell surface marker CCR7 and CD163, respectively, were determined by 
flow cytometry. RAW 264.7 cells were seeded in the T25 flask and cultured in 
complete medium. After 1 day of culture, the medium was replaced by the 
macrophage-conditioned medium obtained as previously described. After another 2 
days, the cells were detached by scraping. Nonspecific protein binding was blocked by 
1% BSA/PBS. Samples were incubated with CCR7 (1:25) (GeneTex, Irvine, 
California, USA) and CD163 antibody (1:100) (AbD Serotec, Raleigh, North Carolina, 
USA) for 30 minutes at 4ºC, followed by incubation with Dylight 488-anti-mouse and 
DyLight 405- anti-goat secondary antibody (DAKO, Multilink, California, USA) for 
30 minutes at 4 ºC. After washing with 1% BSA/PBS, cells were analysed on a FC500 
flow cytometer (Beckman Coulter, Brea, California, USA). The data were analysed 
using Flowing Software (www.flowingsoftware.com).  
Mechanism of the inflammatory gene expression change  
To understand the mechanism of two involved inflammation signalling pathways, 
Wnt5A/Ca2+ (Wnt5A, Fz5, calmodulin-dependent protein kinase II (CaMKII), nuclear 
factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (IκB-α)), 
and TLR pathways (MyD88, Ticam1/2, IκB-α) were evaluated by RT-qPCR and 
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Western blot. RAW 264.7 cells were seeded on the coating surface at a density of 
105/coating disk. Total RNA was extracted using TRIzol reagent (Life Technologies, 
Carlsbad, California, USA) for RT-qPCR detection as described previously.  
The whole cell lysates were collected after 7 and 24 hours of culture for the Western 
Blot detection of CaMKII and IκB-α. 10 μg proteins from each sample were separated 
on SDS-PAGE gels and then transferred onto a nitrocellulose membrane (Pall 
Corporation, East Hills, New York, USA). After being blocked in Odyssey blocking 
buffer for 1 hour (LI-COR Biosciences, Lincoln, Nebraska, USA), the membranes 
were incubated with primary antibodies against IκB-α (1:1000, rabbit anti-
human/mouse; Cell Signaling Technology, Danvers, Massachusetts, USA), CamKII 
(pan, 1:1000, rabbit anti-human/mouse; Cell Signaling Technology, Danvers, 
Massachusetts, USA), and α-tubulin (1:5000, rabbit anti-human; Abcam, Cambridge, 
United Kingdom) overnight at 4 °C. The membranes were washed three times in TBS-
Tween buffer, and then incubated with anti-rabbit IRDye 800 conjugated secondary 
antibodies at 1: 4000 dilutions for 1 hour at room temperature. The protein bands were 
visualized using the Odyssey infrared imaging system (LI-COR Biosciences, Lincoln, 
Nebraska, USA). The relative intensity of protein bands was quantified using Image J 
software (National Institutes of Health, Bethesda, Maryland, USA). 
Supporting information Table 1 RT-qPCR primers used in this study 
Genes Primer sequences 
IL10 Forward: 5’-GAGAAGCATGGCCCAGAAATC-3’ 
Reverse: 5’-GAGAAATCGATGACAGCGCC-3’ 
IL1ra Forward: 5’-CTCCAGCTGGAGGAAGTTAAC-3’ 
Reverse: 5’-CTGACTCAAAGCTGGTGGTG-3’ 
TNFα Forward: 5’-CTGAACTTCGGGGTGATCGG-3’ 
Reverse: 5’-GGCTTGTCACTCGAATTTTGAGA-3’ 
IL1β Forward: 5’-TGGAGAGTGTGGATCCCAAG -3’ 
Reverse: 5’-GGTGCTGATGTACCAGTTGG -3’ 
IL6 Forward: 5’-ATAGTCCTTCCTACCCCAATTTCC-3’ 
Reverse: 5’-GATGAATTGGATGGTCTTGGTCC-3’ 
OSM Forward: 5’-ACGGTCCACTACAACACCAG-3’ 
Reverse: 5’-CCATCGTCCCATTCCCTGAAG-3’ 
WNT5A Forward: 5’-CAACTGGCAGGACTTTCTCAA-3’ 
Reverse: 5’-CCTGATACAAGTGGCAGAGTTTC-3’ 
Fz5 Forward: 5’-AAGTCCATTACGGCGCTG-3’ 
Reverse: 5’-AGCCTCGTAGTGAGTTCAGG-3’ 
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Myd88 Forward: 5’-AGGTAAGCAGCAGAACCAGG-3’ 
Reverse: 5’-TGTCCTAGGGGGTCATCAAGG-3’ 
Ticam1 Forward: 5’-AGATGGTTCAGCTGGGTGTC-3’ 
Reverse: 5’-TGGAGTCTCAAGAAGGGGTTC-3’ 
Ticam2 Forward: 5’-CTTGGCGCTGCAAACCATC-3’ 
Reverse: 5’-GCCTCTCAAATACAGACTCCCG-3’ 
MCSF 
(mouse) 
Forward: 5’-AGCAGAACAAGGCCT GTGTC-3’ 
Reverse: 5’-AAGCTGTTGTTGCAGTTCTTGG-3’ 
TRAP Forward: 5’-CACTCCCACCCTGAGATTTGT-3’ 
Reverse: 5’-CATCGTCTGCACGGTTCTG-3’ 
CTSK Forward: 5’-CCAGTTTTACAGCAGAGGTGTG-3’ 
Reverse:  5’-CTTGCTTCCCTTCTGGGTG-3’ 
CA2 Forward: 5’-AGCAGCGAGCAGATGTCTC-3’ 
Reverse: 5’-TGAGCTGGACGCCAGTTG-3’ 
RANK Forward: 5’-GCAGCTCAACAAGGATACGG-3’ 
Reverse: 5’-GGTGCAGTTGGTCCAAGGTT-3’ 
CT Forward 5’-CTTAGCTGCCAGAGGGTGAC-3’ 
Reverse 5’-TGCAACTTATAGGATCCCGCC-3’ 
MMP9 Forward: 5’-GGGCGTGTCTGGAGATTCG-3’ 
Reverse: 5’-CACCTGGTTCACCTCATGGTC-3’ 
GAPDH 
(mouse) 
Forward: 5’-TGACCACAGTCCATGCCATC-3’ 
Reverse: 5’-GACGGACACATTGGGGGTAG-3’ 
OPG Forward  5’-CGCTCGTGTTTCTGGACATCT-3’ 
Reverse 5’-CACACGGTCTTCCACTTTGC-3’ 
RANKL Forward: 5’-AGAGCAGAGAAAGCGATGGTG-3’ 
Reverse: 5’-GAACCAGATGGGATGTCGGT-3’ 
MCSF 
(human) 
Forward: 5’-AGCATGACAAGGCCTGCGTC-3’ 
Reverse: 5’-AAGCTGTTGTTGCAGTTCTTGC-3’ 
ALP Forward: 5’-TCAGAAGCTAACACCAACG-3’ 
Reverse: 5’-TTGTACGTCTTGGAGAGGGC-3’ 
OPN Forward: 5’-TCACCTGTGCCATACCAGTTAA-3’ 
Reverse: 5’-TGAGATGGGTCAGGGTTTAGC-3’ 
OCN Forward: 5’-GCAAAGGTGCAGCCTTTGTG-3’ 
Reverse: 5’-GGCTCCCAGCCATTGATACAG-3’ 
COL1A1 Forward: 5’-AGAACAGCGTGGCCT-3’ 
Reverse: 5’-TCCGGTGTGACTCGT-3’ 
IBSP Forward: 5’-TTTCTGCTACAACACTGGGCTATG-3’ 
Reverse: 5’-TTGTTATATCCCCAGCCTTCTTG-3’ 
GAPDH 
(human) 
Forward: 5’-TCAGCAATGCCTCCTGCAC-3’ 
Reverse: 5’-TCTGGGTGGCAGTGATGGC-3’ 
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The osteoclateogenesis and osteoclastic activities 
RAW 264.7 cells and osteoclasts were seeded on the coating surface at a density of 
105/coating disk. On day 6, total RNA was extracted using TRIzol reagent for 
detection of osteoclastic activities related gene expression [TRAP, Cathepsin K 
(CTSK), Carbonic Anhydrase II (CA 2), receptor activator of NF-kB (RANK) and 
Calcitonin Receptor (CT), Matrix metalloproteinase-9 (MMP9)] as described 
previously. On day 3 and 6, the conditioned media were collected, and centrifuged at 
1500 rpm to gain the supernatants for the further ions concentration detection. 
Given that osteoblastic cells are the important source of osteoclastogenesis regulating 
cytokines, we further used the macrophage-conditioned media to stimulate the BMSCs 
to detect the gene expression changes of osteoclastogenesis regulating cytokines. 
BMSCs were seeded in the 6 well plates and cultured in complete medium. After 1 
day of culture, the medium was replaced by the macrophage-conditioned medium 
obtained previously. After 3 and 6 days, total RNA was extracted using TRIzol 
reagent (Life Technologies). RT-qPCR detection was carried out to determine the 
osteoclastogenesis regulating cytokines (MCSF, RANKL, and OPG) gene expression 
changes as described previously. 
The osteogenesis for BMSCs cultured with the SMS coating with involvement of 
immune cells 
Alkaline phosphatise activity of BMSCs 
To detect the ALP activity of BMSCs, BMSCs were cultured in 24-well culture plates 
with a seeding density of 35,000 cells per well. ALP activity was assessed at 7 days 
culture in macrophages conditioned-coating media. The cells were lysed in 100 μL of 
0.2% Triton X-100 and then centrifuged at 14 000 rpm for 15 min at 4°C. 50 μL 
supernatants were mixed with 150 μL working solution and determined using the 
QuantiChromTM Alkaline Phosphatase Assay Kit (BioAssay Systems, Hayward, 
California, USA). The total protein content was measured by the BCA Protein Assay 
Kit (Thermo Scientific, Waltham, Massachusetts, USA). The relative ALP activity 
was then obtained as the changed optical density (OD) values divided by the total 
protein content [297]. 
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Bone-related gene expression of BMSCs 
BMSCs were plated at a density of 1.5 × 105 cells per well in separate 6-well plates. 
After 24 hours of incubation, the culture medium was removed and replaced by 
macrophages conditioned media. Cell morphology was observed under a Nikon's 
inverted microscope (Eclipse Ti, Nikon, Tokyo, Japan) and figures were taken. Total 
RNA was extracted using TRIzol reagent after 3 and 7 days of culture for the RT-
qPCR detection as described previously.  
The mineralization of BMSCs 
In order to identify mineralization nodules, Alizarin Red S staining was measured on 
day 14 after BMSCs grown in macrophages conditioned media in a 96-well plate with 
osteogenic supplements. The medium was removed and the cells were washed with 
ddH2O and fixed in 4% paraformaldehyde for 10 min at room temperature. After 
gently rinsing with ddH2O, the cells were stained in a solution of 2% Alizarin Red S at 
pH 4.1 for 20 min and were then washed with ddH2O. The samples were air-dried and 
figures were taken under a light microscope. 
 Ionic concentrations 
SMS and HA coated Ti-6Al-4V were immersed in the complete medium. After 3 and 6 
days, the conditioned media were collected, and centrifuged at 1500 rpm to gain the 
supernatants, which were then mixed with 0.5% HNO3 at a ratio of 1:2 for the further 
ions concentration detection. Macrophages and osteoclasts conditioned supernatants 
obtained from previous section were also mixed with 0.5% HNO3 at a ratio of 1:2 for 
the further ions concentration detection. The ionic concentrations of Sr, Si, Mg, and 
Ca ions in complete culture medium, macrophages and osteoclasts conditioned media 
were quantified by inductive coupled plasma atomic emission spectrometry (ICP-AES, 
PerkinElmer, Waltham, Massachusetts, USA). 
Statistical analysis 
All the analyses were performed using SPSS software (IBM SPSS, Armonk, New 
York, USA). Data is shown as means ± standard deviation (SD) and analysed using 
one-way ANOVA followed by LSD post-hoc test. The level of significance was set at 
P<0.05. 
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RESULTS 
Characterization, bonding strength and apatite mineralization of the SMS coating  
The morphology of reconstituted SMS particles prepared by sinter-crushing method 
was demonstrated in Figure 1 A using SEM. The size of the SMS particles was about 
40-80 μm with an irregular shape. After plasma sprayed, the particles were integrated 
into a coating surface (Figure 1 B, C). The coating had a rough surface built by 
random staking of fully and partially melted SMS particles (Figure 1 B). A higher 
magnification image showed that part of the fully melted coating surface was 
relatively smooth (Figure 1 C). XRD analysis confirmed that the main crystal phase of 
prepared the SMS coating on Ti-6Al-4V was Sr2MgSi2O7 (JCPD 15-0016) (Figure 1 
D). The average linear thermal expansion coefficient of the SMS-coated titanium and 
un-coated titanium in the temperature range of 20-800 oC was 9.39×10-6 and 9.65×10-6 
oC -1, respectively. The mean bonding strength of the SMS coating with Ti-6Al-4V 
substrate was 37.1±3.3 MPa. 
 
Figure 1 SEM for the prepared Sr2MgSi2O7 particles (A) and coatings (B, C). 
XRD analysis for the prepared Sr2MgSi2O7 coatings on Ti alloys (D), in which S 
stands for the characteristic peaks of crystal phase Sr2MgSi2O7 in the XRD 
pattern.  
(A) (B) 
(C) 
(D) 
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After soaked in SBF, there were newly formed apatite clusters on the surface of SMS 
coating (Figure 2 A). Higher magnification SEM images showed that the formed 
clusters were composed of lath-like apatite microcrystals with the diameter of 100 nm 
(Figure 2 B). There were newly formed P-O characteristic peaks at the wavenumber 
of 1080, 603 and 562 cm-1 in FTIR pattern after soaked SMS in SBF (Figure 2 C). Sr 
concentrations in SBF solution increased distinctively at the first 2 days of soaking 
and then decreased with the increase of soaking time. Mg and Si concentrations 
slightly increased at first 2 days, and then maintained a stable release. The Ca and P 
concentrations tended to decrease with the increase of soaking time (Figure 2 D). 
 
Figure 2 SEM (A, B) and FTIR (C) analysis for the prepared Sr2MgSi2O7 
coatings on Ti alloys after soaked in SBF for 14 days. ICP-AES analysis for the 
change of ionic concentrations in SBF soaked with Sr2MgSi2O7 coatings (D). 
 
(A) (B) 
(D) 
(C) 
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The inflammatory response for macrophage RAW 264.7 cells cultured with the SMS 
coating 
Flow cytometry results showed the mean fluorescence intensity of CD163 increased 
after the material stimulation (Figure 3 A a,b). On the contrary, the mean fluorescence 
intensity of CCR7 showed no significant changes under the same treatment (Figure 
3A c,d). Anti-inflammatory genes IL-1ra expression was significantly upregulated by 
the stimulation of the SMS coating in comparison with that on the HA coating 
(P<0.05) (Figure 3 B). On the contrary, inflammatory genes IL-1β, IL-6 and 
Oncostatin M (OSM) expression were significantly downregulated with the same 
treatment (P<0.05) (Figure 3 B).  
To explore the mechanism of inflammation related gene expression changes, we 
examined two inflammation signalling pathways (Wnt5A/Ca2+, TLR). Both Wnt5A 
and Fz5 gene expression were significantly downregulated (Figure 4 A) in 
comparison with the HA coating group. The downstream molecules CamKII also 
showed significant decrease in protein expression (Figure 4 C).  As to the Toll like 
receptor pathway, MyD88, Ticam 1 and 2 gene expression were all significantly 
downregulated (Figure 4 B, P<0.05), while the downstream molecules IκB-α were 
enhanced in protein expression (Figure 4 C, P<0.05). 
The osteoclastogenesis and osteoclastic activities 
Most of the osteoclastic activities related genes (TRAP, CTSK, RANK, CT, and 
MMP9) by macrophages were significantly downregulated by the stimulation of the 
SMS coating compared with that of the HA coating (Figure 5). Similar results were 
observed in the stimulated osteoclasts, with the inhibitions of TRAP, CTSK, CA2, 
RANK, and MMP9 genes expression (Figure 6). 
The expression of RANKL, an osteoclastogenesis enhancing gene, by BMSCs under 
the stimulation by conditioned medium from macrophages on the SMS coating was 
significantly downregulated on both day 3 and day 7 (Figure 7, P<0.05). MCSF, 
another osteoclastogenesis enhancing gene, was also significantly downregulated on 
day 7 (Figure 7, P<0.05). Osteoclastogenesis inhibiting gene OPG showed a different 
pattern. It showed no significant change on day 3, but was significantly upregulated on 
day 7 (Figure 7, P<0.05).  
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Figure 3 (A). FACS results of RAW 264.7 cells cultured in different coatings. The 
mean fluorescence intensity of CD163 increased after the stimulation of SMS (a, 
b); however, the mean fluorescence intensity of CCR7 had only slight increase 
under the same treatment (c, d). (B). Fold changes of inflammation related genes 
IL10, IL1ra, TNFα, IL1β, IL6 and OSM, by comparing RAW 264.7 cells cultured 
in SMS coating with HA (HA group has been standardized as 1, see red bar). *: 
Significant difference (P<0.05). 
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Figure 4 (A) Fold changes of WNT5A/Ca2+ pathway related genes: WNT5A and 
Fz5; (B) Fold changes of Toll-like pathway related genes: MyD88, Ticam1 and 
Ticam2; (C). Western blotting analysis of CaMKII and IκB-α expression. *: 
Significant difference by comparing RAW 264.7 cells cultured in SMS coating 
with HA (P<0.05). (HA group has been standardized as 1, see red bar in Figure A 
and B). 
 
Figure 5 Fold changes of osteoclastogenesis and osteoclast activities related genes: 
MCSF, TRAP, CTSK, CA2, RANK, CT and MMP9. *: Significant difference by 
comparing RAW 264.7 cells cultured in SMS coating with HA (P<0.05). (HA 
group has been standardized as 1, see red bar). 
 158                                                                                                                              Chapter 6: Research Paper Five 
 
 
Figure 6 Fold changes of osteoclast activities related genes: TRAP, CTSK, CA2, 
RANK, CT and MMP9. *: Significant difference by comparing RAW 264.7 cells 
derived osteoclasts cultured in SMS coating with HA (P<0.05). (HA group has 
been standardized as 1, see red bar). 
 
 
Figure 7 Fold changes of osteoclastogenesis related genes: OPG, RANKL, and 
MCSF. (A). Day 3, (B). Day 7. *: Significant difference by comparing BMSCs 
cultured in SMS coating stimulated RAW 264.7 cells conditioned medium with 
HA coating stimulated RAW 264.7 cells conditioned medium (P<0.05). (HA 
group has been standardized as 1, see red bar). 
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Figure 8 Osteogenic differentiation of BMSCs cultured in SMS and HA coatings 
stimulated RAW 264.7 cells conditioned medium. (A). morphologies of BMSCs in 
day 3 and 7; (B). ALP activities; (C&D). osteogenesis related gene expression 
(ALP, OPN, OCN, COL1, IBSP) by BMSCs in day 3 and 7; (E). alizarin red 
results. *: Significant difference by comparing BMSCs cultured in the SMS 
coating stimulated RAW 264.7 cells conditioned medium with the HA coating 
stimulated RAW 264.7 cells conditioned medium (P<0.05). (HA group has been 
standardized as 1, see red bar). 
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Table 1 ICP detection results. The element ionic concentrations (mg/L) of medium for 
SMS and HA coatings at different culture conditions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The osteogenesis for BMSCs cultured with the SMS coating with involvement of 
immune cells 
The osteogenic differentiation of BMSCs stimulated by the macrophage-conditioned 
medium with SMS and HA coatings is shown in Figure 8. Morphology of BMSCs was 
similar in both SMS and HA coatings groups (Figure 8 A). The ALP activity of 
BMSCs with SMS-stimulated RAW cell medium is slightly lower than that of HA 
group (Figure 8 B). Bone-related genes expression (ALP, OPN, OCN, COL1 and 
IBSP) has almost no significant difference between SMS and HA coatings groups 
(Figure 8 C) on both day 3 and 7, (Figure 8 D). Alizarin red staining shows that both 
SMS and HA coatings groups could lead to the formation of mineralisation nodules 
(Figure 8 E).  
 Culture medium immersed 
 HA SMS 
 0-3 d 3-6 d 0-3 d 3-6 d 
Ca 20.19±0.31 17.75±0.53 0.46±0.01 16.69±1.25 
P 5.31±0.08 5.15±3.08 1.78±0.16 7.11±0.22 
Si 0.42±0.02 0.22±0.02 24.51±0.85 19.03±0.21 
Sr 0.26±0.05 0.33±0.11 2.97±0.02 102.06±0.13 
Mg 1.51±0.03 2.70±0.09 75.97±1.95 21.66±0.34 
 Macrophage conditioned 
 HA SMS 
 0-3 d 3-6 d 0-3 d 3-6 d 
Ca 29.89±0.21 25.11±0.49 0.32±0.01 18.07±0.02 
P 4.54±0.26 5.08±0.12 1.51±0.11 7.72±0.09 
Si 0.43±0.04 0.18±0.01 29.46±0.11 20.02±0.35 
Sr 0.17±0.14 0.25±0.03 7.49±0.13 134.23±1.38 
Mg 2.38±0.08 3.53±0.08 73.25±2.16 22.06±0.28 
 Osteoclast conditioned 
 HA SMS 
 0-3 d 3-6 d 0-3 d 3-6 d 
Ca 26.81±0.46 24.93±0.23 0.20±0.02  17.01±0.36 
P 4.54±0.18 5.08±0.12 1.40±0.09 6.85±0.16 
Si 0.41±0.02 0.15±0.02 24.88±0.17 19.20±0.49 
Sr 0.16±0.02 0.21±0.10 5.88±0.19 151.02±3.26 
Mg 1.90±0.08 3.28±0.05 74.12±0.08 22.66±0.41 
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DISCUSSION 
In this study, we successfully prepared a Sr, Mg and Si-containing SMS coating on Ti-
6Al-4V by plasma-spray method. For orthopaedic applications, coating materials on 
titanium alloy should be relatively stable to maintain long-term life span. Although 
bioactive glass coatings possess beneficial bioactivity, their dissolution rate is 
generally higher than that of crystallized bioceramic coatings. Therefore, we tried to 
integrate bioactive elements Sr, Mg and Si to generate a novel crystallized bioceramic 
coating that can induce favourable biological effects, together with higher crystallinity 
for higher chemical stability. Sr2MgSi2O7 is one of the typical crystal phases in the 
ceramic systems containing Sr, Mg and Si. Our previous study has shown that pure 
phase Sr2MgSi2O7 ceramic can be easily prepared. No phase change was observed 
even after high temperature treatment. In addition, the Sr2MgSi2O7 bioceramic exhibits 
positive effects on the osteogenic differentiation of BMSCs [233]. Concerning these 
satisfying physio- chemical and biological properties, we further applied this kind of 
ceramic as a coating material for orthopaedic implant modifications. 
The stability of bioceramic coatings and their bonding strength with Ti alloy is of great 
importance to maintain their long-term survival. After implanted in vivo, coating 
materials experience degradation either by physicochemical dissolution, cell-
medicated dissolution, hydrolysis, enzymatic decomposition, or corrosion [148]. The 
released ions or degraded particles from the coating alter the local microenvironment, 
which determines the response and behaviour of host cells. Therefore, it is vital to coat 
metal substrates with bioactive materials, which can create an environment favourable 
for the new bone formation, like SMS did in this study. To maintain the long-term life 
span of the implants, bioceramic coatings should release some bioactive ions to assist 
osseointegration with host bone tissue and at the same time the prepared coatings 
should have relatively high stability (or slow degradation). In this study, the SMS 
coating showed higher osteoclastogenesis-inhibiting capacity than did the HA coating, 
indicating that the SMS coating may have higher biological stability than the HA 
coating. In addition to the degradation, bonding strength of bioceramic coatings with 
metal substrates is another important factor to maintain the long-term life span of the 
implants, because high bonding strength provides a stable coating interface without 
delamination from titanium to support functional loading before the coating materials 
are completely replaced by new bone tissue. 
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The bonding strength of HA coatings is generally in the range of 15-25 MPa [298]. 
Although the HA coated implants have achieved certain clinical success, the bonding 
strength of HA coatings on titanic alloy is still not strong enough and may lead to the 
delamination phenomenon in clinical applications. It is of great clinical significance to 
develop coated implants with high bonding strength as SMS revealed (37 MPa) in this 
study. Higher bonding strength of the SMS coating makes it more potential for clinical 
translation, since they may have longer life span with functional loading.  
Thermal expansion coefficient of ceramics is one of the main factors in determining 
the bonding strength between the coating and the metallic substrate. Previous studies 
have shown that silicate-based bioceramics possess similar thermal expansion 
coefficient with Ti-6Al-4V, therefore favouring a higher bonding strength and 
reducing the residual stress due to the mismatch of thermal expansion coefficients 
[271, 285, 286]. In this study, it is found that the SMS-coated titanium and uncoated 
titanium have similar linear thermal expansion coefficient. In addition, there are no 
obvious microcracks on the surface of the SMS coating, indicating that the SMS 
coating has strong bonding with titanium substrate. 
In addition to the high bonding strength, the SMS coating could also switch 
macrophage phenotype into M2 extreme, leading to the inhibition of inflammatory 
reaction compared with the HA coating. These effects may be related to the 
downregulation of WNT5A/Ca2+ and TLR pathways. Wnt5A/Ca2+ signalling pathway 
is known to enhance the inflammation [149]. Wnt5A can bind to Fz5, activating the 
Wnt/Ca2+ signalling pathway via CaMKII and protein kinase C, which culminates the 
expression of downstream inflammatory cytokine genes via the transcription factor 
NFκB [149]. After soaked SMS coated implants, the culture medium showed a 
significant decrease of Ca2+ concentration. It is a logical extension to speculate that the 
decrease of Ca2+ concentrations may lead to the inhibition of Wnt/Ca2+ signalling 
pathway, resulting in the anti-inflammatory effects.  
Macrophages recognize the foreign bodies via TLR pathway, inducing innate immune 
response trying to degrade or reject the implants [8]. MyD88 is one of the key 
components in this pathway. Most of the activated TLRs interact with MyD88, which 
then activate downstream cascade [173]. However, TLR3 can only conduct through 0. 
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toll-like receptor adaptor molecule (Ticam), also known as TIR domain containing 
adapter inducing IFN β (TRIF), while TLR4 can signal through both pathways [174]. 
Although producing signal through different adapter proteins, both MyD88-dependent 
and Ticam-dependent pathways eventually activate the NF-κB, resulting in the 
expression of inflammatory cytokines [175]. In the present study, MyD88, Ticam1 and 
Ticam2 gene expressions were all downregulated, while the NFκB inhibitor IκB was 
upregulated. It means that the SMS coating might also lead to the inhibition of 
inflammatory response via TLR pathway. After the immersion of SMS coated 
implants, the culture medium showed a significant increase of Mg2+ concentration. Mg 
was known to suppress inflammatory cytokine production through inhibition of TLR 
pathway [172]. Therefore, the inhibition of this pathway might be related to the release 
of Mg2+ from the SMS coating. Sr2+ is also found to decrease inflammatory cytokine 
production, which was also increased in the culture medium after soaked SMS coated 
implants [204, 205]. However, the underlying mechanism is still unknown. 
Nevertheless, the inhibition of inflammatory response indicates that the SMS coating 
is more compatible than the HA coating, which may prevent the formation of fibrous 
capsule.  
The osteoclastogenesis and osteoclastic activities were both inhibited by the SMS 
coating. The interactions between the SMS coating and osteoclastic cells [pre-
osteoclasts (macrophages) and osteoclasts] were firstly investigated. Our results 
showed that the SMS coating significantly downregulated osteoclast activity-related 
genes of both pre-osteoclasts (macrophages) and osteoclasts, including TRAP, CTSK, 
RANK, and MMP9. Osteoblastic cells are known to regulate the osteoclastogenesis 
via the release of RANKL, MCSF and OPG. MCSF binds to its receptor, c-fms, on 
osteoclast precursors and activates signalling through Akt and MAP kinases pathway 
[23]. RANKL binds to RANK, receptor on the surface of osteoclast precursors, 
activating signalling through NF-κB, activator protein 1 (AP-1) and nuclear factor of 
activated T cells 2 to induce expression of genes for the survive and differentiation of 
osteoclasts [24]. OPG, a decoy receptor derived from osteoblasts, can bind to RANKL 
and interrupt its interaction with RANK receptor, thereby inhibit the 
osteoclastogenesis [32, 33]. Therefore, we further investigated the expression of 
RANKL, MCSF and OPG genes in BMSCs cultured in the conditioned media. It was 
found that the SMS coating could decrease the expression of RANKL and MCSF 
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genes, and increase OPG expression of BMSCs. All these results suggest that the SMS 
coating downregulates the osteoclastogenesis and osteoclastic activities, as compared 
to the HA coating.  
It is found that Sr2+ and Sr-containing biomaterials have inhibitory effect on the 
osteoclastic differentiation and resorptive activity [299, 300]. The underlying 
mechanism might be related to the suppression of IL6 family of cytokines [205]. IL-6 
and OSM are IL6-type cytokines that stimulate osteoclast formation and function, 
which were both downregulated in this study. IL6 is believed to play a positive 
regulatory role in osteoclast differentiation by inducing the expression of RANKL on 
the surface of osteoblasts, activating the RANK signalling pathway on osteoclast 
progenitors [27]. The inhibition of IL6 receptor can directly block the osteoclast 
formation [28]. OSM uses the same receptor subunit, gp130, for signaling, and often 
have similar and overlapping functions with IL6 [29]. OSM can help to enhance the 
osteoclastogenesis in a dose dependent manner, which might be related to its 
synergistic effects with IL6 [30]. 
In this study, the concentrations of the released Sr2+ in the macrophage-conditioned 
medium reach 134 ppm for the SMS coating, which are significantly higher than those 
for the HA coating (only 0.25 ppm) (as shown in Table 1). Therefore, it is reasonable 
to speculate that the possible mechanism for the suppressed osteoclastogenesis by the 
SMS coating is mostly relative to the released Sr2+ ions from coatings. The inhibition 
of osteoclastogenesis may help to obtain properly balanced osteoclastogenesis and 
osteogenesis, extending the applications of SMS coated Ti-6Al-4V to the patients with 
harsh bone qualities (low bone mass and density), especially those with osteoporosis.  
Previous studies have found that ionic products (Si, Mg, Sr) from SMS powders could 
enhance the osteogenesis of BMSCs [233]. It is known that the ion release from 
crystalline materials is mainly due to the dissolution of materials in the aqueous 
environment. The dissolution rate of the crystalline materials mainly depends on the 
chemical compositions and crystal structures. In this study, we found that although the 
dissolution of the SMS coating was slow, it did release Sr, Mg and Si ions, which 
induces favourable biological effects. Given to the importance of immune cells during 
the material stimulated osteogenesis, we further investigated the osteogenic capacity 
of the SMS coating with the involvement of immune cells (macrophages). It was 
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found that the osteogenic differentiation of BMSCs on the SMS coating was 
comparable to that on the HA coating even with the involvement of macrophages, 
indicating that the SMS coating has comparable in vitro osteogenic capacity as the HA 
coating does. Previous studies for evaluation of the in vitro osteogenesis mainly 
focused on the interaction of osteoblastic cells with bioactive coatings [301, 302]. 
Current study extends the method by involving the macrophages to investigate the 
osteogenesis of BMSCs cultured with the SMS coating, which makes the evaluation 
for the in vitro osteogenic capacity of the SMS coating more sufficient and accurate.  
After implanted, coating materials will be completely degraded eventually and 
replaced by new bone tissue. The degradation time differs from compositions and 
structures of materials. It means that coating materials will exist temporarily during 
the integration of titanium substrate with host bone tissue. Titanium materials are not 
effective enough to guide the regeneration of surrounding tissue. Coating with 
bioactive materials can well solve this issue, endowing titanium with bioactivities. The 
major function of coating materials is to regulate an osteogenic environment for better 
integration of the titanium substrate with host bone tissue. One shortcoming of this 
strategy is creating one more interface temporarily between titanium substrate and 
coating materials. The bonding strength should be strong enough for keeping the 
implants steady before the replacement of coating materials with new bone tissue, 
which makes the bonding strength between coating materials and metallic substrates a 
very important property of coating materials. HA has good bioactivities; however, the 
interface between HA and titanium substrate is not strong enough in bonding strength 
limiting its application, while this new SMS coating seems to overcome this problem 
with significantly higher bonding strength. 
CONCLUSIONS 
In this study, a bioactive elements Sr, Mg and Si-containing SMS coating on Ti-6Al-
4V has been successfully prepared by plasma-spray method. The prepared SMS 
coating has significantly higher bonding strength than does HA coating. The SMS 
coating inhibits the inflammatory reaction of immune cells RAW 264.7 possibly via 
inhibition of WNT5A/Ca2+ and TLR pathways. In addition, the SMS coating could 
also inhibit the osteoclastic activities and osteoclastogenesis while maintaining good 
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osteogenic capacity. These multidirectional effects suggest that the SMS-coated Ti-
6Al-4V may be a promising implant material for the orthopaedic applications. 
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In this thesis, the concept of osteoimmunology has been applied to redefine the 
biological principles used in the development and assessment of bone biomaterials. 
In Chapter 3, it is demonstrated how macrophages play a pivotal role in β-TCP-
induced osteogenesis by generating an immune environment that is favourable for 
the osteogenic differentiation of BMSCs. Subsequently, in Chapter 4, we show that 
an in vitro evaluation strategy that includes immune cells more closely mimics the in 
vivo environment and that this method of assessment provides a more accurate 
picture of the osteogenic capacity of bone substitute materials (Co-TCP). The 
concept of osteoimmunomodulation is also applied to modify potential bone 
biomaterials, altering their mechanical and/or physiochemical properties to obtain 
materials with vastly improved biological properties. In Chapter 5, we show how 
coating Mg scaffolds with β-TCP alters the otherwise detrimental osteoimmuno-
modulatory properties of Mg making them better suited for osteogenesis. Finally, in 
Chapter 6, a novel Sr-Mg-Si based bioceramics coating material, when applied to a 
titanium substrate, has a number of positive effects, such as supressing inflammation, 
inhibiting osteoclastogenesis, and enhancing osteogenesis. Therefore, such an 
approach could be used to create “smart” bone biomaterials by targeted changes of 
their osteoimmunomodulatory properties. Bone biomaterials can significantly affect 
the immune response, which in turn affects the behaviours of bone cells and, 
ultimately, the bone regeneration outcome. We have proposed this as the bone 
biomaterial’s osteoimmunomodulatory (OIM) capacity, which emphasises the 
importance of the immune response during the materials-mediated osteogenesis. In 
this chapter, the definition, possible evaluation strategies, and manipulation strategies 
of materials’ OIM were discussed, basing on our research outcomes.  
7.1 DEFINING THE OSTEOIMMUNOMODULATION PROPERTY  
Earlier studies related to material-mediated immune responses have focussed on 
whether or not the foreign body reaction elicited by the materials would lead to 
excessive inflammation and rejection or encapsulation by fibrous tissue, a concept 
known as “biocompatibility”. In contrast to biocompatibility, OIM does not simply 
describe the immune response in relation to the implants, but focuses more on the 
effects that the immune environment has on the behaviour of bone cells–the result of 
the interaction between the immune system and the biomaterials. OIM is a specific 
property that describes the ability of biomaterials to alter the local immune 
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environment, which affects the balance of osteogenesis over osteoclastogenesis, 
thereby determining the in vivo fate of bone biomaterials by either promoting new 
bone formation or fibrous encapsulation (Figure 1). To be specific, advanced bone 
biomaterials with favourable OIM are those that can induce both an adequate and 
appropriate inflammatory response by local immune cells, which also release factors 
that enhance the recruitment and osteogenic differentiation of BMSCs, resulting in 
new bone formation. These materials must further be able to induce proper 
osteoclastogenesis, which is important for bone remodelling and cell-mediating 
materials degradation, while also avoiding excessive bone resorption. Materials with 
poor OIM properties will cause excessive inflammation, an imbalance of 
osteoclastogenesis over osteogenesis and end up with the destruction of normal bone 
tissue and the formation of a fibrous capsule. Such materials would, therefore, be 
excluded from further preclinical or clinical testing.  
7.2 POSSIBLE EVALUATION STRATEGIES OF THE OSTEOIMMUNO-
MODULATION PROPERTY IN VITRO 
Evaluation of OIM will be challenging, because it involves the interaction between 
biomaterials, bone cells, and immune cells but can be achieved by applying a co-
culture system that includes all three factors. The co-culture systems are outlined 
below and would include indirect co-culture using conditioned medium, indirect co-
culture using Boyden chambers, and direct co-culture (Figure 2). 
7.2.1 Indirect co-culture using conditioned medium 
In this thesis, we applied this system to test all the related concepts. Immune cells are 
first cultured on bone biomaterials to stimulate an immune response. The conditioned 
media from these cultures will subsequently be applied to osteoblastic and 
osteoclastic cells, to determine their effects on osteogenesis and osteoclastogenesis, 
respectively. This model has the advantage of being a short and simple procedure 
[303]. Conditioned media can be frozen down so that the same batch of medium can 
be used for several replicates. Not only that, it can also be applied when immune 
cells and bone cells are from different species, thereby extending the range of 
applications (direct co-culture system requires the use of cells from the same species, 
since immune cells will react to xenogeneous cells and trigger an unwanted immune 
reaction).  
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Figure 1 Contents of the osteoimmunomodulation. Different types of immune cells 
elicit different effects in the bone dynamics. This figure used macrophages as an 
example, due to its multiple roles in bone dynamics and pivotal role in the 
degradation of bone biomaterials. Osteoimmunomodulation refers to the immune 
environment that is created by the interaction of biomaterials with immune cells and 
bone cells. Such an immune environment contains inflammatory cytokines, 
osteogenic and osteoclastogenic factors, and fibrosis enhancing factors, which 
determines the outcome of bone biomaterial’s effect on bone repair. (Abbreviations: 
CCR, C-C chemokine receptor; TNF, tumour necrosis factor; IL, interleukin; IFN, 
interferon; BMP, bone morphogenetic protein; WNT, wingless-related MMTV 
integration site; VEGF, vascular endothelial growth factor; OSM, oncostatin M; 
TGF, transforming growth factor; RANKL, receptor activator of nuclear factor 
kappa-B ligand; OPG, osteoprotegerin; M-CSF, macrophage colony stimulating 
factors; BMPR, bone morphogenetic protein receptor; SMAD, Mothers against 
decapentaplegic homologue; OSM, oncostatin M receptor; gp 130, glycoprotein 130; 
STAT, Signal transducer and activator of transcription; ALP, alkaline phosphatase; 
OPN, osteopontin; OCN, osteocalcin; COL, collagen; IBSP, integrin-binding 
sialoprotein; RUNX2, runt-related transcription factor 2; c-FMS, colony stimulating 
factor 1 receptor; AKT, protein Kinase B; MAPK, mitogen-activated protein kinases; 
NF-κB,  nuclear factor kappa-light-chain-enhancer of activated B cells; AP-1, 
activator protein 1; NFAT2, nuclear factor of activated T cells 2; MMP9, matrix 
metalloproteinase-9; CA2, carbonic Anhydrase II; CTSK, cathepsin K; TRAP, 
tartrate-resistant acid phosphatase; CT, calcitonin receptor.) 
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Figure 2 Suggested evaluation methods for the osteoimmunomodulation. All three 
factors (bone biomaterials, immune cells, and bone cells) should be involved in the 
system of evaluation. A. Immune cells first interact with biomaterial, and then the 
effects of the created immune environment (conditioned medium) on 
osteogenesis/osteoclastogenesis are tested in bone cells; B. Bone cells are indirectly 
contact with immune cells/biomaterials; the Boyden chambers allows cell migration 
or molecular penetration depends on the Boyden chambers pore size; C. Bone cells 
and immune cells are co-cultured on the biomaterials directly.  
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However, instead of playing a passive role during the interaction with immune cells, 
bone cells actively regulate the immune response. For example, parathyroid hormone 
stimulated osteoblasts can express CXCL12 and IL-7, which are known to regulate B 
cell development [304]. Osteoclasts have recently been found to have innate immune 
cell properties and participate in the systemic immune responses [305] by secreting 
TNF and other cytokines, such as IL-1, IL-6 and VEGF-C [306, 307], thereby auto-
amplifying osteoclastogenesis and enhancing inflammation. MSCs are also 
recognised as having immunomodulatory properties that protects against excessive 
inflammation [308]. Activated MSCs can induce the alternative macrophage 
phenotype M2 [309], which reduces inflammation and speeds up the healing process. 
This mechanism involves the expression of PGE2 which acts on macrophages 
through the prostaglandin E receptor 2 (EP2) and EP4 receptors [64, 310]. They can 
also express TNF-α stimulated gene/protein 6 (TSG-6) and IL-1ra to decrease the 
amplifying effects of pro-inflammatory cytokines (IL-1, IL-6, and TNF-α) [311, 
312]. Therefore, indirect co-culture using Boyden chambers or direct co-culture can 
better mimic the in vivo environment, in relation to the interaction between bone 
cells and immune cells.   
7.2.2 Indirect co-culture using Boyden chambers 
The initial phase of the biomaterials/host body reaction is typically an acute 
inflammation that results in immune cells attaching to the surface of the materials 
before bone cells, which therefore elicit a greater effect during the early stages of 
biomaterials mediated osteogenesis. For this reason, in an indirect co-culture system, 
the immune cells can be cultured in indirect contact with the materials and the bone 
cells in a Boyden chamber insert. The small pore size (such as 0.4 µm) of the insert 
keeps the bone cells within the insert but allows secreted molecules to flow freely. 
Such an approach allows for the study of the molecular communications that results 
from the interaction between bone cells and immune cells in relation to the bone 
biomaterials. Changes to bone cells and immune cells, including gene and protein 
expression, can be investigated separately, which allows for greater resolution in 
unravelling the underlying mechanisms. By using larger pore sizes (3.0 µm or larger 
depending on the cell size), the migration of bone cells can also be investigated, to 
study the effect of chemoattractant that results from stimulated immune cells.  
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7.2.3 Direct co-culture  
Direct co-cultures enable both immune and bone cells to be in direct contact with the 
materials at the same time, which would be the case in an in vivo environment. It can 
be performed by layering one cell type on top of another, although this method is 
fraught with technical difficulties of which reproducibility of results is the most 
prevalent [313]. It requires the involvement of cells sourced from one individual 
patient, especially when immune cells are involved. Primary culture of whole bone 
marrow tissue derived from surgery or biopsy may meet the requirement of 
providing various types of cells from different tissues, including skeleton and 
immune systems. Inter-patient variability and limited source of suitable donor tissues 
makes it difficult to establish this technique as the standard of in vitro evaluation. 
Another limitation is separating the effects of the different cell types. The cells could 
be sorted by fluorescence-activated cell sorting (FACS) or magnetic-activated cell 
sorting (MACS) and then evaluated by gene expression, but this is fraught with 
difficulties. Also, the proteins in the media cannot be ascribed to one particular cell 
type. Researchers can apply any or combination of the evaluation systems, depending 
on their research aims and laboratory facilities. 
7.3 POSSIBLE STRATEGIES TO ENDOW BONE BIOMATERIALS WITH 
FAVOURABLE OSTEOIMMUNOMODULATION 
It has emerged from both our own and other studies that bone biomaterials elicit 
significant effects on the immune system. The immune response determines 
subsequent osteogenesis and osseointegration and is a reflection of the importance of 
the immune system to both normal and pathological bone physiology. Immune cells, 
such as macrophages, have a high degree of plasticity, which makes it possible to 
modulate the immune response by manipulating the materials’ composition or 
structure. Potential strategies for such manipulations are:  
(1) Modifying the surface topology of materials (size and roughness) – material 
surfaces that provide biomimetic cues, such as nanoscale architectures, have been 
shown to alter cell/biomaterial interactions [110, 314];  
(2) Modifying the surface chemistry of materials (hydrophility and electric potential) 
– macrophages cultured on surfaces with different hydrophilicity results in different  
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protein expression profiles and cytokine responses [93];  
(3) Optimising pore size and porosity – a uniform 30–40 µm pore size appears to 
promote the polarisation towards the M2 phenotype [146], whereas non-porous or 
random-porous-sized materials appear to favour the M1 phenotype [315];  
(4) Incorporating nutrient elements [244, 245] – the immune response can be 
manipulated by a combination of bioactive elements (e.g. Ca, Mg, Sr, Co, Zn) in a 
controlled-release manner;  
(5) Incorporating bioactive molecules (proteins) [83, 280] such as macrophage 
inducers (e.g. IL-4, LPS) or inflammatory cytokines (e.g. IL-10, TNFα, IFNγ);  
(6) Coupling with immunomodulatory drugs [316, 317], e.g. inflammatory 
modulation drug (steroid and non-steroidal anti-inflammatory drugs).  
These strategies should all be considered when designing biomaterials, since their 
combination can have synergistic effects. Needless to say, a better understanding of 
the mechanisms underlying the immune response and their effects on 
osteoclastogenesis and osteogenesis is essential for developing advanced bone 
biomaterials with favourable OIM properties.   
As has already been mentioned, nutrient elements have a fundamental role of in 
human physiology and the ability of these factors to directly affect both skeletal 
immune systems makes them an obvious choice for inclusion when developing 
biomaterials with favourable OIM. The elements Sr, Mg, and Si were combined to 
fabricate a novel bioceramic coating material (Sr2MgSi2O7), which when coated on a 
titanium substrate (Ti-6Al-4V) endowed it with favourable OIM and reduce 
inflammation and osteoclastogenesis. These are promising initial results that 
highlight the feasibility of this strategy and also that the design and preparation of 
bone biomaterials must be done with OIM properties in mind.  
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7.4 LIMITATIONS AND FUTURE STUDY 
The key component of the OIM concept is to facilitate an immune environment that 
is conducive to osteogenesis and osseointegration, thus providing a set of design 
aims for the modification of bone biomaterials. Understanding how the biomaterials 
modulate the immune environment will serve as a guide for the development of the 
materials. Integral part of this effort is the systematic evaluation of various 
modifications, such as those outlined in this thesis, which can endow advanced bone 
biomaterials with favourable OIM.  
In this thesis, RAW246.7 cell line was used as a macrophage model with which to 
investigate the materials-mediating osteogenesis. Future studies should include 
primary macrophages and other cell types (e.g. T and B lymphocytes, neutrophils, 
mast cells) to be able to draw more general conclusions. Indirect co-culture using the 
conditioned medium method was applied to assess OIM, but this method has its 
drawbacks, as described in section 7.2. Therefore, future studies should aim to 
investigate the optimum co-culture method or a combination of such methods to best 
determine OIM.  
We have touched on a number of possible OIM manipulation strategies. For 
example, we investigated manipulating OIM by using a combination of nutrient 
elements. The scientific literature has revealed that nutrient elements can elicit 
significant effects on immune response regulation depending on the concentration 
and combination of the various elements. Therefore, future studies should focus on 
finding the optimum combination of nutrient elements to develop advanced multi-
functional bone biomaterials, one of which is OIM. 
In addition to the immune system, other physiological systems, such as the blood 
coagulation cascade, has been found to participate actively in the material-mediating 
osteogenesis [318]. The traditional biological model (materials/bone cells) which is 
currently applied to assess bone biomaterials is insufficient. The biological model 
should be kept modifying in coincidence with the development of bone biology. 
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7.5 CONTRIBUTIONS OF THIS THESIS 
The major contribution of this project is to introduce the concept of 
osteoimmunology into the field of bone biomaterials in an effort to change many of 
the assumption that existed concerning basic biological principles. Consequently, we 
have proposed ‘osteoimmunomodulation’ as a descriptive term and discuss 
application of this concept in the area of bone biomaterials. This is done to 
emphasise the important role of the immune response when developing or assessing 
novel bone biomaterials. This project has been designed with the aim of paving the 
way for more research to go into modifying the biological principles that form the 
foundation for bone biomaterials design so that it can keep pace with the new 
discoveries being made in bone biology. This will ensure that there are clear design 
paradigms when seeking to develop bone biomaterials.  
This thesis has also made a contribution to better understand the mechanisms 
underlying biomaterials-mediating osteogenensis. The commonly held view is that 
the outcome of bone regeneration is the direct effect of how the bone biomaterials 
interact with osteoblast lineage cells. As this thesis has empathically shown, 
osteogenesis can also be enhanced indirectly via the regulation of the immediate 
local immune environments.  
As for a Real World contribution, the bone biomaterials developed in the course of 
this PhD candidature have potential uses in orthopaedic applications and may, 
therefore, be fabricated and marketed as medical devices, which would benefit not 
only patients but could also have potential commercial benefits. 
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